data_2moz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2moz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 CA-C-O 121.012 0.338 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -77.68 -49.31 14.75 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.808 0.813 . . . . 0.0 112.741 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.4 p -79.59 -28.86 41.04 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.097 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 3.8 mm? -62.49 -45.21 94.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.753 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.15 -21.92 53.37 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.012 1.325 . . . . 0.0 112.525 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -66.39 -33.77 76.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.259 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.48 -31.69 54.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' THR . 81.8 p -65.07 -52.2 57.08 Favored 'General case' 0 C--O 1.201 -1.476 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.408 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.433 HD13 HG23 ' A' ' 12' ' ' ILE . 95.0 mt -54.91 -46.9 76.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.742 1.258 . . . . 0.0 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.25 -44.96 93.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.692 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.87 -28.42 28.94 Favored Glycine 0 CA--C 1.556 2.607 0 CA-C-O 122.308 0.949 . . . . 0.0 112.486 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 11' ' ' SER . 55.4 m -75.41 -27.71 59.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 113.235 -1.483 . . . . 0.0 112.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.1 p -76.51 -29.14 56.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.053 0.454 . . . . 0.0 111.46 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tp -72.03 -25.8 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.541 ' CG2' ' H ' ' A' ' 19' ' ' ALA . 35.4 m -59.61 -54.19 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.123 -1.431 . . . . 0.0 110.042 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.541 ' H ' ' CG2' ' A' ' 18' ' ' VAL . . . -58.38 -32.26 68.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.314 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.6 -44.56 74.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.991 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 74.0 m -78.57 -26.37 45.52 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.942 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -84.32 -16.59 42.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.16 -42.86 18.48 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.675 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 p -69.21 -37.52 9.03 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 24' ' ' THR . 87.1 Cg_exo -48.2 -23.33 4.6 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 123.772 2.982 . . . . 0.0 115.506 -176.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.33 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.737 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 tp -50.25 -28.34 7.51 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.41 -34.06 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.29 -41.14 88.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.57 -50.42 73.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.255 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.48 -40.92 84.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.859 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.6 -43.64 98.71 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.5 t -56.09 -50.17 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.499 ' O ' ' OG ' ' A' ' 37' ' ' SER . 65.1 t -60.02 -42.58 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 122.058 0.932 . . . . 0.0 109.401 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.8 -46.25 93.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.52 -29.45 68.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 0.0 110.784 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.5 p -59.69 -28.06 66.97 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -31.09 56.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.229 1.014 . . . . 0.0 109.526 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.5 -50.29 12.94 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.098 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -101.61 -7.97 22.25 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 52.14 39.19 49.7 Favored Glycine 0 N--CA 1.47 0.9 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.25 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.92 14.71 31.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.965 0.383 . . . . 0.0 111.332 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -56.52 -14.29 3.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.748 -176.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -60.79 -40.6 93.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.6 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 47' ' ' LEU . 69.2 m-85 -58.65 -41.51 86.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.923 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 45' ' ' TYR . 30.2 m -10.88 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' TYR . 61.8 tp -53.49 -47.98 69.34 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.367 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' TYR . 6.7 mp -62.15 -61.66 7.26 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.06 -26.07 13.97 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.508 1.472 . . . . 0.0 112.136 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.52 -30.63 66.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.468 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.01 -38.75 92.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.59 -42.85 97.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.566 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.93 -50.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.682 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.53 -40.15 86.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.787 0.721 . . . . 0.0 110.339 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.63 -42.2 92.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.892 0.853 . . . . 0.0 110.203 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.05 -44.58 66.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.445 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.9 -52.77 13.4 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.443 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 t -50.74 -39.19 51.39 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.334 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.49 -43.26 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.385 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.72 -36.77 74.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.7 72.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.075 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.91 -37.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.349 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' NE2' ' OE1' ' A' ' 67' ' ' GLN . 1.2 pp0? -67.03 -35.12 79.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.272 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 68' ' ' ALA . 57.8 ttt85 -79.09 -21.2 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.257 1.023 . . . . 0.0 111.575 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -74.84 -33.86 62.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.427 1.108 . . . . 0.0 113.381 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -81.33 -34.98 31.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.198 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 98.0 mt-30 -86.69 -12.93 46.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.469 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.67 -40.29 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.748 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.229 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo . . . . . 0 N--CA 1.501 1.967 0 N-CA-C 113.118 0.391 . . . . 0.0 113.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -77.62 -50.24 12.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.597 0.713 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.1 m -80.52 -31.6 37.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.464 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.12 -49.55 69.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.526 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.49 -23.72 50.24 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.291 1.436 . . . . 0.0 113.521 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.1 -30.56 69.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.046 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.82 -39.89 84.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -63.11 -52.49 62.38 Favored 'General case' 0 C--O 1.201 -1.478 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.863 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.0 mm -55.39 -46.61 78.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.613 1.197 . . . . 0.0 110.529 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.91 -42.65 86.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.004 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.17 -50.14 4.69 Favored Glycine 0 CA--C 1.552 2.348 0 CA-C-O 122.864 1.258 . . . . 0.0 110.7 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.715 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.2 m -57.51 -27.63 62.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.028 -2.086 . . . . 0.0 112.811 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.1 t -77.83 -30.33 51.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.024 -0.422 . . . . 0.0 111.615 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.96 -25.66 60.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.74 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.368 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.77 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.35 -46.44 70.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.715 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.2 t -77.52 -26.23 50.93 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.173 0.511 . . . . 0.0 112.023 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -73.01 -14.4 61.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.607 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.7 -40.47 25.32 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.719 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 31.0 m -66.22 -39.1 25.36 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-N 120.684 1.584 . . . . 0.0 115.039 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 24' ' ' THR . 83.8 Cg_exo -45.44 -22.73 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 123.803 3.002 . . . . 0.0 115.166 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -61.61 -45.69 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.485 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.0 tp -48.86 -27.5 3.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.84 -33.6 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.5 -33.64 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.86 -49.99 75.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.44 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.0 mp -55.71 -40.51 72.53 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.807 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -44.02 97.83 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.024 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 37' ' ' SER . 48.9 t -55.79 -50.34 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.06 -42.25 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.176 0.989 . . . . 0.0 108.996 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.29 -46.05 94.45 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.53 -31.43 68.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.378 0.609 . . . . 0.0 110.405 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.5 t -61.39 -40.34 93.97 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.368 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.71 75.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.158 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.86 -51.71 11.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.635 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -95.89 3.27 53.75 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.192 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.43 69.81 1.16 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.301 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 20.27 18.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.97 0.885 . . . . 0.0 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.4 tp -45.99 -59.3 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.404 0.621 . . . . 0.0 112.287 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.99 -40.81 95.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.993 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 47' ' ' LEU . 48.4 m-85 -58.65 -43.55 89.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.454 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' TYR . 11.7 p -11.4 -48.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.7 tp -54.81 -48.58 72.6 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.711 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.39 -57.73 23.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.99 -24.93 5.78 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.717 1.612 . . . . 0.0 112.364 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.26 70.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 7.8 mp -64.94 -40.59 95.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.776 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.01 97.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.697 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 53' ' ' ILE . 96.7 mt -62.9 -51.25 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.842 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.9 -40.76 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.516 0.598 . . . . 0.0 110.544 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.438 ' O ' ' OG1' ' A' ' 58' ' ' THR . 82.5 mt -64.28 -41.62 92.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.718 0.77 . . . . 0.0 109.635 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 -40.99 98.7 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.281 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.59 -28.96 68.92 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 54.9 p -72.34 -37.27 68.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.32 0.581 . . . . 0.0 110.132 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.59 -44.62 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.294 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -57.25 -38.35 73.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.55 -27.19 62.06 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.579 -0.701 . . . . 0.0 112.166 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.63 -43.58 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 1.5 pp0? -63.76 -36.37 83.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.241 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.789 ' O ' ' N ' ' A' ' 68' ' ' ALA . 16.4 mmm180 -62.64 -53.09 59.84 Favored 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -52.42 -25.88 11.15 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -82.98 -49.35 9.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.745 1.157 . . . . 0.0 112.417 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 23.3 mp0 -85.39 -10.28 56.47 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.456 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.789 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.03 -39.5 1.94 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.082 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 t0 . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 N--CA 1.502 2.026 0 N-CA-C 113.479 0.53 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 26.5 mtpp -75.28 -42.34 55.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.862 0.839 . . . . 0.0 110.869 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -80.51 -30.14 37.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.36 -1.746 . . . . 0.0 111.231 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.06 -51.18 57.77 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.52 -22.06 51.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.959 1.303 . . . . 0.0 112.919 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 7.1 mmt180 -68.32 -30.11 69.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.105 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.42 -33.37 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.7 t -70.71 -53.77 14.37 Favored 'General case' 0 C--O 1.202 -1.417 0 CA-C-N 119.77 1.168 . . . . 0.0 111.815 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 13' ' ' ILE . 18.7 tt -53.58 -44.45 57.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.959 1.361 . . . . 0.0 110.198 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.516 ' N ' ' CG2' ' A' ' 12' ' ' ILE . 91.1 mt -60.77 -45.34 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 111.999 -2.364 . . . . 0.0 111.933 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.0 -28.26 29.03 Favored Glycine 0 CA--C 1.553 2.466 0 CA-C-O 122.449 1.027 . . . . 0.0 112.078 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.676 ' N ' ' O ' ' A' ' 11' ' ' SER . 37.2 m -75.99 -27.24 57.37 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.849 -1.676 . . . . 0.0 112.919 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.7 t -78.15 -29.95 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.56 -25.33 60.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 8.4 p -58.32 -54.22 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 117.973 -1.491 . . . . 0.0 109.664 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.525 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.84 -31.56 66.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.274 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.92 -44.3 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.92 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 84.0 p -75.26 -15.84 60.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -77.38 -18.06 57.66 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.963 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.87 -41.57 18.82 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.925 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.546 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 36.1 m -67.74 -38.55 15.15 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 120.679 1.581 . . . . 0.0 114.563 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 24' ' ' THR . 91.9 Cg_exo -46.23 -23.42 1.96 Allowed 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.689 2.926 . . . . 0.0 115.16 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.6 p -59.56 -43.07 90.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 119.302 0.955 . . . . 0.0 110.223 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 57.5 tp -49.03 -26.59 2.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.17 -29.43 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.916 0.389 . . . . 0.0 111.957 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -59.56 -35.99 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.262 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.14 -51.21 70.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.48 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' CD1' ' H ' ' A' ' 31' ' ' LEU . 10.1 mp -55.62 -40.89 72.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.8 0.81 . . . . 0.0 109.699 -178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -44.45 96.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.009 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' SER . 53.4 t -56.32 -50.58 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.473 ' O ' ' OG ' ' A' ' 37' ' ' SER . 61.7 t -58.86 -41.89 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 122.305 1.05 . . . . 0.0 108.722 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.78 94.83 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.41 -32.11 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.26 0.552 . . . . 0.0 110.985 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' GLY . 77.7 p -62.33 -37.54 86.04 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.54 74.63 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.456 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.64 -52.02 11.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.995 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -100.4 -1.34 36.23 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.695 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.85 75.41 0.25 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 115.849 -0.614 . . . . 0.0 114.272 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.5 20.46 17.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.76 0.78 . . . . 0.0 109.193 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 4.1 tt -45.2 -59.63 2.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.83 -39.21 93.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' LEU . 38.5 m-85 -58.22 -41.5 84.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.286 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 31.0 m -11.46 -48.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 45' ' ' TYR . 85.4 mt -56.12 -47.54 77.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.749 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.64 -57.18 26.37 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.768 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.54 -24.98 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.649 1.566 . . . . 0.0 112.6 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.75 -30.34 70.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.314 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 8.9 mp -64.67 -39.26 93.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.452 0.644 . . . . 0.0 109.479 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.8 97.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -63.55 -51.35 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.618 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.35 -41.77 90.0 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.53 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.2 mm -64.37 -42.36 95.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.789 0.804 . . . . 0.0 109.266 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 -40.95 99.86 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.658 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.66 -50.93 70.54 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 46.2 p -52.26 -39.2 60.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.007 0.432 . . . . 0.0 110.861 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.36 -45.63 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.69 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.3 -41.33 62.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -27.08 67.33 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.127 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.83 -41.85 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 4.3 pt20 -67.97 -33.25 74.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 55.0 ttt85 -78.16 -22.12 49.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.972 0.909 . . . . 0.0 113.049 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -76.77 -33.61 58.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.06 -41.02 19.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.287 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 13.9 pt20 -86.1 -11.55 52.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.567 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 64' ' ' ARG . . . -42.25 -42.82 3.2 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.808 -174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.207 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.497 1.728 0 CA-C-O 120.822 0.259 . . . . 0.0 112.616 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -77.26 -50.39 12.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.616 0.722 . . . . 0.0 112.245 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.4 m -80.32 -30.19 38.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.227 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.67 -46.88 86.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.673 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 -21.34 56.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.048 1.339 . . . . 0.0 112.353 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -64.33 -32.09 73.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.96 -31.02 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.724 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.9 p -63.97 -52.51 59.3 Favored 'General case' 0 C--O 1.199 -1.577 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.496 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OG1' ' A' ' 16' ' ' THR . 46.1 mm -54.66 -45.68 72.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.583 1.182 . . . . 0.0 110.046 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.11 -43.15 88.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.956 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.55 -49.81 4.73 Favored Glycine 0 CA--C 1.552 2.378 0 CA-C-O 122.924 1.291 . . . . 0.0 110.82 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.724 ' N ' ' O ' ' A' ' 11' ' ' SER . 28.5 m -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 111.869 -2.165 . . . . 0.0 112.581 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 95.8 m -76.25 -32.34 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 0.0 111.758 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.16 -25.18 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.5 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 10.7 p -54.49 -52.44 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 118.099 -1.44 . . . . 0.0 109.401 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.96 -31.35 66.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.735 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.36 -47.0 68.59 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.251 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 40.3 t -77.74 -27.74 50.58 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 112.092 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -83.7 -16.96 43.0 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.335 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.93 -42.95 18.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.775 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 55.2 m -68.06 -38.6 14.32 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 84.9 Cg_exo -47.78 -23.84 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 123.791 2.994 . . . . 0.0 116.029 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.85 -46.44 96.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 119.455 1.025 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 4.3 mm? -50.03 -26.67 4.55 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.03 -30.22 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 tp -59.3 -35.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.73 -50.18 74.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.674 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.53 -40.74 79.49 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.164 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.34 -44.33 97.04 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' SER . 52.5 t -56.02 -50.27 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.44 -41.66 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 122.138 0.97 . . . . 0.0 108.691 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.21 -44.74 96.22 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.45 -33.27 71.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.549 0.69 . . . . 0.0 110.755 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.4 t -60.75 -40.29 91.88 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.537 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.79 75.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.07 -51.17 16.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.103 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.4 p -94.24 7.47 45.22 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.734 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.88 82.83 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.32 175.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.3 21.53 10.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.4 mt -45.95 -56.59 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.528 . . . . 0.0 112.36 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.79 -39.64 87.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.905 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.9 m-85 -57.86 -41.14 81.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.134 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 45' ' ' TYR . 9.3 p -10.89 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 45' ' ' TYR . 89.7 mt -56.69 -46.14 81.36 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.566 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' TYR . 3.9 mm? -61.57 -58.38 18.84 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.82 -24.67 5.17 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.86 1.707 . . . . 0.0 112.458 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.52 -30.54 71.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.866 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.2 mm? -64.09 -39.34 93.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.527 0.68 . . . . 0.0 109.814 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.0 96.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.843 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.26 -50.51 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.764 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -60.6 -39.1 86.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.244 0.929 . . . . 0.0 110.768 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.85 -41.68 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.78 0.8 . . . . 0.0 109.041 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.05 -41.92 94.88 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.252 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.05 -30.75 70.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.3 p -72.05 -37.69 69.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.5 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.68 -42.45 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.735 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.1 -34.07 13.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.486 -0.292 . . . . 0.0 111.513 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -69.68 -52.97 20.94 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.089 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.434 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 1.8 mp -49.53 -43.26 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.255 0.479 . . . . 0.0 111.58 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.71 -36.49 78.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.911 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -20.16 50.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.861 0.864 . . . . 0.0 111.109 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 61' ' ' ALA . 65.8 tttm -72.3 -35.06 68.56 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.428 ' C ' ' H ' ' A' ' 68' ' ' ALA . 8.9 tpm_? -77.5 -60.44 2.36 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 118.759 -1.176 . . . . 0.0 107.987 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.15 -12.0 4.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.463 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 66' ' ' ARG . . . -42.62 -37.33 1.66 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.858 -175.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 t0 . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.5 1.868 0 CA-C-O 120.648 0.187 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -78.34 -51.28 10.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.422 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.8 p -80.73 -29.6 36.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.71 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 3.5 mm? -62.99 -45.76 90.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.208 -1.814 . . . . 0.0 109.689 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -76.88 -22.54 53.29 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.107 1.363 . . . . 0.0 112.184 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -65.8 -31.67 72.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.658 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.13 -38.79 83.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.077 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 15' ' ' THR . 74.8 m -61.36 -51.68 67.82 Favored 'General case' 0 C--O 1.201 -1.488 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.455 ' O ' ' OG1' ' A' ' 16' ' ' THR . 94.7 mt -55.98 -46.64 80.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.513 1.149 . . . . 0.0 110.728 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mm -59.19 -41.88 85.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.895 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.93 -50.03 4.8 Favored Glycine 0 CA--C 1.553 2.415 0 CA-C-O 122.877 1.265 . . . . 0.0 110.499 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.702 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.3 m -58.0 -27.62 63.67 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 111.942 -2.129 . . . . 0.0 112.41 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 99.6 m -76.43 -32.65 58.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.39 -25.21 61.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.497 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 10.3 p -54.61 -52.23 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 120.451 1.478 . . . . 0.0 109.306 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.497 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.83 -31.46 66.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.014 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.26 -46.55 73.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.342 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 73.6 m -77.16 -22.53 52.38 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 120.906 0.384 . . . . 0.0 111.281 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -84.07 -18.19 37.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.003 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -80.98 -41.89 22.06 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.731 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.555 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -68.44 -39.51 16.03 Favored Pre-proline 0 N--CA 1.483 1.175 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.8 Cg_exo -47.44 -23.29 3.26 Favored 'Trans proline' 0 C--N 1.301 -1.974 0 C-N-CA 123.886 3.057 . . . . 0.0 115.642 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.93 -46.89 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.245 0.93 . . . . 0.0 110.068 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -49.51 -27.96 4.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.4 t -70.41 -33.08 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.55 -42.51 91.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.28 -29.23 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.83 -43.4 46.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.281 1.038 . . . . 0.0 110.353 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.79 -48.77 68.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.788 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 37' ' ' SER . 35.2 m -53.74 -47.27 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.0 t -58.21 -40.97 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 122.185 0.993 . . . . 0.0 108.384 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.6 93.77 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.67 -30.61 67.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.282 0.563 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.759 ' O ' ' N ' ' A' ' 41' ' ' GLY . 66.1 m -60.91 -38.36 85.47 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.14 73.14 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.94 -51.78 14.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.024 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -94.39 5.94 50.25 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.621 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 54.58 70.29 0.99 Allowed Glycine 0 N--CA 1.469 0.899 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.541 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.38 20.46 17.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.991 0.895 . . . . 0.0 109.307 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -46.03 -55.69 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 15.0 p-10 -67.77 -38.42 83.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.65 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 47' ' ' LEU . 35.9 m-85 -58.65 -43.8 89.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.132 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 29.0 m -9.92 -48.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -51.96 -49.15 63.77 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.368 0.604 . . . . 0.0 111.628 -178.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.97 -57.7 22.29 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.77 -27.96 75.83 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.791 1.661 . . . . 0.0 112.699 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.11 -30.79 60.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 111.024 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.49 -41.62 93.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.226 0.536 . . . . 0.0 110.083 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.01 93.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.588 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.78 -51.1 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.158 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.34 -41.67 94.07 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.457 0.571 . . . . 0.0 111.416 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.53 -41.48 92.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.814 0.816 . . . . 0.0 109.352 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.97 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.252 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.87 -30.78 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -71.32 -41.13 70.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 111.608 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 pt -64.79 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.482 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.11 -31.74 14.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.611 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.66 -26.38 61.61 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.44 -37.02 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.027 0.83 . . . . 0.0 111.607 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -33.31 74.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.325 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.785 ' O ' ' N ' ' A' ' 68' ' ' ALA . 76.1 mtp85 -65.29 -53.25 46.78 Favored 'General case' 0 C--O 1.201 -1.452 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.57 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.24 -25.08 12.95 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -82.61 -50.02 9.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.65 1.114 . . . . 0.0 112.247 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -85.59 -10.17 56.26 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.79 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.785 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.65 -39.62 1.71 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.203 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 t0 . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.494 1.508 0 N-CA-C 112.922 0.316 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -78.38 -51.14 10.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -81.3 -31.07 33.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.433 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.08 -46.98 86.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.322 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 8.5 mp -77.05 -20.65 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.653 1.181 . . . . 0.0 112.129 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.1 -33.34 75.57 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.921 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.14 -39.29 82.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.8 p -64.09 -53.19 53.65 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' OG1' ' A' ' 16' ' ' THR . 12.6 pt -53.35 -45.81 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 122.337 1.065 . . . . 0.0 111.451 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.42 -44.09 95.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.146 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -29.25 26.53 Favored Glycine 0 CA--C 1.551 2.312 0 CA-C-O 122.399 1.0 . . . . 0.0 112.183 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 m -75.64 -27.88 58.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.988 -1.606 . . . . 0.0 112.6 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 95.3 m -77.3 -32.93 55.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.07 -27.38 60.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.32 -52.3 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 117.667 -1.613 . . . . 0.0 109.835 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.62 69.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.543 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.29 -47.17 68.35 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.231 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.474 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 86.3 p -75.81 -18.95 59.3 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.918 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 t -75.42 -16.98 60.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.796 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -67.38 -39.76 22.41 Favored Pre-proline 0 N--CA 1.481 1.089 0 CA-C-N 120.692 1.587 . . . . 0.0 114.719 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 69.9 Cg_exo -45.08 -22.78 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 124.051 3.167 . . . . 0.0 114.987 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.79 -44.71 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.78 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 mp -49.6 -26.7 3.79 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.18 -33.35 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -51.7 -33.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.79 -29.82 65.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 tp -75.7 -42.92 49.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.26 -47.5 84.11 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 113.345 -1.752 . . . . 0.0 112.677 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.98 -45.91 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.46 -39.04 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.304 1.049 . . . . 0.0 108.269 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.99 95.61 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.04 -29.75 66.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.733 -0.733 . . . . 0.0 110.507 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' GLY . 67.1 m -60.52 -38.59 84.88 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.39 71.6 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.02 -53.76 6.7 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.132 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLY . 81.5 p -107.42 -13.48 15.08 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.4 115.19 0.01 OUTLIER Glycine 0 N--CA 1.47 0.947 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.855 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' C ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -129.12 23.31 5.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.852 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.09 -62.44 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -67.66 -41.9 83.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 47' ' ' LEU . 66.1 m-85 -59.26 -46.53 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.454 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 11.7 p -10.77 -48.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -52.06 -49.79 62.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.167 0.508 . . . . 0.0 111.842 -178.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.61 -56.74 30.16 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.2 -25.52 80.24 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.723 1.616 . . . . 0.0 112.277 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.83 65.98 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.09 -38.23 90.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.14 97.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.049 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.91 -51.74 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.504 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -59.06 -40.81 86.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.654 0.661 . . . . 0.0 110.205 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' O ' ' OG1' ' A' ' 58' ' ' THR . 6.1 mm -64.4 -41.74 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.8 0.81 . . . . 0.0 109.023 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.05 97.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.073 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.37 -51.0 69.34 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 41.3 p -51.62 -38.68 55.74 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.916 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.29 -44.39 94.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.345 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.94 -34.54 20.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.11 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -62.6 -52.49 63.17 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.405 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 1.8 mp -49.44 -38.63 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.345 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.27 -43.54 81.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.313 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' ALA . 78.6 ttt-85 -79.38 -21.5 45.63 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.651 0.78 . . . . 0.0 112.823 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.9 ttmt -72.27 -31.34 65.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -77.2 -60.06 2.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.95 -14.45 34.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.82 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.92 -38.01 2.06 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.4 t0 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.088 175.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo . . . . . 0 N--CA 1.5 1.879 0 N-CA-C 113.494 0.536 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -77.63 -52.14 9.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.433 0.635 . . . . 0.0 112.63 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -80.45 -30.43 37.55 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.422 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -47.91 80.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.439 -1.709 . . . . 0.0 109.998 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.36 -21.0 56.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.779 1.231 . . . . 0.0 112.247 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -66.52 -33.35 75.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.872 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.07 -38.63 80.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 15' ' ' THR . 67.2 m -71.16 -52.54 18.63 Favored 'General case' 0 C--O 1.199 -1.553 0 C-N-CA 118.928 -1.109 . . . . 0.0 112.311 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 12' ' ' ILE . 97.2 mt -57.78 -49.81 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 122.395 1.093 . . . . 0.0 112.763 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.23 -37.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.48 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.35 -50.93 4.09 Favored Glycine 0 CA--C 1.554 2.498 0 CA-C-O 122.991 1.329 . . . . 0.0 111.103 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.701 ' N ' ' O ' ' A' ' 11' ' ' SER . 66.3 m -57.29 -27.39 62.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.536 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -76.22 -29.14 57.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.83 -24.52 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 11.3 p -54.06 -51.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.028 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.487 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -56.49 -30.7 63.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.413 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.15 -47.97 63.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.519 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 86.1 p -76.48 -21.92 55.2 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.382 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.0 m -84.31 -15.52 46.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.577 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.404 ' CZ ' ' OH ' ' A' ' 60' ' ' TYR . 2.6 m-85 -82.53 -42.46 18.35 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.633 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -69.42 -37.62 8.86 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -176.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 24' ' ' THR . 84.5 Cg_exo -47.18 -23.11 2.69 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 124.029 3.153 . . . . 0.0 115.931 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 7.7 p -58.59 -41.62 82.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.628 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 55.6 tp -50.08 -27.95 6.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 -29.41 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.081 0.467 . . . . 0.0 111.709 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.25 -42.52 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tt -51.42 -53.28 38.35 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.573 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.2 mp -54.13 -40.14 67.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.81 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.16 99.22 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 59.8 t -55.39 -48.95 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.54 -38.87 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.57 -43.63 95.99 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.07 -29.75 66.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.6 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.3 t -59.48 -39.44 83.72 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.82 75.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -77.92 -54.41 6.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.217 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' GLY . 67.2 p -107.92 -13.2 15.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 50.19 113.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.86 0 CA-C-N 115.069 -0.968 . . . . 0.0 113.133 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -131.75 22.78 4.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.898 0.479 . . . . 0.0 110.235 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 mp -45.24 -58.62 3.14 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 p-10 -65.48 -39.37 91.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.353 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' LEU . 29.6 m-85 -58.23 -41.77 84.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.05 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 45' ' ' TYR . 31.5 m -10.74 -49.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.8 tp -55.74 -47.95 76.08 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.093 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.38 -57.4 27.27 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.402 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.76 -25.2 5.55 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.056 1.837 . . . . 0.0 112.795 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.84 71.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.474 0.178 . . . . 0.0 110.643 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 8.0 mp -64.96 -40.11 94.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.534 0.683 . . . . 0.0 109.388 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.09 97.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.357 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.62 -50.82 78.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.967 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.17 -40.41 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.475 0.58 . . . . 0.0 110.433 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.67 -42.63 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.7 -42.41 97.23 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.862 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -51.27 63.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -51.9 -41.96 62.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.382 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -44.23 95.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.356 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.404 ' OH ' ' CZ ' ' A' ' 23' ' ' PHE . 66.8 t80 -55.55 -35.2 65.44 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.06 -26.55 63.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.86 -41.47 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.23 -37.64 78.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.545 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 68' ' ' ALA . 31.3 ptt180 -78.89 -19.76 51.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.127 0.571 . . . . 0.0 112.282 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -72.24 -28.01 62.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.285 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.59 -60.32 2.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 89.0 mt-30 -61.49 -14.52 29.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.657 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -43.46 -38.96 3.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.764 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.3 p-10 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 N-CA-C 111.388 -0.274 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.19 -51.43 10.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.523 0.678 . . . . 0.0 112.063 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -81.04 -30.43 34.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.838 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.48 -43.44 97.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.27 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 tp -77.85 -23.39 48.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.335 1.454 . . . . 0.0 112.518 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -67.42 -32.03 72.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.863 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.09 -40.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.1 t -63.75 -52.59 59.69 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 119.464 1.029 . . . . 0.0 111.051 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.45 ' O ' ' OG1' ' A' ' 16' ' ' THR . 95.8 mt -55.82 -46.53 79.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.779 1.276 . . . . 0.0 110.863 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.99 -42.32 85.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.832 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.15 -50.61 4.49 Favored Glycine 0 CA--C 1.551 2.324 0 CA-C-O 122.924 1.291 . . . . 0.0 110.623 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.707 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.9 m -57.03 -27.85 62.0 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.005 -2.097 . . . . 0.0 112.478 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 98.6 m -76.86 -32.39 57.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 0.0 111.868 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.07 -25.01 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.55 ' CG2' ' H ' ' A' ' 19' ' ' ALA . 32.3 m -61.74 -55.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.976 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' H ' ' CG2' ' A' ' 18' ' ' VAL . . . -57.6 -31.76 66.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.068 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.47 -43.11 91.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.406 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 83.8 p -75.75 -17.64 59.83 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.131 0.491 . . . . 0.0 110.574 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 51.9 p -76.66 -15.5 59.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.821 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -84.47 -41.19 16.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.272 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -68.1 -38.52 13.97 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 120.869 1.668 . . . . 0.0 114.2 -177.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.5 Cg_exo -46.35 -23.45 2.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.877 3.052 . . . . 0.0 114.847 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 10.5 p -59.0 -42.31 85.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.642 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 57.1 tp -49.85 -27.87 5.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.01 -29.3 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.27 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.2 mm -60.93 -43.06 95.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 4.1 mm? -55.64 -52.11 64.91 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.553 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -55.41 -41.27 72.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.88 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.51 -44.14 97.08 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.98 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.73 -50.66 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.49 ' O ' ' OG ' ' A' ' 37' ' ' SER . 60.7 t -59.24 -42.07 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.299 1.047 . . . . 0.0 108.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.32 95.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.27 -30.81 66.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.31 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.716 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.7 p -60.55 -35.58 76.37 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.55 76.88 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.137 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.1 mm? -74.96 -51.63 13.21 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.285 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -96.73 3.75 52.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.655 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 55.47 70.18 1.04 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.0 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.59 19.8 18.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.069 0.935 . . . . 0.0 109.541 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -45.84 -56.75 4.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -66.48 -39.48 88.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.917 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.602 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.8 m-85 -57.41 -41.22 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.974 -0.536 . . . . 0.0 111.12 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 45' ' ' TYR . 60.1 t -11.04 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' TYR . 4.0 mm? -54.31 -47.84 71.99 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 mp -61.14 -59.11 14.78 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.64 -24.88 4.95 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.793 1.662 . . . . 0.0 112.59 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.96 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.853 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.5 mm? -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.432 0.634 . . . . 0.0 109.554 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.01 97.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.606 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -62.75 -51.05 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.605 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.97 -40.52 85.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.657 0.662 . . . . 0.0 110.5 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 55' ' ' ILE . 86.3 mt -65.31 -42.36 93.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.0 109.781 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.28 -43.48 96.9 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.225 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.49 -49.8 73.95 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.769 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.7 m -52.95 -41.95 65.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.14 -44.16 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.768 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.05 -39.86 72.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -72.77 -53.86 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.082 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.4 mt -50.18 -45.2 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 67' ' ' GLN . 3.2 pp0? -68.46 -33.8 74.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.086 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.02 -21.81 50.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.137 0.975 . . . . 0.0 111.593 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' ALA . 18.8 tptm -76.54 -33.71 58.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -83.24 -39.74 20.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.596 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 63' ' ' GLN . 10.7 pt20 -86.13 -11.59 52.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.624 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.82 -39.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.791 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.4 t0 . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.209 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.498 1.77 0 CA-C-O 120.764 0.235 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -77.73 -51.02 11.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.1 p -80.99 -29.87 35.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.134 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.71 -46.38 88.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.233 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.46 -21.12 53.39 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.573 1.149 . . . . 0.0 112.397 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.25 -36.56 79.64 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.382 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.5 -32.51 36.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' THR . 69.2 m -74.42 -53.88 8.69 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-N 119.97 1.259 . . . . 0.0 111.866 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 13' ' ' ILE . 23.5 pt -54.72 -48.83 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 122.501 1.143 . . . . 0.0 112.686 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 ' N ' HG13 ' A' ' 12' ' ' ILE . 19.9 tt -59.54 -38.81 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.908 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.28 -51.79 3.81 Favored Glycine 0 CA--C 1.549 2.171 0 CA-C-O 122.963 1.313 . . . . 0.0 110.448 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.703 ' N ' ' O ' ' A' ' 11' ' ' SER . 36.3 m -56.93 -27.54 61.11 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 111.851 -2.174 . . . . 0.0 112.222 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 98.6 m -77.4 -32.77 55.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 tp -74.03 -26.52 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.41 -51.7 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 117.668 -1.613 . . . . 0.0 109.313 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -32.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.522 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.82 -44.33 81.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.045 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 t -75.9 -23.64 55.55 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 p -70.29 -13.49 62.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.867 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -80.36 -39.92 27.61 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.702 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 27.3 m -64.79 -39.24 37.11 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.673 1.578 . . . . 0.0 115.158 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 24' ' ' THR . 70.9 Cg_exo -44.41 -21.9 0.5 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.692 2.928 . . . . 0.0 115.386 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -60.38 -44.4 95.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.271 0.941 . . . . 0.0 110.172 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.16 -26.28 2.72 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.0 -29.94 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.713 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -57.11 -34.12 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.62 -52.85 63.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.447 0.567 . . . . 0.0 110.614 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.91 -40.26 75.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.678 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.64 98.7 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' SER . 54.3 t -56.62 -50.35 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.76 -42.64 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.24 -44.99 96.06 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.42 -33.3 72.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.535 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 41' ' ' GLY . 73.3 m -61.96 -39.77 93.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.07 -37.78 75.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.96 -53.62 6.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.883 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 m -107.83 -16.23 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 57.01 94.4 0.01 OUTLIER Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.966 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.92 20.89 13.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 91.8 mt -46.26 -56.82 5.22 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.164 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.742 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.6 m-85 -55.77 -41.65 74.33 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.492 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 43' ' ' LEU . 9.8 p -20.56 -14.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.742 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.8 tt -88.65 -47.03 8.56 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.047 0.84 . . . . 0.0 110.15 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.3 mp -60.5 -45.51 97.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.577 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 55.9 Cg_endo -68.35 -25.29 36.21 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.576 1.518 . . . . 0.0 112.453 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.68 -30.1 63.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.648 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.26 -39.05 93.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.36 92.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.162 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.29 -50.84 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.533 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -59.74 -38.64 82.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.055 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.426 ' O ' ' OG1' ' A' ' 58' ' ' THR . 87.8 mt -65.02 -41.14 91.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.837 0.827 . . . . 0.0 109.127 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.94 99.14 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.109 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.01 -49.62 75.29 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.817 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 50.1 p -51.56 -37.92 51.9 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.292 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.86 -44.72 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.192 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -48.17 -33.15 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.321 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.85 63.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 1.6 mp -73.76 -43.27 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 118.397 0.544 . . . . 0.0 112.2 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.2 -39.94 93.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.417 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 68' ' ' ALA . 15.9 mmm180 -66.26 -54.48 24.41 Favored 'General case' 0 C--O 1.204 -1.299 0 C-N-CA 118.894 -1.123 . . . . 0.0 108.515 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -52.03 -25.74 9.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -83.63 -51.89 6.91 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 119.354 0.979 . . . . 0.0 113.146 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.47 -11.47 51.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.595 1.158 . . . . 0.0 112.725 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.75 -42.89 2.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.274 -174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.88 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 N-CA-C 111.29 -0.311 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.15 -50.38 12.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.723 0.773 . . . . 0.0 112.244 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.3 p -80.91 -29.97 35.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.043 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.47 -43.15 98.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.58 -1.645 . . . . 0.0 109.653 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.6 -23.0 46.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.4 1.48 . . . . 0.0 112.918 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -67.78 -35.03 77.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.868 -1.514 . . . . 0.0 113.524 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.01 -31.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -68.56 -53.5 22.56 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 120.037 1.289 . . . . 0.0 111.249 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 ' O ' ' OG1' ' A' ' 16' ' ' THR . 17.3 tt -53.99 -44.92 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 122.505 1.145 . . . . 0.0 110.781 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.48 -41.93 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 113.008 -1.906 . . . . 0.0 111.535 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.57 -51.21 4.16 Favored Glycine 0 CA--C 1.548 2.101 0 CA-C-O 122.936 1.298 . . . . 0.0 110.589 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.686 ' N ' ' O ' ' A' ' 11' ' ' SER . 32.3 m -56.91 -28.83 62.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.875 -2.162 . . . . 0.0 113.085 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 33.2 p -78.09 -30.01 49.38 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.802 -0.561 . . . . 0.0 112.104 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -74.14 -27.54 60.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.98 -52.26 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 117.598 -1.641 . . . . 0.0 109.681 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.29 -31.92 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.982 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tt -67.7 -44.61 77.32 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.673 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 80.5 p -75.17 -16.28 60.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.027 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -78.26 -19.12 54.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.496 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -41.46 17.09 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.308 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.2 p -68.92 -37.2 8.91 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 120.837 1.653 . . . . 0.0 115.027 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 24' ' ' THR . 82.5 Cg_exo -47.13 -22.96 2.51 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.893 3.062 . . . . 0.0 115.041 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.98 -38.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.806 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -50.52 -26.52 5.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.16 -29.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.11 -41.57 86.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.35 -50.74 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.009 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.0 mp -56.14 -40.62 74.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.054 0.843 . . . . 0.0 110.178 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.22 -43.59 98.33 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 55.3 t -56.26 -50.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.1 -42.22 85.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 122.161 0.981 . . . . 0.0 109.01 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -46.09 94.35 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.6 -31.08 67.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.311 0.577 . . . . 0.0 110.649 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' GLY . 47.0 t -61.51 -41.35 97.17 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.92 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.77 76.0 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.82 -51.49 13.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.244 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.1 p -95.77 4.83 52.56 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 53.47 72.88 0.47 Allowed Glycine 0 N--CA 1.469 0.858 0 CA-C-N 115.613 -0.722 . . . . 0.0 114.015 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.62 20.6 15.82 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -46.27 -55.59 6.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 19.6 p-10 -68.31 -38.83 82.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.906 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.3 m-85 -58.98 -41.37 87.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.784 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 45' ' ' TYR . 11.8 p -11.27 -47.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 45' ' ' TYR . 97.3 mt -55.65 -46.41 77.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.081 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.7 mt -62.67 -59.95 11.24 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.341 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.9 -26.08 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.509 1.472 . . . . 0.0 112.066 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.14 66.41 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.017 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.13 -39.54 93.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.521 0.677 . . . . 0.0 109.484 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.77 97.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.428 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.93 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.495 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -59.5 -41.44 89.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.63 0.65 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 55' ' ' ILE . 82.8 mt -65.6 -43.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 0.0 109.983 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.2 97.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.925 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.56 -50.62 70.61 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.4 m -53.3 -42.26 66.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.016 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -43.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.48 -37.32 72.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -74.16 -55.49 6.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.007 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 pt -50.59 -38.01 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.031 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.629 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 20.6 pt20 -70.02 -36.83 75.38 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.87 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -78.11 -20.36 52.32 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.697 0.799 . . . . 0.0 111.424 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.4 ttpt -71.52 -31.21 66.81 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.645 -1.161 . . . . 0.0 113.897 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -78.08 -60.84 2.21 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.0 mp0 -60.68 -12.68 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.752 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -31.91 0.52 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.958 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.299 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.46 -38.8 91.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 52.71 59.34 14.03 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.416 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.25 65.98 7.1 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.239 2.626 . . . . 0.0 111.24 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -77.68 -49.31 14.75 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.808 0.813 . . . . 0.0 112.741 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.4 p -79.59 -28.86 41.04 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.097 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.8 mm? -62.49 -45.21 94.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.753 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.15 -21.92 53.37 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.012 1.325 . . . . 0.0 112.525 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -66.39 -33.77 76.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.259 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.48 -31.69 54.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' THR . 81.8 p -65.07 -52.2 57.08 Favored 'General case' 0 C--O 1.201 -1.476 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.408 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.433 HG23 HD13 ' A' ' 12' ' ' ILE . 95.0 mt -54.91 -46.9 76.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.742 1.258 . . . . 0.0 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.25 -44.96 93.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.692 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.87 -28.42 28.94 Favored Glycine 0 CA--C 1.556 2.607 0 CA-C-O 122.308 0.949 . . . . 0.0 112.486 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 11' ' ' SER . 55.4 m -75.41 -27.71 59.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 113.235 -1.483 . . . . 0.0 112.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.1 p -76.51 -29.14 56.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.053 0.454 . . . . 0.0 111.46 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tp -72.03 -25.8 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.541 ' CG2' ' H ' ' A' ' 19' ' ' ALA . 35.4 m -59.61 -54.19 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.123 -1.431 . . . . 0.0 110.042 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.541 ' H ' ' CG2' ' A' ' 18' ' ' VAL . . . -58.38 -32.26 68.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.314 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.6 -44.56 74.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.991 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 74.0 m -78.57 -26.37 45.52 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.942 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -84.32 -16.59 42.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.16 -42.86 18.48 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.675 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 p -69.21 -37.52 9.03 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 24' ' ' THR . 87.1 Cg_exo -48.2 -23.33 4.6 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 123.772 2.982 . . . . 0.0 115.506 -176.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.33 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.737 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 tp -50.25 -28.34 7.51 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.41 -34.06 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.29 -41.14 88.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.57 -50.42 73.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.255 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.48 -40.92 84.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.859 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.6 -43.64 98.71 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.5 t -56.09 -50.17 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.499 ' O ' ' OG ' ' A' ' 37' ' ' SER . 65.1 t -60.02 -42.58 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 122.058 0.932 . . . . 0.0 109.401 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.8 -46.25 93.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.52 -29.45 68.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 0.0 110.784 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.5 p -59.69 -28.06 66.97 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -31.09 56.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.229 1.014 . . . . 0.0 109.526 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.5 -50.29 12.94 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.098 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -101.61 -7.97 22.25 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 52.14 39.19 49.7 Favored Glycine 0 N--CA 1.47 0.9 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.25 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.92 14.71 31.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.965 0.383 . . . . 0.0 111.332 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -56.52 -14.29 3.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.748 -176.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -60.79 -40.6 93.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.6 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 47' ' ' LEU . 69.2 m-85 -58.65 -41.51 86.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.923 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 45' ' ' TYR . 30.2 m -10.88 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' TYR . 61.8 tp -53.49 -47.98 69.34 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.367 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' TYR . 6.7 mp -62.15 -61.66 7.26 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.06 -26.07 13.97 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.508 1.472 . . . . 0.0 112.136 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.52 -30.63 66.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.468 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.01 -38.75 92.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.59 -42.85 97.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.566 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.93 -50.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.682 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.53 -40.15 86.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.787 0.721 . . . . 0.0 110.339 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.63 -42.2 92.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.892 0.853 . . . . 0.0 110.203 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.05 -44.58 66.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.445 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.9 -52.77 13.4 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.443 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 t -50.74 -39.19 51.39 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.334 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 mm -65.49 -43.26 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.385 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.72 -36.77 74.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.7 72.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.075 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.91 -37.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.349 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' NE2' ' OE1' ' A' ' 67' ' ' GLN . 1.2 pp0? -67.03 -35.12 79.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.272 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 68' ' ' ALA . 57.8 ttt85 -79.09 -21.2 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.257 1.023 . . . . 0.0 111.575 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -74.84 -33.86 62.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.427 1.108 . . . . 0.0 113.381 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -81.33 -34.98 31.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.198 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 70' ' ' ALA . 98.0 mt-30 -86.69 -12.93 46.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.469 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.67 -40.29 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.748 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.25 -50.73 72.48 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.26 -39.49 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 59.96 -79.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.527 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ALA . 83.1 p -71.58 161.74 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.409 . . . . 0.0 111.028 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -61.38 139.37 94.8 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.72 139.92 23.51 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.508 1.472 . . . . 0.0 111.851 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -61.72 -39.45 91.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.06 -39.31 94.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.516 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.64 109.49 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.43 171.4 38.27 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.21 159.15 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.601 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.19 -39.37 92.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.565 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.439 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 63.8 mttp -77.93 136.54 38.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 7' ' ' LEU . 56.5 m-20 -133.58 72.92 73.54 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.669 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -53.89 -24.21 30.58 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.174 2.583 . . . . 0.0 113.118 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -77.62 -50.24 12.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.597 0.713 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.1 m -80.52 -31.6 37.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.464 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 3' ' ' ASP . 59.6 tp -65.12 -49.55 69.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.526 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.49 -23.72 50.24 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.291 1.436 . . . . 0.0 113.521 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.1 -30.56 69.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.046 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.82 -39.89 84.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -63.11 -52.49 62.38 Favored 'General case' 0 C--O 1.201 -1.478 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.863 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.0 mm -55.39 -46.61 78.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.613 1.197 . . . . 0.0 110.529 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.91 -42.65 86.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.004 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.17 -50.14 4.69 Favored Glycine 0 CA--C 1.552 2.348 0 CA-C-O 122.864 1.258 . . . . 0.0 110.7 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.715 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.2 m -57.51 -27.63 62.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.028 -2.086 . . . . 0.0 112.811 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.1 t -77.83 -30.33 51.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.024 -0.422 . . . . 0.0 111.615 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.96 -25.66 60.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.74 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.368 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.77 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.35 -46.44 70.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.715 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.2 t -77.52 -26.23 50.93 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.173 0.511 . . . . 0.0 112.023 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -73.01 -14.4 61.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.607 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.7 -40.47 25.32 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.719 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 31.0 m -66.22 -39.1 25.36 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-N 120.684 1.584 . . . . 0.0 115.039 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 24' ' ' THR . 83.8 Cg_exo -45.44 -22.73 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 123.803 3.002 . . . . 0.0 115.166 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -61.61 -45.69 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.485 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.0 tp -48.86 -27.5 3.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.84 -33.6 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.5 -33.64 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.86 -49.99 75.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.44 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.0 mp -55.71 -40.51 72.53 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.807 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -44.02 97.83 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.024 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 37' ' ' SER . 48.9 t -55.79 -50.34 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.06 -42.25 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.176 0.989 . . . . 0.0 108.996 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.29 -46.05 94.45 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.53 -31.43 68.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.378 0.609 . . . . 0.0 110.405 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.5 t -61.39 -40.34 93.97 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.368 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.71 75.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.158 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.86 -51.71 11.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.635 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -95.89 3.27 53.75 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.192 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.43 69.81 1.16 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.301 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 20.27 18.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.97 0.885 . . . . 0.0 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.4 tp -45.99 -59.3 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.404 0.621 . . . . 0.0 112.287 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.99 -40.81 95.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.993 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 47' ' ' LEU . 48.4 m-85 -58.65 -43.55 89.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.454 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 45' ' ' TYR . 11.7 p -11.4 -48.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.7 tp -54.81 -48.58 72.6 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.711 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.39 -57.73 23.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.99 -24.93 5.78 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.717 1.612 . . . . 0.0 112.364 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.26 70.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 7.8 mp -64.94 -40.59 95.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.776 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.01 97.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.697 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 53' ' ' ILE . 96.7 mt -62.9 -51.25 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.842 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.9 -40.76 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.516 0.598 . . . . 0.0 110.544 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.438 ' O ' ' OG1' ' A' ' 58' ' ' THR . 82.5 mt -64.28 -41.62 92.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.718 0.77 . . . . 0.0 109.635 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 -40.99 98.7 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.281 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.59 -28.96 68.92 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 54.9 p -72.34 -37.27 68.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.32 0.581 . . . . 0.0 110.132 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.59 -44.62 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.294 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -57.25 -38.35 73.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.55 -27.19 62.06 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.579 -0.701 . . . . 0.0 112.166 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.63 -43.58 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 1.5 pp0? -63.76 -36.37 83.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.241 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.789 ' O ' ' N ' ' A' ' 68' ' ' ALA . 16.4 mmm180 -62.64 -53.09 59.84 Favored 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -52.42 -25.88 11.15 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -82.98 -49.35 9.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.745 1.157 . . . . 0.0 112.417 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' ALA . 23.3 mp0 -85.39 -10.28 56.47 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.456 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.789 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.03 -39.5 1.94 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.082 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.59 -51.62 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.23 -39.76 91.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.807 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.9 t 57.67 -115.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.7 m -66.21 147.94 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.989 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.9 p -70.35 152.26 95.58 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.115 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.4 67.46 7.06 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.044 1.829 . . . . 0.0 112.481 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -70.0 -21.99 63.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.141 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.77 -39.32 91.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -61.45 131.26 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.95 -164.57 48.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.7 t -112.93 124.48 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 110.429 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.4 -42.82 99.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.042 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.203 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -138.21 -23.09 1.02 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.29 131.34 93.66 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.716 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.05 -22.41 5.04 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 122.215 1.943 . . . . 0.0 113.479 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 26.5 mtpp -75.28 -42.34 55.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.862 0.839 . . . . 0.0 110.869 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -80.51 -30.14 37.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.36 -1.746 . . . . 0.0 111.231 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.06 -51.18 57.77 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.799 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -77.52 -22.06 51.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.959 1.303 . . . . 0.0 112.919 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 7.1 mmt180 -68.32 -30.11 69.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.105 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.42 -33.37 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.7 t -70.71 -53.77 14.37 Favored 'General case' 0 C--O 1.202 -1.417 0 CA-C-N 119.77 1.168 . . . . 0.0 111.815 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 13' ' ' ILE . 18.7 tt -53.58 -44.45 57.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.959 1.361 . . . . 0.0 110.198 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.516 ' N ' ' CG2' ' A' ' 12' ' ' ILE . 91.1 mt -60.77 -45.34 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 111.999 -2.364 . . . . 0.0 111.933 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.0 -28.26 29.03 Favored Glycine 0 CA--C 1.553 2.466 0 CA-C-O 122.449 1.027 . . . . 0.0 112.078 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.676 ' N ' ' O ' ' A' ' 11' ' ' SER . 37.2 m -75.99 -27.24 57.37 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.849 -1.676 . . . . 0.0 112.919 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.7 t -78.15 -29.95 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mp -73.56 -25.33 60.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 8.4 p -58.32 -54.22 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 117.973 -1.491 . . . . 0.0 109.664 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.84 -31.56 66.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.274 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.92 -44.3 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.92 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 84.0 p -75.26 -15.84 60.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -77.38 -18.06 57.66 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.963 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.87 -41.57 18.82 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.925 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.546 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 36.1 m -67.74 -38.55 15.15 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 120.679 1.581 . . . . 0.0 114.563 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 24' ' ' THR . 91.9 Cg_exo -46.23 -23.42 1.96 Allowed 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.689 2.926 . . . . 0.0 115.16 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.6 p -59.56 -43.07 90.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 119.302 0.955 . . . . 0.0 110.223 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 57.5 tp -49.03 -26.59 2.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.17 -29.43 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.916 0.389 . . . . 0.0 111.957 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.8 tt -59.56 -35.99 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.262 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.14 -51.21 70.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.48 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' CD1' ' H ' ' A' ' 31' ' ' LEU . 10.1 mp -55.62 -40.89 72.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.8 0.81 . . . . 0.0 109.699 -178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -44.45 96.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.009 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' SER . 53.4 t -56.32 -50.58 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.473 ' O ' ' OG ' ' A' ' 37' ' ' SER . 61.7 t -58.86 -41.89 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 122.305 1.05 . . . . 0.0 108.722 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.78 94.83 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.41 -32.11 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.26 0.552 . . . . 0.0 110.985 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' GLY . 77.7 p -62.33 -37.54 86.04 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.54 74.63 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.456 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.64 -52.02 11.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.995 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -100.4 -1.34 36.23 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.695 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.85 75.41 0.25 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 115.849 -0.614 . . . . 0.0 114.272 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.5 20.46 17.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.76 0.78 . . . . 0.0 109.193 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 4.1 tt -45.2 -59.63 2.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.83 -39.21 93.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' LEU . 38.5 m-85 -58.22 -41.5 84.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.286 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 45' ' ' TYR . 31.0 m -11.46 -48.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 45' ' ' TYR . 85.4 mt -56.12 -47.54 77.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.749 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.64 -57.18 26.37 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.768 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.54 -24.98 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.649 1.566 . . . . 0.0 112.6 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.75 -30.34 70.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.314 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 8.9 mp -64.67 -39.26 93.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.452 0.644 . . . . 0.0 109.479 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.8 97.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -63.55 -51.35 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.618 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -59.35 -41.77 90.0 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.53 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.436 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.2 mm -64.37 -42.36 95.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.789 0.804 . . . . 0.0 109.266 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 -40.95 99.86 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.658 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.66 -50.93 70.54 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 46.2 p -52.26 -39.2 60.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.007 0.432 . . . . 0.0 110.861 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.36 -45.63 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.69 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.3 -41.33 62.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -27.08 67.33 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.127 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.83 -41.85 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 4.3 pt20 -67.97 -33.25 74.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 55.0 ttt85 -78.16 -22.12 49.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.972 0.909 . . . . 0.0 113.049 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -76.77 -33.61 58.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.06 -41.02 19.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.287 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' ALA . 13.9 pt20 -86.1 -11.55 52.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.567 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 64' ' ' ARG . . . -42.25 -42.82 3.2 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.808 -174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 72' ' ' SER . 97.8 m-20 -59.52 -50.07 75.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.12 -37.89 81.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.04 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.3 m -60.98 -40.05 91.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.505 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' ASP . 40.9 t -124.84 132.34 53.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.43 . . . . 0.0 111.338 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m 50.51 59.6 16.07 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.655 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.47 150.93 58.66 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.558 2.172 . . . . 0.0 111.946 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.05 -44.07 97.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.43 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -62.66 128.27 35.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.629 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -138.3 17.62 2.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.516 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.96 168.05 54.32 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.8 t -118.91 127.01 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -62.28 -39.55 93.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.353 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 tttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.358 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -87.74 94.8 9.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.934 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.6 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 12.1 t0 -62.54 -39.51 55.98 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 22.9 Cg_exo -64.47 0.45 2.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.748 2.299 . . . . 0.0 112.616 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -77.26 -50.39 12.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.616 0.722 . . . . 0.0 112.245 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.4 m -80.32 -30.19 38.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.227 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.67 -46.88 86.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.673 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 -21.34 56.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.048 1.339 . . . . 0.0 112.353 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -64.33 -32.09 73.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.96 -31.02 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.724 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.9 p -63.97 -52.51 59.3 Favored 'General case' 0 C--O 1.199 -1.577 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.496 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.453 ' O ' ' OG1' ' A' ' 16' ' ' THR . 46.1 mm -54.66 -45.68 72.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.583 1.182 . . . . 0.0 110.046 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.11 -43.15 88.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.956 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.55 -49.81 4.73 Favored Glycine 0 CA--C 1.552 2.378 0 CA-C-O 122.924 1.291 . . . . 0.0 110.82 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.724 ' N ' ' O ' ' A' ' 11' ' ' SER . 28.5 m -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 111.869 -2.165 . . . . 0.0 112.581 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 95.8 m -76.25 -32.34 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 0.0 111.758 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.16 -25.18 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.5 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 10.7 p -54.49 -52.44 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 118.099 -1.44 . . . . 0.0 109.401 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.96 -31.35 66.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.735 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.36 -47.0 68.59 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.251 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 40.3 t -77.74 -27.74 50.58 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 112.092 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -83.7 -16.96 43.0 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.335 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.93 -42.95 18.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.775 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 55.2 m -68.06 -38.6 14.32 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 84.9 Cg_exo -47.78 -23.84 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 123.791 2.994 . . . . 0.0 116.029 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.85 -46.44 96.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 119.455 1.025 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.3 mm? -50.03 -26.67 4.55 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.03 -30.22 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 tp -59.3 -35.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.73 -50.18 74.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.674 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.53 -40.74 79.49 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.164 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.34 -44.33 97.04 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' SER . 52.5 t -56.02 -50.27 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.44 -41.66 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 122.138 0.97 . . . . 0.0 108.691 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.21 -44.74 96.22 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.45 -33.27 71.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.549 0.69 . . . . 0.0 110.755 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.4 t -60.75 -40.29 91.88 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.537 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.79 75.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.07 -51.17 16.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.103 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.4 p -94.24 7.47 45.22 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.734 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.88 82.83 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.32 175.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.3 21.53 10.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.4 mt -45.95 -56.59 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.528 . . . . 0.0 112.36 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.79 -39.64 87.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.905 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.9 m-85 -57.86 -41.14 81.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.134 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 45' ' ' TYR . 9.3 p -10.89 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 45' ' ' TYR . 89.7 mt -56.69 -46.14 81.36 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.566 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' TYR . 3.9 mm? -61.57 -58.38 18.84 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.82 -24.67 5.17 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.86 1.707 . . . . 0.0 112.458 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.52 -30.54 71.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.866 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.2 mm? -64.09 -39.34 93.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.527 0.68 . . . . 0.0 109.814 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.0 96.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.843 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 mp -63.26 -50.51 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.764 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -60.6 -39.1 86.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.244 0.929 . . . . 0.0 110.768 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.85 -41.68 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.78 0.8 . . . . 0.0 109.041 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.05 -41.92 94.88 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.252 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.05 -30.75 70.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.3 p -72.05 -37.69 69.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.5 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.68 -42.45 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.735 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.1 -34.07 13.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.486 -0.292 . . . . 0.0 111.513 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -69.68 -52.97 20.94 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.089 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.434 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 1.8 mp -49.53 -43.26 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.255 0.479 . . . . 0.0 111.58 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.71 -36.49 78.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.911 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -20.16 50.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.861 0.864 . . . . 0.0 111.109 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 61' ' ' ALA . 65.8 tttm -72.3 -35.06 68.56 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.428 ' C ' ' H ' ' A' ' 68' ' ' ALA . 8.9 tpm_? -77.5 -60.44 2.36 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 118.759 -1.176 . . . . 0.0 107.987 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ALA . 20.5 pt20 -59.15 -12.0 4.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.463 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 66' ' ' ARG . . . -42.62 -37.33 1.66 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.858 -175.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.64 -56.73 18.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.56 -39.52 91.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 63.19 35.43 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 110.295 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 91.0 p -156.67 164.02 38.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.6 t -131.77 140.3 37.84 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.062 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.95 152.26 62.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 112.058 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -89.2 -3.68 58.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ASN . 88.3 m-85 55.86 -177.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.284 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 79.5 m-20 55.12 109.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.22 97.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.81 136.6 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.819 0.343 . . . . 0.0 110.398 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.88 -39.68 95.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.336 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -153.48 142.85 21.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -70.88 -48.6 14.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.18 70.66 3.77 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.604 1.536 . . . . 0.0 111.946 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -78.34 -51.28 10.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.422 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.8 p -80.73 -29.6 36.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.71 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.5 mm? -62.99 -45.76 90.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.208 -1.814 . . . . 0.0 109.689 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -76.88 -22.54 53.29 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.107 1.363 . . . . 0.0 112.184 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -65.8 -31.67 72.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.658 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.13 -38.79 83.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.077 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 15' ' ' THR . 74.8 m -61.36 -51.68 67.82 Favored 'General case' 0 C--O 1.201 -1.488 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.455 ' O ' ' OG1' ' A' ' 16' ' ' THR . 94.7 mt -55.98 -46.64 80.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.513 1.149 . . . . 0.0 110.728 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 mm -59.19 -41.88 85.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.895 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.93 -50.03 4.8 Favored Glycine 0 CA--C 1.553 2.415 0 CA-C-O 122.877 1.265 . . . . 0.0 110.499 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.702 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.3 m -58.0 -27.62 63.67 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 111.942 -2.129 . . . . 0.0 112.41 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 99.6 m -76.43 -32.65 58.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.39 -25.21 61.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.497 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 10.3 p -54.61 -52.23 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 120.451 1.478 . . . . 0.0 109.306 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.83 -31.46 66.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.014 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.26 -46.55 73.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.342 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 73.6 m -77.16 -22.53 52.38 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 120.906 0.384 . . . . 0.0 111.281 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -84.07 -18.19 37.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.003 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -80.98 -41.89 22.06 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.731 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.555 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -68.44 -39.51 16.03 Favored Pre-proline 0 N--CA 1.483 1.175 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.8 Cg_exo -47.44 -23.29 3.26 Favored 'Trans proline' 0 C--N 1.301 -1.974 0 C-N-CA 123.886 3.057 . . . . 0.0 115.642 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.93 -46.89 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.245 0.93 . . . . 0.0 110.068 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -49.51 -27.96 4.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.4 t -70.41 -33.08 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.55 -42.51 91.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.28 -29.23 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.83 -43.4 46.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.281 1.038 . . . . 0.0 110.353 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.79 -48.77 68.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.788 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 37' ' ' SER . 35.2 m -53.74 -47.27 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.0 t -58.21 -40.97 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 122.185 0.993 . . . . 0.0 108.384 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.6 93.77 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.67 -30.61 67.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.282 0.563 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.759 ' O ' ' N ' ' A' ' 41' ' ' GLY . 66.1 m -60.91 -38.36 85.47 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.14 73.14 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.94 -51.78 14.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.024 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -94.39 5.94 50.25 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.621 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 54.58 70.29 0.99 Allowed Glycine 0 N--CA 1.469 0.899 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.541 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.38 20.46 17.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.991 0.895 . . . . 0.0 109.307 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.5 mt -46.03 -55.69 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 15.0 p-10 -67.77 -38.42 83.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.65 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 47' ' ' LEU . 35.9 m-85 -58.65 -43.8 89.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.132 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' TYR . 29.0 m -9.92 -48.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -51.96 -49.15 63.77 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.368 0.604 . . . . 0.0 111.628 -178.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.97 -57.7 22.29 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.77 -27.96 75.83 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.791 1.661 . . . . 0.0 112.699 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.11 -30.79 60.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 111.024 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.49 -41.62 93.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.226 0.536 . . . . 0.0 110.083 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.01 93.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.588 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.78 -51.1 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.158 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.34 -41.67 94.07 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.457 0.571 . . . . 0.0 111.416 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.53 -41.48 92.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.814 0.816 . . . . 0.0 109.352 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.97 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.252 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.87 -30.78 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -71.32 -41.13 70.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 111.608 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 pt -64.79 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.482 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.11 -31.74 14.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.611 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.66 -26.38 61.61 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.44 -37.02 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.027 0.83 . . . . 0.0 111.607 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -33.31 74.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.325 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.785 ' O ' ' N ' ' A' ' 68' ' ' ALA . 76.1 mtp85 -65.29 -53.25 46.78 Favored 'General case' 0 C--O 1.201 -1.452 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.57 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.24 -25.08 12.95 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -82.61 -50.02 9.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.65 1.114 . . . . 0.0 112.247 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 70' ' ' ALA . 97.1 mt-30 -85.59 -10.17 56.26 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.79 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.785 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.65 -39.62 1.71 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.203 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.42 -51.63 68.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.9 -39.96 91.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.865 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t 52.26 48.15 23.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.521 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.0 p -155.07 162.04 41.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.6 p -70.53 149.86 95.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.091 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.62 -21.79 38.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.052 1.835 . . . . 0.0 111.806 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -153.58 159.59 42.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.595 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -138.25 101.97 4.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.205 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -63.39 -42.67 98.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.68 -170.73 54.92 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.3 t -121.18 127.36 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -60.81 -43.51 98.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 tptm . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.471 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.02 -44.77 83.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -131.74 71.13 80.99 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.07 -9.45 19.28 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.907 2.405 . . . . 0.0 112.922 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -78.38 -51.14 10.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -81.3 -31.07 33.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.433 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.08 -46.98 86.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.322 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 8.5 mp -77.05 -20.65 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.653 1.181 . . . . 0.0 112.129 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.1 -33.34 75.57 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.921 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.14 -39.29 82.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.8 p -64.09 -53.19 53.65 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.439 ' O ' ' OG1' ' A' ' 16' ' ' THR . 12.6 pt -53.35 -45.81 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 122.337 1.065 . . . . 0.0 111.451 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.3 mt -60.42 -44.09 95.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.146 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -29.25 26.53 Favored Glycine 0 CA--C 1.551 2.312 0 CA-C-O 122.399 1.0 . . . . 0.0 112.183 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 m -75.64 -27.88 58.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.988 -1.606 . . . . 0.0 112.6 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 95.3 m -77.3 -32.93 55.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.07 -27.38 60.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.32 -52.3 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 117.667 -1.613 . . . . 0.0 109.835 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.62 69.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.543 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.29 -47.17 68.35 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.231 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.474 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 86.3 p -75.81 -18.95 59.3 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.918 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 t -75.42 -16.98 60.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.796 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -67.38 -39.76 22.41 Favored Pre-proline 0 N--CA 1.481 1.089 0 CA-C-N 120.692 1.587 . . . . 0.0 114.719 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 69.9 Cg_exo -45.08 -22.78 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 124.051 3.167 . . . . 0.0 114.987 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.79 -44.71 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.78 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 mp -49.6 -26.7 3.79 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.18 -33.35 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -51.7 -33.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.79 -29.82 65.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 tp -75.7 -42.92 49.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.26 -47.5 84.11 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 113.345 -1.752 . . . . 0.0 112.677 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -52.98 -45.91 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.46 -39.04 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.304 1.049 . . . . 0.0 108.269 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.99 95.61 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.04 -29.75 66.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.733 -0.733 . . . . 0.0 110.507 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' GLY . 67.1 m -60.52 -38.59 84.88 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.39 71.6 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.02 -53.76 6.7 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.132 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLY . 81.5 p -107.42 -13.48 15.08 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.4 115.19 0.01 OUTLIER Glycine 0 N--CA 1.47 0.947 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.855 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -129.12 23.31 5.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.852 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.09 -62.44 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -67.66 -41.9 83.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 47' ' ' LEU . 66.1 m-85 -59.26 -46.53 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.454 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 11.7 p -10.77 -48.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -52.06 -49.79 62.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.167 0.508 . . . . 0.0 111.842 -178.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.61 -56.74 30.16 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.2 -25.52 80.24 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.723 1.616 . . . . 0.0 112.277 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.83 65.98 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.09 -38.23 90.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.14 97.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.049 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.91 -51.74 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.504 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -59.06 -40.81 86.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.654 0.661 . . . . 0.0 110.205 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' O ' ' OG1' ' A' ' 58' ' ' THR . 6.1 mm -64.4 -41.74 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.8 0.81 . . . . 0.0 109.023 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.05 97.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.073 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.37 -51.0 69.34 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 41.3 p -51.62 -38.68 55.74 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.916 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.29 -44.39 94.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.345 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.94 -34.54 20.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.11 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -62.6 -52.49 63.17 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.405 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 1.8 mp -49.44 -38.63 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.345 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.27 -43.54 81.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.313 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' ALA . 78.6 ttt-85 -79.38 -21.5 45.63 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.651 0.78 . . . . 0.0 112.823 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.9 ttmt -72.27 -31.34 65.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -77.2 -60.06 2.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ALA . 77.1 mt-30 -61.95 -14.45 34.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.82 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.92 -38.01 2.06 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -56.97 15.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.088 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -62.14 -40.27 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 72' ' ' SER . 5.1 t 62.15 70.79 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 71' ' ' SER . 4.0 p 85.16 141.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.903 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.9 m -56.82 112.24 4.3 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.638 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.82 141.83 95.96 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.663 1.575 . . . . 0.0 112.223 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -75.29 -12.34 60.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.871 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -67.11 -31.96 72.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.6 -41.89 91.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.484 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.84 -158.13 52.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t 57.55 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.45 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -61.96 -22.51 65.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.262 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -152.86 42.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.29 150.88 97.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.104 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.12 -14.59 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.462 2.108 . . . . 0.0 113.494 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -77.63 -52.14 9.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.433 0.635 . . . . 0.0 112.63 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -80.45 -30.43 37.55 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.422 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -47.91 80.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.439 -1.709 . . . . 0.0 109.998 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.36 -21.0 56.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.779 1.231 . . . . 0.0 112.247 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -66.52 -33.35 75.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.872 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.07 -38.63 80.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 15' ' ' THR . 67.2 m -71.16 -52.54 18.63 Favored 'General case' 0 C--O 1.199 -1.553 0 C-N-CA 118.928 -1.109 . . . . 0.0 112.311 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 12' ' ' ILE . 97.2 mt -57.78 -49.81 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 122.395 1.093 . . . . 0.0 112.763 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.23 -37.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.48 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.35 -50.93 4.09 Favored Glycine 0 CA--C 1.554 2.498 0 CA-C-O 122.991 1.329 . . . . 0.0 111.103 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.701 ' N ' ' O ' ' A' ' 11' ' ' SER . 66.3 m -57.29 -27.39 62.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.536 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -76.22 -29.14 57.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.83 -24.52 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' CG1' ' H ' ' A' ' 19' ' ' ALA . 11.3 p -54.06 -51.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.028 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.487 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -56.49 -30.7 63.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.413 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.15 -47.97 63.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.519 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 86.1 p -76.48 -21.92 55.2 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.382 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.0 m -84.31 -15.52 46.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.577 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.404 ' CZ ' ' OH ' ' A' ' 60' ' ' TYR . 2.6 m-85 -82.53 -42.46 18.35 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.633 178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -69.42 -37.62 8.86 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -176.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 24' ' ' THR . 84.5 Cg_exo -47.18 -23.11 2.69 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 124.029 3.153 . . . . 0.0 115.931 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 7.7 p -58.59 -41.62 82.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.628 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 55.6 tp -50.08 -27.95 6.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 m -70.25 -29.41 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.081 0.467 . . . . 0.0 111.709 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.25 -42.52 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tt -51.42 -53.28 38.35 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.573 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.2 mp -54.13 -40.14 67.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.81 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.16 99.22 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 59.8 t -55.39 -48.95 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.54 -38.87 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.57 -43.63 95.99 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.07 -29.75 66.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.6 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.3 t -59.48 -39.44 83.72 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.82 75.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -77.92 -54.41 6.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.217 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' GLY . 67.2 p -107.92 -13.2 15.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 50.19 113.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.86 0 CA-C-N 115.069 -0.968 . . . . 0.0 113.133 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -131.75 22.78 4.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.898 0.479 . . . . 0.0 110.235 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 mp -45.24 -58.62 3.14 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 p-10 -65.48 -39.37 91.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.353 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' LEU . 29.6 m-85 -58.23 -41.77 84.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.05 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' C ' ' O ' ' A' ' 45' ' ' TYR . 31.5 m -10.74 -49.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.8 tp -55.74 -47.95 76.08 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.093 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.38 -57.4 27.27 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.402 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.76 -25.2 5.55 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.056 1.837 . . . . 0.0 112.795 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.39 -30.84 71.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.474 0.178 . . . . 0.0 110.643 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 8.0 mp -64.96 -40.11 94.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.534 0.683 . . . . 0.0 109.388 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.09 97.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.357 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.62 -50.82 78.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.967 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.17 -40.41 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.475 0.58 . . . . 0.0 110.433 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.67 -42.63 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.7 -42.41 97.23 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.862 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -51.27 63.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -51.9 -41.96 62.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.382 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -44.23 95.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.356 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' OH ' ' CZ ' ' A' ' 23' ' ' PHE . 66.8 t80 -55.55 -35.2 65.44 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.06 -26.55 63.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.86 -41.47 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -69.23 -37.64 78.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.545 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 68' ' ' ALA . 31.3 ptt180 -78.89 -19.76 51.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.127 0.571 . . . . 0.0 112.282 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -72.24 -28.01 62.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.285 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.59 -60.32 2.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 89.0 mt-30 -61.49 -14.52 29.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.657 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -43.46 -38.96 3.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.764 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.3 p-10 -55.54 -57.72 10.76 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' H ' ' CG ' ' A' ' 69' ' ' ASP . . . -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 72' ' ' SER . 4.7 t 64.92 47.85 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.467 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . 10.5 m 59.93 138.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.524 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.63 -63.53 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.38 147.22 77.34 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.959 1.773 . . . . 0.0 111.876 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.12 -44.79 96.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -156.86 -14.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.1 43.19 30.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.57 136.6 13.17 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.98 -45.44 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.753 0.311 . . . . 0.0 110.306 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.58 148.08 25.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.555 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.9 tttt 48.39 53.35 12.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 109.748 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -72.11 149.81 92.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.659 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.54 67.75 7.11 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.403 2.069 . . . . 0.0 111.388 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.19 -51.43 10.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.523 0.678 . . . . 0.0 112.063 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -81.04 -30.43 34.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.838 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.48 -43.44 97.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.27 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 tp -77.85 -23.39 48.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.335 1.454 . . . . 0.0 112.518 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -67.42 -32.03 72.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.863 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.09 -40.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.1 t -63.75 -52.59 59.69 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 119.464 1.029 . . . . 0.0 111.051 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.45 ' O ' ' OG1' ' A' ' 16' ' ' THR . 95.8 mt -55.82 -46.53 79.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.779 1.276 . . . . 0.0 110.863 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.99 -42.32 85.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.832 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.15 -50.61 4.49 Favored Glycine 0 CA--C 1.551 2.324 0 CA-C-O 122.924 1.291 . . . . 0.0 110.623 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.707 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.9 m -57.03 -27.85 62.0 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.005 -2.097 . . . . 0.0 112.478 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 98.6 m -76.86 -32.39 57.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 0.0 111.868 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.07 -25.01 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.55 ' CG2' ' H ' ' A' ' 19' ' ' ALA . 32.3 m -61.74 -55.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.976 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' H ' ' CG2' ' A' ' 18' ' ' VAL . . . -57.6 -31.76 66.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.068 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.47 -43.11 91.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.406 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 83.8 p -75.75 -17.64 59.83 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.131 0.491 . . . . 0.0 110.574 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 51.9 p -76.66 -15.5 59.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.821 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -84.47 -41.19 16.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.272 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -68.1 -38.52 13.97 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 120.869 1.668 . . . . 0.0 114.2 -177.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.5 Cg_exo -46.35 -23.45 2.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.877 3.052 . . . . 0.0 114.847 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 10.5 p -59.0 -42.31 85.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.642 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 57.1 tp -49.85 -27.87 5.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 m -71.01 -29.3 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.27 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.2 mm -60.93 -43.06 95.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 4.1 mm? -55.64 -52.11 64.91 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.553 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -55.41 -41.27 72.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.88 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.51 -44.14 97.08 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.98 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.73 -50.66 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.49 ' O ' ' OG ' ' A' ' 37' ' ' SER . 60.7 t -59.24 -42.07 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.299 1.047 . . . . 0.0 108.871 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.32 95.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.27 -30.81 66.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.31 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.716 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.7 p -60.55 -35.58 76.37 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.55 76.88 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.137 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.1 mm? -74.96 -51.63 13.21 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.285 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -96.73 3.75 52.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.655 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 55.47 70.18 1.04 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.0 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.59 19.8 18.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.069 0.935 . . . . 0.0 109.541 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -45.84 -56.75 4.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -66.48 -39.48 88.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.917 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.602 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.8 m-85 -57.41 -41.22 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.974 -0.536 . . . . 0.0 111.12 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 45' ' ' TYR . 60.1 t -11.04 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' TYR . 4.0 mm? -54.31 -47.84 71.99 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 mp -61.14 -59.11 14.78 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.64 -24.88 4.95 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.793 1.662 . . . . 0.0 112.59 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.48 -29.96 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.853 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.5 mm? -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.432 0.634 . . . . 0.0 109.554 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.01 97.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.606 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -62.75 -51.05 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.605 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.97 -40.52 85.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.657 0.662 . . . . 0.0 110.5 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 55' ' ' ILE . 86.3 mt -65.31 -42.36 93.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.0 109.781 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.28 -43.48 96.9 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.225 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.49 -49.8 73.95 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.769 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.7 m -52.95 -41.95 65.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.14 -44.16 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.768 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.05 -39.86 72.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -72.77 -53.86 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.082 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.4 mt -50.18 -45.2 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 67' ' ' GLN . 3.2 pp0? -68.46 -33.8 74.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.086 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -78.02 -21.81 50.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.137 0.975 . . . . 0.0 111.593 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' ALA . 18.8 tptm -76.54 -33.71 58.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -83.24 -39.74 20.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.596 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 70' ' ' ALA . 10.7 pt20 -86.13 -11.59 52.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.624 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.82 -39.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.791 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -60.81 -51.85 67.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -62.37 -40.44 96.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.483 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 70' ' ' ALA . 2.7 p 78.34 162.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.275 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -60.84 -41.34 95.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.527 ' HG1' ' CG2' ' A' ' 15' ' ' THR . 37.9 p -125.06 80.47 64.12 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.96 -39.11 69.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.77 2.314 . . . . 0.0 112.589 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp 51.88 44.27 29.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.496 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -127.77 128.04 44.64 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 62.61 155.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.68 -173.83 46.4 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.75 138.77 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.426 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.48 145.18 45.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 tptp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.463 179.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -62.16 -39.81 93.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.898 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 48.74 57.05 18.4 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.39 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.15 -14.37 37.9 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.008 2.472 . . . . 0.0 112.704 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -77.73 -51.02 11.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.1 p -80.99 -29.87 35.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.134 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.71 -46.38 88.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.233 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.46 -21.12 53.39 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.573 1.149 . . . . 0.0 112.397 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -68.25 -36.56 79.64 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.382 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.5 -32.51 36.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 15' ' ' THR . 69.2 m -74.42 -53.88 8.69 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-N 119.97 1.259 . . . . 0.0 111.866 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 13' ' ' ILE . 23.5 pt -54.72 -48.83 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 122.501 1.143 . . . . 0.0 112.686 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 ' N ' HG13 ' A' ' 12' ' ' ILE . 19.9 tt -59.54 -38.81 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.908 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.28 -51.79 3.81 Favored Glycine 0 CA--C 1.549 2.171 0 CA-C-O 122.963 1.313 . . . . 0.0 110.448 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.703 ' N ' ' O ' ' A' ' 11' ' ' SER . 36.3 m -56.93 -27.54 61.11 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 111.851 -2.174 . . . . 0.0 112.222 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 98.6 m -77.4 -32.77 55.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 tp -74.03 -26.52 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.41 -51.7 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 117.668 -1.613 . . . . 0.0 109.313 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -32.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.522 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.82 -44.33 81.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.045 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 t -75.9 -23.64 55.55 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 p -70.29 -13.49 62.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.867 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -80.36 -39.92 27.61 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.702 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 27.3 m -64.79 -39.24 37.11 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.673 1.578 . . . . 0.0 115.158 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 24' ' ' THR . 70.9 Cg_exo -44.41 -21.9 0.5 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.692 2.928 . . . . 0.0 115.386 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -60.38 -44.4 95.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.271 0.941 . . . . 0.0 110.172 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.16 -26.28 2.72 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.0 -29.94 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.713 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -57.11 -34.12 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.62 -52.85 63.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.447 0.567 . . . . 0.0 110.614 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.91 -40.26 75.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.678 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.64 98.7 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' SER . 54.3 t -56.62 -50.35 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.76 -42.64 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.24 -44.99 96.06 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.42 -33.3 72.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.535 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 41' ' ' GLY . 73.3 m -61.96 -39.77 93.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.07 -37.78 75.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.96 -53.62 6.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.883 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 m -107.83 -16.23 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 57.01 94.4 0.01 OUTLIER Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.966 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.92 20.89 13.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 91.8 mt -46.26 -56.82 5.22 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.164 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.742 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.6 m-85 -55.77 -41.65 74.33 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.492 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 43' ' ' LEU . 9.8 p -20.56 -14.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.742 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.8 tt -88.65 -47.03 8.56 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.047 0.84 . . . . 0.0 110.15 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 9.3 mp -60.5 -45.51 97.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.577 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 55.9 Cg_endo -68.35 -25.29 36.21 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.576 1.518 . . . . 0.0 112.453 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.68 -30.1 63.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.648 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.26 -39.05 93.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.36 92.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.162 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.29 -50.84 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.533 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -59.74 -38.64 82.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.055 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.426 ' O ' ' OG1' ' A' ' 58' ' ' THR . 87.8 mt -65.02 -41.14 91.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.837 0.827 . . . . 0.0 109.127 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.94 99.14 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.109 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.01 -49.62 75.29 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.817 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 50.1 p -51.56 -37.92 51.9 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.292 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.86 -44.72 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.192 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -48.17 -33.15 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.321 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.85 63.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 1.6 mp -73.76 -43.27 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 118.397 0.544 . . . . 0.0 112.2 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.2 -39.94 93.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.417 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 68' ' ' ALA . 15.9 mmm180 -66.26 -54.48 24.41 Favored 'General case' 0 C--O 1.204 -1.299 0 C-N-CA 118.894 -1.123 . . . . 0.0 108.515 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -52.03 -25.74 9.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -83.63 -51.89 6.91 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 119.354 0.979 . . . . 0.0 113.146 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' ALA . 8.8 pt20 -86.47 -11.47 51.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.595 1.158 . . . . 0.0 112.725 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.75 -42.89 2.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.274 -174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.79 -50.27 74.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.48 -38.9 88.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.41 ' OG ' ' NH1' ' A' ' 64' ' ' ARG . 28.6 t -57.45 -17.08 11.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.202 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.2 m -59.15 -40.84 86.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.967 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.36 -56.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.069 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.36 151.32 53.85 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.945 1.763 . . . . 0.0 112.392 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? 46.13 90.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.789 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -138.52 127.5 23.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.379 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.8 t30 54.2 42.87 31.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.65 -131.84 52.25 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.02 141.91 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.797 0.332 . . . . 0.0 110.481 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' CG ' ' H ' ' A' ' 81' ' ' LYS . 14.5 tptp 50.64 -136.87 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.537 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' H ' ' CG ' ' A' ' 80' ' ' LYS . 65.0 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.408 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 53.91 42.02 31.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 23.7 p-10 -132.62 59.27 42.09 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 120.761 0.315 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.7 65.88 7.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.15 -50.38 12.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.723 0.773 . . . . 0.0 112.244 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.3 p -80.91 -29.97 35.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.043 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.47 -43.15 98.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.58 -1.645 . . . . 0.0 109.653 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.6 -23.0 46.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.4 1.48 . . . . 0.0 112.918 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -67.78 -35.03 77.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.868 -1.514 . . . . 0.0 113.524 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.01 -31.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -68.56 -53.5 22.56 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 120.037 1.289 . . . . 0.0 111.249 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 ' O ' ' OG1' ' A' ' 16' ' ' THR . 17.3 tt -53.99 -44.92 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 122.505 1.145 . . . . 0.0 110.781 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 72.8 mt -59.48 -41.93 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 113.008 -1.906 . . . . 0.0 111.535 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.57 -51.21 4.16 Favored Glycine 0 CA--C 1.548 2.101 0 CA-C-O 122.936 1.298 . . . . 0.0 110.589 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.686 ' N ' ' O ' ' A' ' 11' ' ' SER . 32.3 m -56.91 -28.83 62.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.875 -2.162 . . . . 0.0 113.085 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 12' ' ' ILE . 33.2 p -78.09 -30.01 49.38 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.802 -0.561 . . . . 0.0 112.104 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -74.14 -27.54 60.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.98 -52.26 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 117.598 -1.641 . . . . 0.0 109.681 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.29 -31.92 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.982 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tt -67.7 -44.61 77.32 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.673 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 80.5 p -75.17 -16.28 60.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.027 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -78.26 -19.12 54.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.496 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -41.46 17.09 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.308 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.2 p -68.92 -37.2 8.91 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 120.837 1.653 . . . . 0.0 115.027 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 24' ' ' THR . 82.5 Cg_exo -47.13 -22.96 2.51 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.893 3.062 . . . . 0.0 115.041 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -57.98 -38.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.806 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -50.52 -26.52 5.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -70.16 -29.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.11 -41.57 86.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.35 -50.74 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.009 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 31' ' ' LEU . 10.0 mp -56.14 -40.62 74.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.054 0.843 . . . . 0.0 110.178 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.22 -43.59 98.33 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 55.3 t -56.26 -50.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.1 -42.22 85.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 122.161 0.981 . . . . 0.0 109.01 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -46.09 94.35 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.6 -31.08 67.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.311 0.577 . . . . 0.0 110.649 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' GLY . 47.0 t -61.51 -41.35 97.17 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.92 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.77 76.0 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.82 -51.49 13.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.244 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.1 p -95.77 4.83 52.56 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 53.47 72.88 0.47 Allowed Glycine 0 N--CA 1.469 0.858 0 CA-C-N 115.613 -0.722 . . . . 0.0 114.015 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.62 20.6 15.82 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -46.27 -55.59 6.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.6 p-10 -68.31 -38.83 82.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.906 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.3 m-85 -58.98 -41.37 87.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.784 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 45' ' ' TYR . 11.8 p -11.27 -47.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 45' ' ' TYR . 97.3 mt -55.65 -46.41 77.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.081 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.7 mt -62.67 -59.95 11.24 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.341 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.9 -26.08 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.509 1.472 . . . . 0.0 112.066 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.14 66.41 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.017 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.13 -39.54 93.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.521 0.677 . . . . 0.0 109.484 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.77 97.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.428 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.93 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.495 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -59.5 -41.44 89.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.63 0.65 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 55' ' ' ILE . 82.8 mt -65.6 -43.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 0.0 109.983 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.2 97.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.925 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.56 -50.62 70.61 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.4 m -53.3 -42.26 66.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.016 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -43.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.48 -37.32 72.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -74.16 -55.49 6.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.007 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.2 pt -50.59 -38.01 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.031 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.629 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 20.6 pt20 -70.02 -36.83 75.38 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.87 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -78.11 -20.36 52.32 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.697 0.799 . . . . 0.0 111.424 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.4 ttpt -71.52 -31.21 66.81 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.645 -1.161 . . . . 0.0 113.897 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -78.08 -60.84 2.21 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.0 mp0 -60.68 -12.68 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.752 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -31.91 0.52 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.958 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -54.48 -55.56 27.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.39 -40.16 89.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 70' ' ' ALA . 6.1 p 64.78 11.92 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.727 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.3 p -153.96 161.77 41.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.52 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.39 -62.25 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.431 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 149.68 68.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.009 1.806 . . . . 0.0 111.965 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -150.21 136.91 19.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -127.2 145.35 50.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -61.35 -40.71 95.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.458 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.39 162.65 27.92 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.43 -34.51 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.08 131.58 47.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.375 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.555 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 CA-C-O 121.012 0.338 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -77.68 -49.31 14.75 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.808 0.813 . . . . 0.0 112.741 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.4 p -79.59 -28.86 41.04 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.097 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.8 mm? -62.49 -45.21 94.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.753 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.15 -21.92 53.37 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.012 1.325 . . . . 0.0 112.525 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -66.39 -33.77 76.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.259 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 7' ' ' LEU . 5.3 p -65.48 -31.69 54.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' THR . 81.8 p -65.07 -52.2 57.08 Favored 'General case' 0 C--O 1.201 -1.476 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.408 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 16' ' ' THR . 95.0 mt -54.91 -46.9 76.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.742 1.258 . . . . 0.0 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.25 -44.96 93.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.692 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.87 -28.42 28.94 Favored Glycine 0 CA--C 1.556 2.607 0 CA-C-O 122.308 0.949 . . . . 0.0 112.486 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 11' ' ' SER . 55.4 m -75.41 -27.71 59.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 113.235 -1.483 . . . . 0.0 112.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 12' ' ' ILE . 28.1 p -76.51 -29.14 56.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.053 0.454 . . . . 0.0 111.46 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tp -72.03 -25.8 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.663 HG23 ' N ' ' A' ' 19' ' ' ALA . 35.4 m -59.61 -54.19 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.123 -1.431 . . . . 0.0 110.042 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -58.38 -32.26 68.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.314 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.6 -44.56 74.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.991 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 74.0 m -78.57 -26.37 45.52 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.942 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -84.32 -16.59 42.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.16 -42.86 18.48 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.675 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 p -69.21 -37.52 9.03 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 24' ' ' THR . 87.1 Cg_exo -48.2 -23.33 4.6 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 123.772 2.982 . . . . 0.0 115.506 -176.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.33 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.737 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 tp -50.25 -28.34 7.51 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.41 -34.06 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 45.5 mm -61.29 -41.14 88.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.432 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.57 -50.42 73.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.255 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.48 -40.92 84.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.859 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.6 -43.64 98.71 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.5 t -56.09 -50.17 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 37' ' ' SER . 65.1 t -60.02 -42.58 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 122.058 0.932 . . . . 0.0 109.401 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.8 -46.25 93.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.52 -29.45 68.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 0.0 110.784 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.5 p -59.69 -28.06 66.97 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -31.09 56.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.229 1.014 . . . . 0.0 109.526 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -77.5 -50.29 12.94 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.098 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -101.61 -7.97 22.25 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 52.14 39.19 49.7 Favored Glycine 0 N--CA 1.47 0.9 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.25 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.92 14.71 31.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.965 0.383 . . . . 0.0 111.332 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.663 ' O ' HG13 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -56.52 -14.29 3.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.748 -176.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.634 ' N ' HD12 ' A' ' 43' ' ' LEU . 66.3 t0 -60.79 -40.6 93.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.6 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 47' ' ' LEU . 69.2 m-85 -58.65 -41.51 86.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.923 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 43' ' ' LEU . 30.2 m -10.88 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' TYR . 61.8 tp -53.49 -47.98 69.34 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.367 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' TYR . 6.7 mp -62.15 -61.66 7.26 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.06 -26.07 13.97 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.508 1.472 . . . . 0.0 112.136 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.52 -30.63 66.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.468 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.01 -38.75 92.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.59 -42.85 97.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.566 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.93 -50.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.682 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' THR . 80.6 t80 -59.53 -40.15 86.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.787 0.721 . . . . 0.0 110.339 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.63 -42.2 92.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.892 0.853 . . . . 0.0 110.203 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.05 -44.58 66.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.445 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.9 -52.77 13.4 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.443 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 59' ' ' ILE . 11.6 t -50.74 -39.19 51.39 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.334 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.44 ' N ' HG23 ' A' ' 58' ' ' THR . 9.3 mm -65.49 -43.26 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.385 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.72 -36.77 74.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.7 72.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.075 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.91 -37.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.349 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' NE2' ' OE1' ' A' ' 67' ' ' GLN . 1.2 pp0? -67.03 -35.12 79.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.272 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 68' ' ' ALA . 57.8 ttt85 -79.09 -21.2 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.257 1.023 . . . . 0.0 111.575 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -74.84 -33.86 62.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.427 1.108 . . . . 0.0 113.381 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -81.33 -34.98 31.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.198 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 98.0 mt-30 -86.69 -12.93 46.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.469 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.67 -40.29 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.748 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.229 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo . . . . . 0 N--CA 1.501 1.967 0 N-CA-C 113.118 0.391 . . . . 0.0 113.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -77.62 -50.24 12.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.597 0.713 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.1 m -80.52 -31.6 37.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.464 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.12 -49.55 69.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.526 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.49 -23.72 50.24 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.291 1.436 . . . . 0.0 113.521 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.1 -30.56 69.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.046 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.82 -39.89 84.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -63.11 -52.49 62.38 Favored 'General case' 0 C--O 1.201 -1.478 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.863 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 16' ' ' THR . 45.0 mm -55.39 -46.61 78.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.613 1.197 . . . . 0.0 110.529 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.91 -42.65 86.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.004 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.17 -50.14 4.69 Favored Glycine 0 CA--C 1.552 2.348 0 CA-C-O 122.864 1.258 . . . . 0.0 110.7 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.715 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.2 m -57.51 -27.63 62.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.028 -2.086 . . . . 0.0 112.811 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 12' ' ' ILE . 13.1 t -77.83 -30.33 51.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.024 -0.422 . . . . 0.0 111.615 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.96 -25.66 60.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.74 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.368 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.77 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.35 -46.44 70.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.715 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 38.2 t -77.52 -26.23 50.93 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.173 0.511 . . . . 0.0 112.023 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -73.01 -14.4 61.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.607 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.7 -40.47 25.32 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.719 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 31.0 m -66.22 -39.1 25.36 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-N 120.684 1.584 . . . . 0.0 115.039 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 24' ' ' THR . 83.8 Cg_exo -45.44 -22.73 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 123.803 3.002 . . . . 0.0 115.166 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -61.61 -45.69 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.485 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.0 tp -48.86 -27.5 3.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.84 -33.6 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.5 -33.64 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.86 -49.99 75.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.44 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -55.71 -40.51 72.53 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.807 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -44.02 97.83 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.024 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 37' ' ' SER . 48.9 t -55.79 -50.34 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.06 -42.25 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.176 0.989 . . . . 0.0 108.996 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.29 -46.05 94.45 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.53 -31.43 68.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.378 0.609 . . . . 0.0 110.405 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.5 t -61.39 -40.34 93.97 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.368 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.71 75.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.158 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.86 -51.71 11.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.635 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -95.89 3.27 53.75 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.192 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.43 69.81 1.16 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.301 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 20.27 18.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.97 0.885 . . . . 0.0 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.4 tp -45.99 -59.3 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.404 0.621 . . . . 0.0 112.287 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.99 -40.81 95.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.993 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 47' ' ' LEU . 48.4 m-85 -58.65 -43.55 89.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.454 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.58 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -11.4 -48.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.7 tp -54.81 -48.58 72.6 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.711 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.39 -57.73 23.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.99 -24.93 5.78 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.717 1.612 . . . . 0.0 112.364 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.85 -30.26 70.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 51' ' ' LEU . 7.8 mp -64.94 -40.59 95.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.776 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.01 97.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.697 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.25 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.842 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 58' ' ' THR . 85.0 t80 -58.9 -40.76 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.516 0.598 . . . . 0.0 110.544 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.28 -41.62 92.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.718 0.77 . . . . 0.0 109.635 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 -40.99 98.7 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.281 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.59 -28.96 68.92 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 54' ' ' PHE . 54.9 p -72.34 -37.27 68.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.32 0.581 . . . . 0.0 110.132 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ILE . 41.3 mm -66.59 -44.62 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.294 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -57.25 -38.35 73.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.55 -27.19 62.06 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.579 -0.701 . . . . 0.0 112.166 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.63 -43.58 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 1.5 pp0? -63.76 -36.37 83.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.241 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.784 ' O ' ' N ' ' A' ' 68' ' ' ALA . 16.4 mmm180 -62.64 -53.09 59.84 Favored 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -52.42 -25.88 11.15 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -82.98 -49.35 9.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.745 1.157 . . . . 0.0 112.417 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 23.3 mp0 -85.39 -10.28 56.47 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.456 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.03 -39.5 1.94 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.082 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 t0 . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.834 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 N--CA 1.502 2.026 0 N-CA-C 113.479 0.53 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 26.5 mtpp -75.28 -42.34 55.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.862 0.839 . . . . 0.0 110.869 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -80.51 -30.14 37.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.36 -1.746 . . . . 0.0 111.231 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.06 -51.18 57.77 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.799 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.4 mp -77.52 -22.06 51.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.959 1.303 . . . . 0.0 112.919 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 7.1 mmt180 -68.32 -30.11 69.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.105 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 7' ' ' LEU . 4.8 p -70.42 -33.37 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.7 t -70.71 -53.77 14.37 Favored 'General case' 0 C--O 1.202 -1.417 0 CA-C-N 119.77 1.168 . . . . 0.0 111.815 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 13' ' ' ILE . 18.7 tt -53.58 -44.45 57.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.959 1.361 . . . . 0.0 110.198 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.52 ' N ' HG23 ' A' ' 12' ' ' ILE . 91.1 mt -60.77 -45.34 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 111.999 -2.364 . . . . 0.0 111.933 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.0 -28.26 29.03 Favored Glycine 0 CA--C 1.553 2.466 0 CA-C-O 122.449 1.027 . . . . 0.0 112.078 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.676 ' N ' ' O ' ' A' ' 11' ' ' SER . 37.2 m -75.99 -27.24 57.37 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.849 -1.676 . . . . 0.0 112.919 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 17' ' ' LEU . 13.7 t -78.15 -29.95 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 16' ' ' THR . 5.2 mp -73.56 -25.33 60.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 19' ' ' ALA . 8.4 p -58.32 -54.22 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 117.973 -1.491 . . . . 0.0 109.664 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.651 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.84 -31.56 66.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.274 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.92 -44.3 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.92 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 84.0 p -75.26 -15.84 60.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -77.38 -18.06 57.66 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.963 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HZ ' ' HH ' ' A' ' 60' ' ' TYR . 3.3 m-85 -82.87 -41.57 18.82 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.925 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.546 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 36.1 m -67.74 -38.55 15.15 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 120.679 1.581 . . . . 0.0 114.563 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.74 ' O ' HG22 ' A' ' 28' ' ' VAL . 91.9 Cg_exo -46.23 -23.42 1.96 Allowed 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.689 2.926 . . . . 0.0 115.16 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 9.6 p -59.56 -43.07 90.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 119.302 0.955 . . . . 0.0 110.223 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.519 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.5 tp -49.03 -26.59 2.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.17 -29.43 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.916 0.389 . . . . 0.0 111.957 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.8 tt -59.56 -35.99 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.262 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.14 -51.21 70.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.48 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.1 mp -55.62 -40.89 72.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.8 0.81 . . . . 0.0 109.699 -178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -44.45 96.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.009 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' SER . 53.4 t -56.32 -50.58 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.432 ' O ' ' OG ' ' A' ' 37' ' ' SER . 61.7 t -58.86 -41.89 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 122.305 1.05 . . . . 0.0 108.722 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.78 94.83 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.41 -32.11 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.26 0.552 . . . . 0.0 110.985 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' GLY . 77.7 p -62.33 -37.54 86.04 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.54 74.63 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.456 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.64 -52.02 11.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.995 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -100.4 -1.34 36.23 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.85 75.41 0.25 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 115.849 -0.614 . . . . 0.0 114.272 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.5 20.46 17.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.76 0.78 . . . . 0.0 109.193 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.1 tt -45.2 -59.63 2.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.83 -39.21 93.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' LEU . 38.5 m-85 -58.22 -41.5 84.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.286 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.0 m -11.46 -48.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 45' ' ' TYR . 85.4 mt -56.12 -47.54 77.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.749 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 51' ' ' LEU . 4.4 mm? -61.64 -57.18 26.37 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.768 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.54 -24.98 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.649 1.566 . . . . 0.0 112.6 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.75 -30.34 70.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.314 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 51' ' ' LEU . 8.9 mp -64.67 -39.26 93.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.452 0.644 . . . . 0.0 109.479 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.8 97.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -63.55 -51.35 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.618 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 58' ' ' THR . 90.4 t80 -59.35 -41.77 90.0 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.53 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.403 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.2 mm -64.37 -42.36 95.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.789 0.804 . . . . 0.0 109.266 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 -40.95 99.86 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.658 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.66 -50.93 70.54 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 54' ' ' PHE . 46.2 p -52.26 -39.2 60.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.007 0.432 . . . . 0.0 110.861 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.36 -45.63 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.69 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.4 ' HH ' ' HZ ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -52.3 -41.33 62.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -27.08 67.33 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.127 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.83 -41.85 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 4.3 pt20 -67.97 -33.25 74.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 55.0 ttt85 -78.16 -22.12 49.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.972 0.909 . . . . 0.0 113.049 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -76.77 -33.61 58.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.06 -41.02 19.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.287 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.584 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.8 pt20 -86.1 -11.55 52.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.567 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -42.25 -42.82 3.2 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.808 -174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.207 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.497 1.728 0 CA-C-O 120.822 0.259 . . . . 0.0 112.616 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -77.26 -50.39 12.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.616 0.722 . . . . 0.0 112.245 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.4 m -80.32 -30.19 38.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.227 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 10' ' ' VAL . 2.7 tt -62.67 -46.88 86.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.673 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 -21.34 56.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.048 1.339 . . . . 0.0 112.353 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -64.33 -32.09 73.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' LEU . 6.2 m -62.96 -31.02 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.724 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.9 p -63.97 -52.51 59.3 Favored 'General case' 0 C--O 1.199 -1.577 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.496 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.1 mm -54.66 -45.68 72.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.583 1.182 . . . . 0.0 110.046 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.484 ' O ' HD23 ' A' ' 17' ' ' LEU . 35.8 mm -59.11 -43.15 88.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.956 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.55 -49.81 4.73 Favored Glycine 0 CA--C 1.552 2.378 0 CA-C-O 122.924 1.291 . . . . 0.0 110.82 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.724 ' N ' ' O ' ' A' ' 11' ' ' SER . 28.5 m -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 111.869 -2.165 . . . . 0.0 112.581 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -76.25 -32.34 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.4 mm? -72.16 -25.18 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.639 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.7 p -54.49 -52.44 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 118.099 -1.44 . . . . 0.0 109.401 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.639 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.96 -31.35 66.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.735 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.36 -47.0 68.59 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.251 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 40.3 t -77.74 -27.74 50.58 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 112.092 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -83.7 -16.96 43.0 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.335 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.93 -42.95 18.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.775 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 55.2 m -68.06 -38.6 14.32 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.9 Cg_exo -47.78 -23.84 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 123.791 2.994 . . . . 0.0 116.029 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 29' ' ' ILE . 70.5 t -62.85 -46.44 96.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 119.455 1.025 . . . . 0.0 111.101 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.3 mm? -50.03 -26.67 4.55 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.4 m -72.03 -30.22 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 26' ' ' VAL . 3.8 tp -59.3 -35.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.73 -50.18 74.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.674 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.53 -40.74 79.49 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.164 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.34 -44.33 97.04 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 37' ' ' SER . 52.5 t -56.02 -50.27 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.44 -41.66 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 122.138 0.97 . . . . 0.0 108.691 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.21 -44.74 96.22 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.45 -33.27 71.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.549 0.69 . . . . 0.0 110.755 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.4 t -60.75 -40.29 91.88 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.537 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.79 75.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.07 -51.17 16.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.103 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.4 p -94.24 7.47 45.22 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.734 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.88 82.83 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.32 175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.3 21.53 10.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.4 mt -45.95 -56.59 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.528 . . . . 0.0 112.36 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.79 -39.64 87.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.905 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.9 m-85 -57.86 -41.14 81.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.134 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 47' ' ' LEU . 9.3 p -10.89 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 45' ' ' TYR . 89.7 mt -56.69 -46.14 81.36 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.566 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' TYR . 3.9 mm? -61.57 -58.38 18.84 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.82 -24.67 5.17 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.86 1.707 . . . . 0.0 112.458 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -65.52 -30.54 71.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.866 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.2 mm? -64.09 -39.34 93.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.527 0.68 . . . . 0.0 109.814 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.0 96.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.843 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 53' ' ' ILE . 2.4 mp -63.26 -50.51 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.764 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 58' ' ' THR . 52.7 m-85 -60.6 -39.1 86.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.244 0.929 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -66.85 -41.68 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.78 0.8 . . . . 0.0 109.041 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.05 -41.92 94.88 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.252 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.05 -30.75 70.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 54' ' ' PHE . 44.3 p -72.05 -37.69 69.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.5 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.68 -42.45 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.735 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.1 -34.07 13.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.486 -0.292 . . . . 0.0 111.513 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -69.68 -52.97 20.94 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.089 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.53 -43.26 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.255 0.479 . . . . 0.0 111.58 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -68.71 -36.49 78.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.911 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -20.16 50.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.861 0.864 . . . . 0.0 111.109 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 61' ' ' ALA . 65.8 tttm -72.3 -35.06 68.56 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -77.5 -60.44 2.36 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 118.759 -1.176 . . . . 0.0 107.987 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.15 -12.0 4.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.463 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.62 -37.33 1.66 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.858 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 t0 . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.737 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.5 1.868 0 CA-C-O 120.648 0.187 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -78.34 -51.28 10.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.422 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.8 p -80.73 -29.6 36.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.71 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.5 mm? -62.99 -45.76 90.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.208 -1.814 . . . . 0.0 109.689 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -76.88 -22.54 53.29 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.107 1.363 . . . . 0.0 112.184 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -65.8 -31.67 72.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.658 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.13 -38.79 83.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.077 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' THR . 74.8 m -61.36 -51.68 67.82 Favored 'General case' 0 C--O 1.201 -1.488 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 94.7 mt -55.98 -46.64 80.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.513 1.149 . . . . 0.0 110.728 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HD23 ' A' ' 17' ' ' LEU . 29.5 mm -59.19 -41.88 85.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.895 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.93 -50.03 4.8 Favored Glycine 0 CA--C 1.553 2.415 0 CA-C-O 122.877 1.265 . . . . 0.0 110.499 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.3 m -58.0 -27.62 63.67 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 111.942 -2.129 . . . . 0.0 112.41 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.6 m -76.43 -32.65 58.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.6 mm? -72.39 -25.21 61.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.3 p -54.61 -52.23 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 120.451 1.478 . . . . 0.0 109.306 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.83 -31.46 66.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.014 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.26 -46.55 73.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.342 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 73.6 m -77.16 -22.53 52.38 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 120.906 0.384 . . . . 0.0 111.281 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -84.07 -18.19 37.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.003 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -80.98 -41.89 22.06 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.731 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.555 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -68.44 -39.51 16.03 Favored Pre-proline 0 N--CA 1.483 1.175 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.8 Cg_exo -47.44 -23.29 3.26 Favored 'Trans proline' 0 C--N 1.301 -1.974 0 C-N-CA 123.886 3.057 . . . . 0.0 115.642 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.93 -46.89 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.245 0.93 . . . . 0.0 110.068 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -49.51 -27.96 4.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.4 t -70.41 -33.08 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.55 -42.51 91.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.28 -29.23 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.83 -43.4 46.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.281 1.038 . . . . 0.0 110.353 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.79 -48.77 68.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.788 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 34' ' ' VAL . 35.2 m -53.74 -47.27 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 33' ' ' VAL . 56.0 t -58.21 -40.97 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 122.185 0.993 . . . . 0.0 108.384 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.6 93.77 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.67 -30.61 67.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.282 0.563 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.759 ' O ' ' N ' ' A' ' 41' ' ' GLY . 66.1 m -60.91 -38.36 85.47 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.14 73.14 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -73.94 -51.78 14.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.024 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -94.39 5.94 50.25 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.621 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 54.58 70.29 0.99 Allowed Glycine 0 N--CA 1.469 0.899 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.541 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.38 20.46 17.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.991 0.895 . . . . 0.0 109.307 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HG22 ' A' ' 46' ' ' VAL . 92.5 mt -46.03 -55.69 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 15.0 p-10 -67.77 -38.42 83.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.65 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 47' ' ' LEU . 35.9 m-85 -58.65 -43.8 89.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.132 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 47' ' ' LEU . 29.0 m -9.92 -48.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -51.96 -49.15 63.77 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.368 0.604 . . . . 0.0 111.628 -178.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.6 mp -61.97 -57.7 22.29 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 37.1 Cg_endo -62.77 -27.96 75.83 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.791 1.661 . . . . 0.0 112.699 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.11 -30.79 60.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 111.024 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.49 -41.62 93.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.226 0.536 . . . . 0.0 110.083 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.01 93.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.588 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.78 -51.1 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.158 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.34 -41.67 94.07 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.457 0.571 . . . . 0.0 111.416 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.53 -41.48 92.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.814 0.816 . . . . 0.0 109.352 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.97 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.252 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.87 -30.78 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -71.32 -41.13 70.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 111.608 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 pt -64.79 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.482 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.11 -31.74 14.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.611 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.66 -26.38 61.61 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.44 -37.02 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.027 0.83 . . . . 0.0 111.607 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.61 -33.31 74.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.325 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.785 ' O ' ' N ' ' A' ' 68' ' ' ALA . 76.1 mtp85 -65.29 -53.25 46.78 Favored 'General case' 0 C--O 1.201 -1.452 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.57 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.24 -25.08 12.95 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -82.61 -50.02 9.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.65 1.114 . . . . 0.0 112.247 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -85.59 -10.17 56.26 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.79 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.785 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.65 -39.62 1.71 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.203 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 t0 . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.816 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.494 1.508 0 N-CA-C 112.922 0.316 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -78.38 -51.14 10.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -81.3 -31.07 33.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.433 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.08 -46.98 86.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.322 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.5 mp -77.05 -20.65 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.653 1.181 . . . . 0.0 112.129 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.1 -33.34 75.57 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.921 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.14 -39.29 82.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.8 p -64.09 -53.19 53.65 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 13' ' ' ILE . 12.6 pt -53.35 -45.81 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 122.337 1.065 . . . . 0.0 111.451 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 12' ' ' ILE . 79.3 mt -60.42 -44.09 95.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.146 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -29.25 26.53 Favored Glycine 0 CA--C 1.551 2.312 0 CA-C-O 122.399 1.0 . . . . 0.0 112.183 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 m -75.64 -27.88 58.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.988 -1.606 . . . . 0.0 112.6 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.3 m -77.3 -32.93 55.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.07 -27.38 60.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.32 -52.3 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 117.667 -1.613 . . . . 0.0 109.835 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.62 69.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.543 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 20' ' ' LEU . 2.1 tt -68.29 -47.17 68.35 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.474 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 86.3 p -75.81 -18.95 59.3 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.918 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 t -75.42 -16.98 60.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.796 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -67.38 -39.76 22.41 Favored Pre-proline 0 N--CA 1.481 1.089 0 CA-C-N 120.692 1.587 . . . . 0.0 114.719 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 69.9 Cg_exo -45.08 -22.78 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 124.051 3.167 . . . . 0.0 114.987 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.79 -44.71 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.78 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 27' ' ' LEU . 11.3 mp -49.6 -26.7 3.79 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.18 -33.35 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -51.7 -33.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.79 -29.82 65.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 tp -75.7 -42.92 49.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.26 -47.5 84.11 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 113.345 -1.752 . . . . 0.0 112.677 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' VAL . 30.8 m -52.98 -45.91 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' VAL . 53.7 t -58.46 -39.04 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.304 1.049 . . . . 0.0 108.269 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.99 95.61 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.04 -29.75 66.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.733 -0.733 . . . . 0.0 110.507 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' GLY . 67.1 m -60.52 -38.59 84.88 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.39 71.6 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.02 -53.76 6.7 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.132 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLY . 81.5 p -107.42 -13.48 15.08 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.4 115.19 0.01 OUTLIER Glycine 0 N--CA 1.47 0.947 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.855 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -129.12 23.31 5.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.852 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -46.09 -62.44 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -67.66 -41.9 83.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 47' ' ' LEU . 66.1 m-85 -59.26 -46.53 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.454 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -10.77 -48.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -52.06 -49.79 62.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.167 0.508 . . . . 0.0 111.842 -178.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.61 -56.74 30.16 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 30.1 Cg_endo -60.2 -25.52 80.24 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.723 1.616 . . . . 0.0 112.277 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.83 65.98 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.09 -38.23 90.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.14 97.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.049 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.91 -51.74 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.504 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 58' ' ' THR . 84.5 t80 -59.06 -40.81 86.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.654 0.661 . . . . 0.0 110.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 58' ' ' THR . 6.1 mm -64.4 -41.74 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.8 0.81 . . . . 0.0 109.023 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.05 97.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.073 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.37 -51.0 69.34 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 54' ' ' PHE . 41.3 p -51.62 -38.68 55.74 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.916 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.29 -44.39 94.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.345 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.94 -34.54 20.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.11 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -62.6 -52.49 63.17 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.44 -38.63 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.345 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.27 -43.54 81.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.313 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' ALA . 78.6 ttt-85 -79.38 -21.5 45.63 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.651 0.78 . . . . 0.0 112.823 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.9 ttmt -72.27 -31.34 65.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -77.2 -60.06 2.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.95 -14.45 34.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.82 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.92 -38.01 2.06 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.4 t0 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.088 175.907 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo . . . . . 0 N--CA 1.5 1.879 0 N-CA-C 113.494 0.536 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -77.63 -52.14 9.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.433 0.635 . . . . 0.0 112.63 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -80.45 -30.43 37.55 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.422 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -63.09 -47.91 80.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.439 -1.709 . . . . 0.0 109.998 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.36 -21.0 56.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.779 1.231 . . . . 0.0 112.247 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 13' ' ' ILE . 72.7 ttt-85 -66.52 -33.35 75.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.872 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.07 -38.63 80.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 15' ' ' THR . 67.2 m -71.16 -52.54 18.63 Favored 'General case' 0 C--O 1.199 -1.553 0 C-N-CA 118.928 -1.109 . . . . 0.0 112.311 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 16' ' ' THR . 97.2 mt -57.78 -49.81 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 122.395 1.093 . . . . 0.0 112.763 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 9' ' ' ARG . 2.2 pp -58.23 -37.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.48 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.35 -50.93 4.09 Favored Glycine 0 CA--C 1.554 2.498 0 CA-C-O 122.991 1.329 . . . . 0.0 111.103 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 11' ' ' SER . 66.3 m -57.29 -27.39 62.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.536 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 12' ' ' ILE . 37.9 p -76.22 -29.14 57.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.83 -24.52 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 19' ' ' ALA . 11.3 p -54.06 -51.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.028 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.627 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -56.49 -30.7 63.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.413 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -69.15 -47.97 63.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.519 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 86.1 p -76.48 -21.92 55.2 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.382 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.0 m -84.31 -15.52 46.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.577 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.53 -42.46 18.35 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.633 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -69.42 -37.62 8.86 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -176.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.677 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.5 Cg_exo -47.18 -23.11 2.69 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 124.029 3.153 . . . . 0.0 115.931 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 27' ' ' LEU . 7.7 p -58.59 -41.62 82.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.628 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 26' ' ' VAL . 55.6 tp -50.08 -27.95 6.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.25 -29.41 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.081 0.467 . . . . 0.0 111.709 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.25 -42.52 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.8 tt -51.42 -53.28 38.35 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.2 mp -54.13 -40.14 67.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.81 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.16 99.22 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 59.8 t -55.39 -48.95 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.54 -38.87 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.57 -43.63 95.99 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.07 -29.75 66.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.6 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.3 t -59.48 -39.44 83.72 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.82 75.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -77.92 -54.41 6.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.217 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' GLY . 67.2 p -107.92 -13.2 15.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 50.19 113.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.86 0 CA-C-N 115.069 -0.968 . . . . 0.0 113.133 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -131.75 22.78 4.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.898 0.479 . . . . 0.0 110.235 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.4 mp -45.24 -58.62 3.14 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 p-10 -65.48 -39.37 91.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.353 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' LEU . 29.6 m-85 -58.23 -41.77 84.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.05 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.5 m -10.74 -49.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.8 tp -55.74 -47.95 76.08 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.093 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD13 HD22 ' A' ' 51' ' ' LEU . 4.3 mm? -59.38 -57.4 27.27 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.402 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.76 -25.2 5.55 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.056 1.837 . . . . 0.0 112.795 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.39 -30.84 71.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.474 0.178 . . . . 0.0 110.643 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.0 mp -64.96 -40.11 94.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.534 0.683 . . . . 0.0 109.388 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.09 97.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.357 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.62 -50.82 78.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.967 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.17 -40.41 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.475 0.58 . . . . 0.0 110.433 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -67.67 -42.63 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.7 -42.41 97.23 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.862 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.71 -51.27 63.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -51.9 -41.96 62.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.382 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -44.23 95.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.356 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -55.55 -35.2 65.44 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.06 -26.55 63.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.86 -41.47 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 63' ' ' GLN . 17.6 pt20 -69.23 -37.64 78.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.545 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 68' ' ' ALA . 31.3 ptt180 -78.89 -19.76 51.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.127 0.571 . . . . 0.0 112.282 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -72.24 -28.01 62.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.285 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.59 -60.32 2.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 89.0 mt-30 -61.49 -14.52 29.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.657 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -43.46 -38.96 3.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.764 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.3 p-10 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 N-CA-C 111.388 -0.274 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.19 -51.43 10.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.523 0.678 . . . . 0.0 112.063 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -81.04 -30.43 34.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.838 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.48 -43.44 97.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.27 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 tp -77.85 -23.39 48.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.335 1.454 . . . . 0.0 112.518 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -67.42 -32.03 72.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.863 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.09 -40.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.1 t -63.75 -52.59 59.69 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 119.464 1.029 . . . . 0.0 111.051 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.82 -46.53 79.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.779 1.276 . . . . 0.0 110.863 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.99 -42.32 85.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.832 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.15 -50.61 4.49 Favored Glycine 0 CA--C 1.551 2.324 0 CA-C-O 122.924 1.291 . . . . 0.0 110.623 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.707 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.9 m -57.03 -27.85 62.0 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.005 -2.097 . . . . 0.0 112.478 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -76.86 -32.39 57.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 0.0 111.868 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.07 -25.01 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.656 HG23 ' N ' ' A' ' 19' ' ' ALA . 32.3 m -61.74 -55.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.976 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.656 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -57.6 -31.76 66.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.068 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.47 -43.11 91.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.406 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 83.8 p -75.75 -17.64 59.83 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.131 0.491 . . . . 0.0 110.574 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.9 p -76.66 -15.5 59.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.821 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -84.47 -41.19 16.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.272 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -68.1 -38.52 13.97 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 120.869 1.668 . . . . 0.0 114.2 -177.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.678 ' O ' HG22 ' A' ' 28' ' ' VAL . 79.5 Cg_exo -46.35 -23.45 2.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.877 3.052 . . . . 0.0 114.847 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 27' ' ' LEU . 10.5 p -59.0 -42.31 85.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.642 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.1 tp -49.85 -27.87 5.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.1 m -71.01 -29.3 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.27 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.2 mm -60.93 -43.06 95.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.1 mm? -55.64 -52.11 64.91 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.553 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -55.41 -41.27 72.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.88 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -63.51 -44.14 97.08 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.98 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.73 -50.66 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.24 -42.07 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.299 1.047 . . . . 0.0 108.871 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.32 95.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.4 mp -71.27 -30.81 66.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.716 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.7 p -60.55 -35.58 76.37 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.55 76.88 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.137 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.1 mm? -74.96 -51.63 13.21 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.285 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -96.73 3.75 52.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.655 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 55.47 70.18 1.04 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.0 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.59 19.8 18.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.069 0.935 . . . . 0.0 109.541 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 46' ' ' VAL . 90.2 mt -45.84 -56.75 4.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -66.48 -39.48 88.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.917 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.602 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.8 m-85 -57.41 -41.22 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.974 -0.536 . . . . 0.0 111.12 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.1 t -11.04 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' TYR . 4.0 mm? -54.31 -47.84 71.99 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 mp -61.14 -59.11 14.78 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.64 -24.88 4.95 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.793 1.662 . . . . 0.0 112.59 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.48 -29.96 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.853 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.5 mm? -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.432 0.634 . . . . 0.0 109.554 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.01 97.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.606 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -62.75 -51.05 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.605 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.97 -40.52 85.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.657 0.662 . . . . 0.0 110.5 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.31 -42.36 93.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.0 109.781 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.28 -43.48 96.9 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.225 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.49 -49.8 73.95 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.769 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.7 m -52.95 -41.95 65.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.14 -44.16 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.768 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.05 -39.86 72.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -72.77 -53.86 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.082 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.4 mt -50.18 -45.2 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 67' ' ' GLN . 3.2 pp0? -68.46 -33.8 74.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.086 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 38.4 ttp180 -78.02 -21.81 50.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.137 0.975 . . . . 0.0 111.593 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' ALA . 18.8 tptm -76.54 -33.71 58.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -83.24 -39.74 20.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.596 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 63' ' ' GLN . 10.7 pt20 -86.13 -11.59 52.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.624 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -41.82 -39.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.791 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.4 t0 . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.209 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.498 1.77 0 CA-C-O 120.764 0.235 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -77.73 -51.02 11.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.1 p -80.99 -29.87 35.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.134 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.71 -46.38 88.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.233 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.46 -21.12 53.39 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.573 1.149 . . . . 0.0 112.397 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' ILE . 67.0 ttt180 -68.25 -36.56 79.64 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.382 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.5 -32.51 36.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 15' ' ' THR . 69.2 m -74.42 -53.88 8.69 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-N 119.97 1.259 . . . . 0.0 111.866 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 13' ' ' ILE . 23.5 pt -54.72 -48.83 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 122.501 1.143 . . . . 0.0 112.686 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' N ' HG13 ' A' ' 12' ' ' ILE . 19.9 tt -59.54 -38.81 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.908 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.28 -51.79 3.81 Favored Glycine 0 CA--C 1.549 2.171 0 CA-C-O 122.963 1.313 . . . . 0.0 110.448 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.658 ' N ' ' O ' ' A' ' 11' ' ' SER . 36.3 m -56.93 -27.54 61.11 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 111.851 -2.174 . . . . 0.0 112.222 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -77.4 -32.77 55.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 tp -74.03 -26.52 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.41 -51.7 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 117.668 -1.613 . . . . 0.0 109.313 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -32.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.522 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.82 -44.33 81.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.045 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 36.8 t -75.9 -23.64 55.55 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 p -70.29 -13.49 62.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.867 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -80.36 -39.92 27.61 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.702 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 27.3 m -64.79 -39.24 37.11 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.673 1.578 . . . . 0.0 115.158 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.9 Cg_exo -44.41 -21.9 0.5 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.692 2.928 . . . . 0.0 115.386 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -60.38 -44.4 95.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.271 0.941 . . . . 0.0 110.172 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? -49.16 -26.28 2.72 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 25' ' ' PRO . 2.8 p -69.0 -29.94 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.713 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -57.11 -34.12 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.3 tt -56.62 -52.85 63.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.447 0.567 . . . . 0.0 110.614 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.91 -40.26 75.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.678 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.64 98.7 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' SER . 54.3 t -56.62 -50.35 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.76 -42.64 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.24 -44.99 96.06 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.42 -33.3 72.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.535 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 41' ' ' GLY . 73.3 m -61.96 -39.77 93.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.07 -37.78 75.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.96 -53.62 6.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.883 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 m -107.83 -16.23 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 57.01 94.4 0.01 OUTLIER Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.966 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.92 20.89 13.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 91.8 mt -46.26 -56.82 5.22 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.164 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.742 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.6 m-85 -55.77 -41.65 74.33 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.492 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 43' ' ' LEU . 9.8 p -20.56 -14.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.742 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.8 tt -88.65 -47.03 8.56 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.047 0.84 . . . . 0.0 110.15 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -60.5 -45.51 97.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.577 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 55.9 Cg_endo -68.35 -25.29 36.21 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.576 1.518 . . . . 0.0 112.453 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.68 -30.1 63.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.648 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.26 -39.05 93.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.36 92.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.162 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.29 -50.84 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.533 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' THR . 60.6 m-85 -59.74 -38.64 82.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.055 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 87.8 mt -65.02 -41.14 91.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.837 0.827 . . . . 0.0 109.127 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.94 99.14 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.109 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.01 -49.62 75.29 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.817 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PHE . 50.1 p -51.56 -37.92 51.9 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.292 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.86 -44.72 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.192 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -48.17 -33.15 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.321 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.85 63.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.6 mp -73.76 -43.27 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 118.397 0.544 . . . . 0.0 112.2 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.2 -39.94 93.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.417 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 68' ' ' ALA . 15.9 mmm180 -66.26 -54.48 24.41 Favored 'General case' 0 C--O 1.204 -1.299 0 C-N-CA 118.894 -1.123 . . . . 0.0 108.515 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -52.03 -25.74 9.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -83.63 -51.89 6.91 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 119.354 0.979 . . . . 0.0 113.146 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -86.47 -11.47 51.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.595 1.158 . . . . 0.0 112.725 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.75 -42.89 2.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.274 -174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.88 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 N-CA-C 111.29 -0.311 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.15 -50.38 12.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.723 0.773 . . . . 0.0 112.244 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.3 p -80.91 -29.97 35.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.043 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.47 -43.15 98.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.58 -1.645 . . . . 0.0 109.653 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.6 -23.0 46.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.4 1.48 . . . . 0.0 112.918 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -67.78 -35.03 77.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.868 -1.514 . . . . 0.0 113.524 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.01 -31.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -68.56 -53.5 22.56 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 120.037 1.289 . . . . 0.0 111.249 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' THR . 17.3 tt -53.99 -44.92 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 122.505 1.145 . . . . 0.0 110.781 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 12' ' ' ILE . 72.8 mt -59.48 -41.93 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 113.008 -1.906 . . . . 0.0 111.535 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.57 -51.21 4.16 Favored Glycine 0 CA--C 1.548 2.101 0 CA-C-O 122.936 1.298 . . . . 0.0 110.589 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 11' ' ' SER . 32.3 m -56.91 -28.83 62.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.875 -2.162 . . . . 0.0 113.085 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' ILE . 33.2 p -78.09 -30.01 49.38 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.802 -0.561 . . . . 0.0 112.104 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -74.14 -27.54 60.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.98 -52.26 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 117.598 -1.641 . . . . 0.0 109.681 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.29 -31.92 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.982 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 20' ' ' LEU . 3.1 tt -67.7 -44.61 77.32 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.673 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 80.5 p -75.17 -16.28 60.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.027 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -78.26 -19.12 54.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.496 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -41.46 17.09 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.308 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.2 p -68.92 -37.2 8.91 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 120.837 1.653 . . . . 0.0 115.027 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 28' ' ' VAL . 82.5 Cg_exo -47.13 -22.96 2.51 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.893 3.062 . . . . 0.0 115.041 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 27' ' ' LEU . 33.9 m -57.98 -38.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.806 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HG23 ' A' ' 26' ' ' VAL . 93.7 mt -50.52 -26.52 5.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 25' ' ' PRO . 3.9 p -70.16 -29.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.11 -41.57 86.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.35 -50.74 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.009 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -56.14 -40.62 74.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.054 0.843 . . . . 0.0 110.178 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.22 -43.59 98.33 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.26 -50.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.1 -42.22 85.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 122.161 0.981 . . . . 0.0 109.01 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -46.09 94.35 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.6 -31.08 67.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.311 0.577 . . . . 0.0 110.649 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' GLY . 47.0 t -61.51 -41.35 97.17 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.92 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.77 76.0 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.82 -51.49 13.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.244 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.1 p -95.77 4.83 52.56 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 53.47 72.88 0.47 Allowed Glycine 0 N--CA 1.469 0.858 0 CA-C-N 115.613 -0.722 . . . . 0.0 114.015 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.62 20.6 15.82 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -46.27 -55.59 6.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.6 p-10 -68.31 -38.83 82.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.906 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.3 m-85 -58.98 -41.37 87.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.784 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.8 p -11.27 -47.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 45' ' ' TYR . 97.3 mt -55.65 -46.41 77.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.081 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.7 mt -62.67 -59.95 11.24 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.341 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.9 -26.08 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.509 1.472 . . . . 0.0 112.066 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.14 66.41 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.017 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.13 -39.54 93.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.521 0.677 . . . . 0.0 109.484 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.77 97.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.428 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.93 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.495 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -59.5 -41.44 89.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.63 0.65 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.6 -43.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 0.0 109.983 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.2 97.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.925 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.56 -50.62 70.61 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.4 m -53.3 -42.26 66.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.016 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -43.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.48 -37.32 72.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -74.16 -55.49 6.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.007 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 62' ' ' ILE . 29.2 pt -50.59 -38.01 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.031 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.629 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 20.6 pt20 -70.02 -36.83 75.38 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.87 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -78.11 -20.36 52.32 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.697 0.799 . . . . 0.0 111.424 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.4 ttpt -71.52 -31.21 66.81 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.645 -1.161 . . . . 0.0 113.897 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -78.08 -60.84 2.21 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.0 mp0 -60.68 -12.68 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.752 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -31.91 0.52 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.958 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.299 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.46 -38.8 91.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 52.71 59.34 14.03 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.416 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.25 65.98 7.1 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.239 2.626 . . . . 0.0 111.24 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -77.68 -49.31 14.75 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.808 0.813 . . . . 0.0 112.741 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.4 p -79.59 -28.86 41.04 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.097 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.8 mm? -62.49 -45.21 94.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.753 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.15 -21.92 53.37 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.012 1.325 . . . . 0.0 112.525 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -66.39 -33.77 76.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.259 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 7' ' ' LEU . 5.3 p -65.48 -31.69 54.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' THR . 81.8 p -65.07 -52.2 57.08 Favored 'General case' 0 C--O 1.201 -1.476 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.408 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 16' ' ' THR . 95.0 mt -54.91 -46.9 76.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.742 1.258 . . . . 0.0 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.25 -44.96 93.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.692 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.87 -28.42 28.94 Favored Glycine 0 CA--C 1.556 2.607 0 CA-C-O 122.308 0.949 . . . . 0.0 112.486 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 11' ' ' SER . 55.4 m -75.41 -27.71 59.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 113.235 -1.483 . . . . 0.0 112.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 12' ' ' ILE . 28.1 p -76.51 -29.14 56.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.053 0.454 . . . . 0.0 111.46 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tp -72.03 -25.8 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.663 HG23 ' N ' ' A' ' 19' ' ' ALA . 35.4 m -59.61 -54.19 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.123 -1.431 . . . . 0.0 110.042 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -58.38 -32.26 68.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.314 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.6 -44.56 74.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.991 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 74.0 m -78.57 -26.37 45.52 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.942 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -84.32 -16.59 42.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.16 -42.86 18.48 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.675 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 p -69.21 -37.52 9.03 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 24' ' ' THR . 87.1 Cg_exo -48.2 -23.33 4.6 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 123.772 2.982 . . . . 0.0 115.506 -176.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.33 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.737 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 tp -50.25 -28.34 7.51 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.41 -34.06 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 45.5 mm -61.29 -41.14 88.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.432 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.57 -50.42 73.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.255 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.48 -40.92 84.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.859 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.6 -43.64 98.71 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.5 t -56.09 -50.17 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 37' ' ' SER . 65.1 t -60.02 -42.58 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 122.058 0.932 . . . . 0.0 109.401 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.8 -46.25 93.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.52 -29.45 68.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 0.0 110.784 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.5 p -59.69 -28.06 66.97 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -31.09 56.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.229 1.014 . . . . 0.0 109.526 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -77.5 -50.29 12.94 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.098 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -101.61 -7.97 22.25 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 52.14 39.19 49.7 Favored Glycine 0 N--CA 1.47 0.9 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.25 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.92 14.71 31.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.965 0.383 . . . . 0.0 111.332 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.663 ' O ' HG13 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -56.52 -14.29 3.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.748 -176.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.634 ' N ' HD12 ' A' ' 43' ' ' LEU . 66.3 t0 -60.79 -40.6 93.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.6 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 47' ' ' LEU . 69.2 m-85 -58.65 -41.51 86.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.923 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 43' ' ' LEU . 30.2 m -10.88 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' TYR . 61.8 tp -53.49 -47.98 69.34 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.367 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' TYR . 6.7 mp -62.15 -61.66 7.26 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.06 -26.07 13.97 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.508 1.472 . . . . 0.0 112.136 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.52 -30.63 66.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.468 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.01 -38.75 92.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.59 -42.85 97.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.566 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.93 -50.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.682 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' THR . 80.6 t80 -59.53 -40.15 86.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.787 0.721 . . . . 0.0 110.339 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.63 -42.2 92.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.892 0.853 . . . . 0.0 110.203 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.05 -44.58 66.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.445 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.9 -52.77 13.4 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.443 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 59' ' ' ILE . 11.6 t -50.74 -39.19 51.39 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.334 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.44 ' N ' HG23 ' A' ' 58' ' ' THR . 9.3 mm -65.49 -43.26 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.385 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.72 -36.77 74.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.7 72.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.075 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.91 -37.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.349 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' NE2' ' OE1' ' A' ' 67' ' ' GLN . 1.2 pp0? -67.03 -35.12 79.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.272 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 68' ' ' ALA . 57.8 ttt85 -79.09 -21.2 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.257 1.023 . . . . 0.0 111.575 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -74.84 -33.86 62.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.427 1.108 . . . . 0.0 113.381 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -81.33 -34.98 31.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.198 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 70' ' ' ALA . 98.0 mt-30 -86.69 -12.93 46.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.469 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.67 -40.29 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.748 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.25 -50.73 72.48 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.26 -39.49 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 59.96 -79.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.527 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ALA . 83.1 p -71.58 161.74 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.409 . . . . 0.0 111.028 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -61.38 139.37 94.8 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.72 139.92 23.51 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.508 1.472 . . . . 0.0 111.851 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -61.72 -39.45 91.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.06 -39.31 94.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.516 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.64 109.49 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.43 171.4 38.27 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.21 159.15 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.601 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.19 -39.37 92.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.565 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.439 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 63.8 mttp -77.93 136.54 38.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 56.5 m-20 -133.58 72.92 73.54 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.669 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -53.89 -24.21 30.58 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.174 2.583 . . . . 0.0 113.118 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -77.62 -50.24 12.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.597 0.713 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.1 m -80.52 -31.6 37.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.464 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 59.6 tp -65.12 -49.55 69.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.526 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.49 -23.72 50.24 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.291 1.436 . . . . 0.0 113.521 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.1 -30.56 69.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.046 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.82 -39.89 84.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -63.11 -52.49 62.38 Favored 'General case' 0 C--O 1.201 -1.478 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.863 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 16' ' ' THR . 45.0 mm -55.39 -46.61 78.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.613 1.197 . . . . 0.0 110.529 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.91 -42.65 86.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.004 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.17 -50.14 4.69 Favored Glycine 0 CA--C 1.552 2.348 0 CA-C-O 122.864 1.258 . . . . 0.0 110.7 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.715 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.2 m -57.51 -27.63 62.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.028 -2.086 . . . . 0.0 112.811 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 12' ' ' ILE . 13.1 t -77.83 -30.33 51.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.024 -0.422 . . . . 0.0 111.615 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.96 -25.66 60.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.74 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.368 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.77 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.35 -46.44 70.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.715 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 38.2 t -77.52 -26.23 50.93 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.173 0.511 . . . . 0.0 112.023 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -73.01 -14.4 61.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.607 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.7 -40.47 25.32 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.719 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 31.0 m -66.22 -39.1 25.36 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-N 120.684 1.584 . . . . 0.0 115.039 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 24' ' ' THR . 83.8 Cg_exo -45.44 -22.73 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 123.803 3.002 . . . . 0.0 115.166 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -61.61 -45.69 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.485 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.0 tp -48.86 -27.5 3.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.84 -33.6 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.5 -33.64 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.86 -49.99 75.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.44 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -55.71 -40.51 72.53 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.807 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -44.02 97.83 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.024 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 37' ' ' SER . 48.9 t -55.79 -50.34 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.06 -42.25 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.176 0.989 . . . . 0.0 108.996 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.29 -46.05 94.45 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.53 -31.43 68.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.378 0.609 . . . . 0.0 110.405 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.5 t -61.39 -40.34 93.97 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.368 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.71 75.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.158 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.86 -51.71 11.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.635 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -95.89 3.27 53.75 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.192 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.43 69.81 1.16 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.301 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 20.27 18.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.97 0.885 . . . . 0.0 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.4 tp -45.99 -59.3 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.404 0.621 . . . . 0.0 112.287 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.99 -40.81 95.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.993 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 47' ' ' LEU . 48.4 m-85 -58.65 -43.55 89.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.454 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.58 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -11.4 -48.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.7 tp -54.81 -48.58 72.6 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.711 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.39 -57.73 23.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.99 -24.93 5.78 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.717 1.612 . . . . 0.0 112.364 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.85 -30.26 70.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 51' ' ' LEU . 7.8 mp -64.94 -40.59 95.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.776 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.01 97.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.697 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.25 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.842 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 58' ' ' THR . 85.0 t80 -58.9 -40.76 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.516 0.598 . . . . 0.0 110.544 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.28 -41.62 92.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.718 0.77 . . . . 0.0 109.635 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 -40.99 98.7 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.281 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.59 -28.96 68.92 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 54' ' ' PHE . 54.9 p -72.34 -37.27 68.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.32 0.581 . . . . 0.0 110.132 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ILE . 41.3 mm -66.59 -44.62 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.294 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -57.25 -38.35 73.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.55 -27.19 62.06 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.579 -0.701 . . . . 0.0 112.166 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.63 -43.58 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 1.5 pp0? -63.76 -36.37 83.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.241 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.784 ' O ' ' N ' ' A' ' 68' ' ' ALA . 16.4 mmm180 -62.64 -53.09 59.84 Favored 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -52.42 -25.88 11.15 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -82.98 -49.35 9.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.745 1.157 . . . . 0.0 112.417 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' ALA . 23.3 mp0 -85.39 -10.28 56.47 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.456 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.03 -39.5 1.94 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.082 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.59 -51.62 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.23 -39.76 91.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.807 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.9 t 57.67 -115.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.7 m -66.21 147.94 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.989 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.9 p -70.35 152.26 95.58 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.115 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.4 67.46 7.06 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.044 1.829 . . . . 0.0 112.481 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -70.0 -21.99 63.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.141 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.77 -39.32 91.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -61.45 131.26 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.95 -164.57 48.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.7 t -112.93 124.48 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 110.429 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.4 -42.82 99.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.042 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.203 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -138.21 -23.09 1.02 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.29 131.34 93.66 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.716 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.05 -22.41 5.04 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 122.215 1.943 . . . . 0.0 113.479 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 26.5 mtpp -75.28 -42.34 55.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.862 0.839 . . . . 0.0 110.869 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -80.51 -30.14 37.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.36 -1.746 . . . . 0.0 111.231 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.06 -51.18 57.77 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.799 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.4 mp -77.52 -22.06 51.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.959 1.303 . . . . 0.0 112.919 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 7.1 mmt180 -68.32 -30.11 69.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.105 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 7' ' ' LEU . 4.8 p -70.42 -33.37 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.7 t -70.71 -53.77 14.37 Favored 'General case' 0 C--O 1.202 -1.417 0 CA-C-N 119.77 1.168 . . . . 0.0 111.815 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 13' ' ' ILE . 18.7 tt -53.58 -44.45 57.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.959 1.361 . . . . 0.0 110.198 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.52 ' N ' HG23 ' A' ' 12' ' ' ILE . 91.1 mt -60.77 -45.34 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 111.999 -2.364 . . . . 0.0 111.933 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.0 -28.26 29.03 Favored Glycine 0 CA--C 1.553 2.466 0 CA-C-O 122.449 1.027 . . . . 0.0 112.078 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.676 ' N ' ' O ' ' A' ' 11' ' ' SER . 37.2 m -75.99 -27.24 57.37 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.849 -1.676 . . . . 0.0 112.919 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 17' ' ' LEU . 13.7 t -78.15 -29.95 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 16' ' ' THR . 5.2 mp -73.56 -25.33 60.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 19' ' ' ALA . 8.4 p -58.32 -54.22 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 117.973 -1.491 . . . . 0.0 109.664 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.651 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.84 -31.56 66.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.274 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.92 -44.3 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.92 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 84.0 p -75.26 -15.84 60.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -77.38 -18.06 57.66 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.963 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HZ ' ' HH ' ' A' ' 60' ' ' TYR . 3.3 m-85 -82.87 -41.57 18.82 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.925 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.546 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 36.1 m -67.74 -38.55 15.15 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 120.679 1.581 . . . . 0.0 114.563 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.74 ' O ' HG22 ' A' ' 28' ' ' VAL . 91.9 Cg_exo -46.23 -23.42 1.96 Allowed 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.689 2.926 . . . . 0.0 115.16 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 9.6 p -59.56 -43.07 90.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 119.302 0.955 . . . . 0.0 110.223 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.519 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.5 tp -49.03 -26.59 2.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.17 -29.43 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.916 0.389 . . . . 0.0 111.957 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.8 tt -59.56 -35.99 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.262 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.14 -51.21 70.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.48 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.1 mp -55.62 -40.89 72.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.8 0.81 . . . . 0.0 109.699 -178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -44.45 96.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.009 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' SER . 53.4 t -56.32 -50.58 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.432 ' O ' ' OG ' ' A' ' 37' ' ' SER . 61.7 t -58.86 -41.89 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 122.305 1.05 . . . . 0.0 108.722 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.78 94.83 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.41 -32.11 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.26 0.552 . . . . 0.0 110.985 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' GLY . 77.7 p -62.33 -37.54 86.04 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.54 74.63 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.456 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.64 -52.02 11.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.995 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -100.4 -1.34 36.23 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.85 75.41 0.25 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 115.849 -0.614 . . . . 0.0 114.272 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.5 20.46 17.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.76 0.78 . . . . 0.0 109.193 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.1 tt -45.2 -59.63 2.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.83 -39.21 93.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' LEU . 38.5 m-85 -58.22 -41.5 84.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.286 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.0 m -11.46 -48.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 45' ' ' TYR . 85.4 mt -56.12 -47.54 77.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.749 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 51' ' ' LEU . 4.4 mm? -61.64 -57.18 26.37 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.768 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.54 -24.98 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.649 1.566 . . . . 0.0 112.6 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.75 -30.34 70.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.314 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 51' ' ' LEU . 8.9 mp -64.67 -39.26 93.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.452 0.644 . . . . 0.0 109.479 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.8 97.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -63.55 -51.35 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.618 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 58' ' ' THR . 90.4 t80 -59.35 -41.77 90.0 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.53 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.403 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.2 mm -64.37 -42.36 95.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.789 0.804 . . . . 0.0 109.266 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 -40.95 99.86 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.658 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.66 -50.93 70.54 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 54' ' ' PHE . 46.2 p -52.26 -39.2 60.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.007 0.432 . . . . 0.0 110.861 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.36 -45.63 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.69 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.4 ' HH ' ' HZ ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -52.3 -41.33 62.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -27.08 67.33 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.127 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.83 -41.85 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 4.3 pt20 -67.97 -33.25 74.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 55.0 ttt85 -78.16 -22.12 49.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.972 0.909 . . . . 0.0 113.049 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -76.77 -33.61 58.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.06 -41.02 19.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.287 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.584 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.8 pt20 -86.1 -11.55 52.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.567 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -42.25 -42.82 3.2 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.808 -174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 72' ' ' SER . 97.8 m-20 -59.52 -50.07 75.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.12 -37.89 81.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.04 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.3 m -60.98 -40.05 91.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.505 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' ASP . 40.9 t -124.84 132.34 53.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.43 . . . . 0.0 111.338 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m 50.51 59.6 16.07 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.655 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.47 150.93 58.66 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.558 2.172 . . . . 0.0 111.946 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.05 -44.07 97.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.43 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -62.66 128.27 35.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.629 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -138.3 17.62 2.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.516 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.96 168.05 54.32 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.8 t -118.91 127.01 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -62.28 -39.55 93.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.353 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 tttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.358 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -87.74 94.8 9.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.934 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.6 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 12.1 t0 -62.54 -39.51 55.98 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 22.9 Cg_exo -64.47 0.45 2.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.748 2.299 . . . . 0.0 112.616 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -77.26 -50.39 12.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.616 0.722 . . . . 0.0 112.245 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.4 m -80.32 -30.19 38.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.227 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 10' ' ' VAL . 2.7 tt -62.67 -46.88 86.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.673 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 -21.34 56.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.048 1.339 . . . . 0.0 112.353 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -64.33 -32.09 73.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' LEU . 6.2 m -62.96 -31.02 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.724 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.9 p -63.97 -52.51 59.3 Favored 'General case' 0 C--O 1.199 -1.577 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.496 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.1 mm -54.66 -45.68 72.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.583 1.182 . . . . 0.0 110.046 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.484 ' O ' HD23 ' A' ' 17' ' ' LEU . 35.8 mm -59.11 -43.15 88.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.956 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.55 -49.81 4.73 Favored Glycine 0 CA--C 1.552 2.378 0 CA-C-O 122.924 1.291 . . . . 0.0 110.82 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.724 ' N ' ' O ' ' A' ' 11' ' ' SER . 28.5 m -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 111.869 -2.165 . . . . 0.0 112.581 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -76.25 -32.34 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.4 mm? -72.16 -25.18 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.639 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.7 p -54.49 -52.44 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 118.099 -1.44 . . . . 0.0 109.401 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.96 -31.35 66.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.735 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.36 -47.0 68.59 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.251 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 40.3 t -77.74 -27.74 50.58 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 112.092 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -83.7 -16.96 43.0 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.335 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.93 -42.95 18.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.775 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 55.2 m -68.06 -38.6 14.32 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.9 Cg_exo -47.78 -23.84 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 123.791 2.994 . . . . 0.0 116.029 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 29' ' ' ILE . 70.5 t -62.85 -46.44 96.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 119.455 1.025 . . . . 0.0 111.101 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.3 mm? -50.03 -26.67 4.55 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.4 m -72.03 -30.22 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 26' ' ' VAL . 3.8 tp -59.3 -35.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.73 -50.18 74.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.674 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.53 -40.74 79.49 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.164 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.34 -44.33 97.04 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 37' ' ' SER . 52.5 t -56.02 -50.27 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.44 -41.66 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 122.138 0.97 . . . . 0.0 108.691 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.21 -44.74 96.22 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.45 -33.27 71.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.549 0.69 . . . . 0.0 110.755 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.4 t -60.75 -40.29 91.88 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.537 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.79 75.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.07 -51.17 16.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.103 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.4 p -94.24 7.47 45.22 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.734 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.88 82.83 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.32 175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.3 21.53 10.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.4 mt -45.95 -56.59 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.528 . . . . 0.0 112.36 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.79 -39.64 87.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.905 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.9 m-85 -57.86 -41.14 81.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.134 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 47' ' ' LEU . 9.3 p -10.89 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 45' ' ' TYR . 89.7 mt -56.69 -46.14 81.36 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.566 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' TYR . 3.9 mm? -61.57 -58.38 18.84 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.82 -24.67 5.17 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.86 1.707 . . . . 0.0 112.458 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -65.52 -30.54 71.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.866 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.2 mm? -64.09 -39.34 93.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.527 0.68 . . . . 0.0 109.814 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.0 96.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.843 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 53' ' ' ILE . 2.4 mp -63.26 -50.51 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.764 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 58' ' ' THR . 52.7 m-85 -60.6 -39.1 86.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.244 0.929 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -66.85 -41.68 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.78 0.8 . . . . 0.0 109.041 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.05 -41.92 94.88 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.252 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.05 -30.75 70.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 54' ' ' PHE . 44.3 p -72.05 -37.69 69.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.5 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.68 -42.45 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.735 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.1 -34.07 13.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.486 -0.292 . . . . 0.0 111.513 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -69.68 -52.97 20.94 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.089 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.53 -43.26 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.255 0.479 . . . . 0.0 111.58 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -68.71 -36.49 78.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.911 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -20.16 50.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.861 0.864 . . . . 0.0 111.109 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 61' ' ' ALA . 65.8 tttm -72.3 -35.06 68.56 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -77.5 -60.44 2.36 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 118.759 -1.176 . . . . 0.0 107.987 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ALA . 20.5 pt20 -59.15 -12.0 4.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.463 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.62 -37.33 1.66 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.858 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.64 -56.73 18.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.56 -39.52 91.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 63.19 35.43 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 110.295 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 91.0 p -156.67 164.02 38.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.6 t -131.77 140.3 37.84 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.062 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.95 152.26 62.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 112.058 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -89.2 -3.68 58.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ASN . 88.3 m-85 55.86 -177.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.284 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 79.5 m-20 55.12 109.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.22 97.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 81' ' ' LYS . 11.5 p -142.81 136.6 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.819 0.343 . . . . 0.0 110.398 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.88 -39.68 95.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' VAL . 65.0 tttp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.428 ' HZ2' HD22 ' A' ' 8' ' ' LEU . 62.1 pttt -153.48 142.85 21.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.415 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 94.2 m-20 -70.88 -48.6 14.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 3' ' ' ASP . 72.1 Cg_endo -73.18 70.66 3.77 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.604 1.536 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -78.34 -51.28 10.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.422 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.8 p -80.73 -29.6 36.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.71 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.5 mm? -62.99 -45.76 90.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.208 -1.814 . . . . 0.0 109.689 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.428 HD22 ' HZ2' ' A' ' 2' ' ' LYS . 5.9 tt -76.88 -22.54 53.29 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.107 1.363 . . . . 0.0 112.184 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -65.8 -31.67 72.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.658 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.13 -38.79 83.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.077 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' THR . 74.8 m -61.36 -51.68 67.82 Favored 'General case' 0 C--O 1.201 -1.488 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 94.7 mt -55.98 -46.64 80.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.513 1.149 . . . . 0.0 110.728 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HD23 ' A' ' 17' ' ' LEU . 29.5 mm -59.19 -41.88 85.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.895 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.93 -50.03 4.8 Favored Glycine 0 CA--C 1.553 2.415 0 CA-C-O 122.877 1.265 . . . . 0.0 110.499 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.3 m -58.0 -27.62 63.67 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 111.942 -2.129 . . . . 0.0 112.41 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.6 m -76.43 -32.65 58.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.6 mm? -72.39 -25.21 61.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.3 p -54.61 -52.23 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 120.451 1.478 . . . . 0.0 109.306 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.83 -31.46 66.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.014 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.26 -46.55 73.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.342 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 73.6 m -77.16 -22.53 52.38 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 120.906 0.384 . . . . 0.0 111.281 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -84.07 -18.19 37.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.003 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -80.98 -41.89 22.06 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.731 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.555 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -68.44 -39.51 16.03 Favored Pre-proline 0 N--CA 1.483 1.175 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.8 Cg_exo -47.44 -23.29 3.26 Favored 'Trans proline' 0 C--N 1.301 -1.974 0 C-N-CA 123.886 3.057 . . . . 0.0 115.642 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.93 -46.89 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.245 0.93 . . . . 0.0 110.068 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -49.51 -27.96 4.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.4 t -70.41 -33.08 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.55 -42.51 91.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.28 -29.23 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.83 -43.4 46.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.281 1.038 . . . . 0.0 110.353 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.79 -48.77 68.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.788 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 34' ' ' VAL . 35.2 m -53.74 -47.27 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 33' ' ' VAL . 56.0 t -58.21 -40.97 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 122.185 0.993 . . . . 0.0 108.384 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.6 93.77 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.67 -30.61 67.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.282 0.563 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.759 ' O ' ' N ' ' A' ' 41' ' ' GLY . 66.1 m -60.91 -38.36 85.47 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.14 73.14 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -73.94 -51.78 14.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.024 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -94.39 5.94 50.25 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.621 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 54.58 70.29 0.99 Allowed Glycine 0 N--CA 1.469 0.899 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.541 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.38 20.46 17.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.991 0.895 . . . . 0.0 109.307 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HG22 ' A' ' 46' ' ' VAL . 92.5 mt -46.03 -55.69 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 15.0 p-10 -67.77 -38.42 83.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.65 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 47' ' ' LEU . 35.9 m-85 -58.65 -43.8 89.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.132 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 47' ' ' LEU . 29.0 m -9.92 -48.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -51.96 -49.15 63.77 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.368 0.604 . . . . 0.0 111.628 -178.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.6 mp -61.97 -57.7 22.29 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 37.1 Cg_endo -62.77 -27.96 75.83 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.791 1.661 . . . . 0.0 112.699 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.11 -30.79 60.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 111.024 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.49 -41.62 93.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.226 0.536 . . . . 0.0 110.083 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.01 93.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.588 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.78 -51.1 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.158 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.34 -41.67 94.07 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.457 0.571 . . . . 0.0 111.416 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.53 -41.48 92.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.814 0.816 . . . . 0.0 109.352 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.97 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.252 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.87 -30.78 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -71.32 -41.13 70.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 111.608 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 pt -64.79 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.482 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.11 -31.74 14.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.611 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.66 -26.38 61.61 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.44 -37.02 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.027 0.83 . . . . 0.0 111.607 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.61 -33.31 74.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.325 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.785 ' O ' ' N ' ' A' ' 68' ' ' ALA . 76.1 mtp85 -65.29 -53.25 46.78 Favored 'General case' 0 C--O 1.201 -1.452 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.57 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.24 -25.08 12.95 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -82.61 -50.02 9.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.65 1.114 . . . . 0.0 112.247 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 70' ' ' ALA . 97.1 mt-30 -85.59 -10.17 56.26 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.79 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.785 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.65 -39.62 1.71 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.203 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.42 -51.63 68.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.9 -39.96 91.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.865 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t 52.26 48.15 23.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.521 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.0 p -155.07 162.04 41.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.6 p -70.53 149.86 95.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.091 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.62 -21.79 38.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.052 1.835 . . . . 0.0 111.806 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -153.58 159.59 42.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.595 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -138.25 101.97 4.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.205 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -63.39 -42.67 98.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.68 -170.73 54.92 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.3 t -121.18 127.36 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -60.81 -43.51 98.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 tptm . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.471 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.02 -44.77 83.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -131.74 71.13 80.99 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.07 -9.45 19.28 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.907 2.405 . . . . 0.0 112.922 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -78.38 -51.14 10.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -81.3 -31.07 33.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.433 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.08 -46.98 86.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.322 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.5 mp -77.05 -20.65 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.653 1.181 . . . . 0.0 112.129 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.1 -33.34 75.57 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.921 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.14 -39.29 82.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.8 p -64.09 -53.19 53.65 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 13' ' ' ILE . 12.6 pt -53.35 -45.81 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 122.337 1.065 . . . . 0.0 111.451 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 12' ' ' ILE . 79.3 mt -60.42 -44.09 95.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.146 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -29.25 26.53 Favored Glycine 0 CA--C 1.551 2.312 0 CA-C-O 122.399 1.0 . . . . 0.0 112.183 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 m -75.64 -27.88 58.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.988 -1.606 . . . . 0.0 112.6 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.3 m -77.3 -32.93 55.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.07 -27.38 60.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.32 -52.3 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 117.667 -1.613 . . . . 0.0 109.835 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.62 69.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.543 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 20' ' ' LEU . 2.1 tt -68.29 -47.17 68.35 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.474 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 86.3 p -75.81 -18.95 59.3 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.918 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 t -75.42 -16.98 60.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.796 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -67.38 -39.76 22.41 Favored Pre-proline 0 N--CA 1.481 1.089 0 CA-C-N 120.692 1.587 . . . . 0.0 114.719 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 69.9 Cg_exo -45.08 -22.78 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 124.051 3.167 . . . . 0.0 114.987 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.79 -44.71 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.78 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 27' ' ' LEU . 11.3 mp -49.6 -26.7 3.79 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.18 -33.35 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -51.7 -33.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.79 -29.82 65.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 tp -75.7 -42.92 49.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.26 -47.5 84.11 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 113.345 -1.752 . . . . 0.0 112.677 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' VAL . 30.8 m -52.98 -45.91 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' VAL . 53.7 t -58.46 -39.04 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.304 1.049 . . . . 0.0 108.269 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.99 95.61 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.04 -29.75 66.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.733 -0.733 . . . . 0.0 110.507 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' GLY . 67.1 m -60.52 -38.59 84.88 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.39 71.6 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.02 -53.76 6.7 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.132 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLY . 81.5 p -107.42 -13.48 15.08 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.4 115.19 0.01 OUTLIER Glycine 0 N--CA 1.47 0.947 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.855 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -129.12 23.31 5.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.852 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -46.09 -62.44 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -67.66 -41.9 83.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 47' ' ' LEU . 66.1 m-85 -59.26 -46.53 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.454 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -10.77 -48.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -52.06 -49.79 62.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.167 0.508 . . . . 0.0 111.842 -178.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.61 -56.74 30.16 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 30.1 Cg_endo -60.2 -25.52 80.24 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.723 1.616 . . . . 0.0 112.277 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.83 65.98 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.09 -38.23 90.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.14 97.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.049 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.91 -51.74 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.504 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 58' ' ' THR . 84.5 t80 -59.06 -40.81 86.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.654 0.661 . . . . 0.0 110.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 58' ' ' THR . 6.1 mm -64.4 -41.74 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.8 0.81 . . . . 0.0 109.023 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.05 97.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.073 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.37 -51.0 69.34 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 54' ' ' PHE . 41.3 p -51.62 -38.68 55.74 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.916 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.29 -44.39 94.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.345 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.94 -34.54 20.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.11 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -62.6 -52.49 63.17 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.44 -38.63 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.345 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.27 -43.54 81.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.313 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' ALA . 78.6 ttt-85 -79.38 -21.5 45.63 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.651 0.78 . . . . 0.0 112.823 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.9 ttmt -72.27 -31.34 65.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -77.2 -60.06 2.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ALA . 77.1 mt-30 -61.95 -14.45 34.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.82 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.92 -38.01 2.06 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -56.97 15.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.088 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -62.14 -40.27 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 72' ' ' SER . 5.1 t 62.15 70.79 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 71' ' ' SER . 4.0 p 85.16 141.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.903 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.9 m -56.82 112.24 4.3 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.638 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.82 141.83 95.96 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.663 1.575 . . . . 0.0 112.223 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -75.29 -12.34 60.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.871 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -67.11 -31.96 72.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.6 -41.89 91.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.484 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.84 -158.13 52.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t 57.55 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.45 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -61.96 -22.51 65.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.262 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -152.86 42.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.29 150.88 97.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.104 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.12 -14.59 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.462 2.108 . . . . 0.0 113.494 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -77.63 -52.14 9.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.433 0.635 . . . . 0.0 112.63 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -80.45 -30.43 37.55 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.422 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -63.09 -47.91 80.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.439 -1.709 . . . . 0.0 109.998 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.36 -21.0 56.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.779 1.231 . . . . 0.0 112.247 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 13' ' ' ILE . 72.7 ttt-85 -66.52 -33.35 75.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.872 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.07 -38.63 80.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 15' ' ' THR . 67.2 m -71.16 -52.54 18.63 Favored 'General case' 0 C--O 1.199 -1.553 0 C-N-CA 118.928 -1.109 . . . . 0.0 112.311 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 16' ' ' THR . 97.2 mt -57.78 -49.81 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 122.395 1.093 . . . . 0.0 112.763 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 9' ' ' ARG . 2.2 pp -58.23 -37.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.48 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.35 -50.93 4.09 Favored Glycine 0 CA--C 1.554 2.498 0 CA-C-O 122.991 1.329 . . . . 0.0 111.103 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 11' ' ' SER . 66.3 m -57.29 -27.39 62.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.536 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 12' ' ' ILE . 37.9 p -76.22 -29.14 57.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.83 -24.52 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 19' ' ' ALA . 11.3 p -54.06 -51.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.028 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.627 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -56.49 -30.7 63.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.413 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -69.15 -47.97 63.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.519 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 86.1 p -76.48 -21.92 55.2 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.382 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.0 m -84.31 -15.52 46.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.577 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.53 -42.46 18.35 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.633 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -69.42 -37.62 8.86 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -176.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.677 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.5 Cg_exo -47.18 -23.11 2.69 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 124.029 3.153 . . . . 0.0 115.931 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 27' ' ' LEU . 7.7 p -58.59 -41.62 82.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.628 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 26' ' ' VAL . 55.6 tp -50.08 -27.95 6.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.25 -29.41 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.081 0.467 . . . . 0.0 111.709 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.25 -42.52 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.8 tt -51.42 -53.28 38.35 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.2 mp -54.13 -40.14 67.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.81 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.16 99.22 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 59.8 t -55.39 -48.95 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.54 -38.87 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.57 -43.63 95.99 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.07 -29.75 66.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.6 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.3 t -59.48 -39.44 83.72 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.82 75.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -77.92 -54.41 6.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.217 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' GLY . 67.2 p -107.92 -13.2 15.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 50.19 113.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.86 0 CA-C-N 115.069 -0.968 . . . . 0.0 113.133 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -131.75 22.78 4.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.898 0.479 . . . . 0.0 110.235 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.4 mp -45.24 -58.62 3.14 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 p-10 -65.48 -39.37 91.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.353 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' LEU . 29.6 m-85 -58.23 -41.77 84.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.05 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.5 m -10.74 -49.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.8 tp -55.74 -47.95 76.08 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.093 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD13 HD22 ' A' ' 51' ' ' LEU . 4.3 mm? -59.38 -57.4 27.27 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.402 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.76 -25.2 5.55 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.056 1.837 . . . . 0.0 112.795 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.39 -30.84 71.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.474 0.178 . . . . 0.0 110.643 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.0 mp -64.96 -40.11 94.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.534 0.683 . . . . 0.0 109.388 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.09 97.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.357 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.62 -50.82 78.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.967 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.17 -40.41 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.475 0.58 . . . . 0.0 110.433 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -67.67 -42.63 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.7 -42.41 97.23 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.862 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.71 -51.27 63.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -51.9 -41.96 62.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.382 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -44.23 95.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.356 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -55.55 -35.2 65.44 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.06 -26.55 63.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.86 -41.47 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 63' ' ' GLN . 17.6 pt20 -69.23 -37.64 78.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.545 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 68' ' ' ALA . 31.3 ptt180 -78.89 -19.76 51.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.127 0.571 . . . . 0.0 112.282 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -72.24 -28.01 62.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.285 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.59 -60.32 2.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 89.0 mt-30 -61.49 -14.52 29.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.657 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -43.46 -38.96 3.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.764 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.3 p-10 -55.54 -57.72 10.76 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' N ' ' OD1' ' A' ' 69' ' ' ASP . . . -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 72' ' ' SER . 4.7 t 64.92 47.85 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.467 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . 10.5 m 59.93 138.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.524 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.465 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -152.63 -63.53 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 73' ' ' THR . 55.9 Cg_endo -67.38 147.22 77.34 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.959 1.773 . . . . 0.0 111.876 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.12 -44.79 96.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -156.86 -14.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.1 43.19 30.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.57 136.6 13.17 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.98 -45.44 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.753 0.311 . . . . 0.0 110.306 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.58 148.08 25.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.555 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.9 tttt 48.39 53.35 12.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 109.748 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -72.11 149.81 92.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.659 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.54 67.75 7.11 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.403 2.069 . . . . 0.0 111.388 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.19 -51.43 10.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.523 0.678 . . . . 0.0 112.063 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -81.04 -30.43 34.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.838 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.48 -43.44 97.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.27 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 tp -77.85 -23.39 48.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.335 1.454 . . . . 0.0 112.518 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -67.42 -32.03 72.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.863 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.09 -40.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.1 t -63.75 -52.59 59.69 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 119.464 1.029 . . . . 0.0 111.051 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.82 -46.53 79.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.779 1.276 . . . . 0.0 110.863 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.99 -42.32 85.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.832 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.15 -50.61 4.49 Favored Glycine 0 CA--C 1.551 2.324 0 CA-C-O 122.924 1.291 . . . . 0.0 110.623 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.707 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.9 m -57.03 -27.85 62.0 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.005 -2.097 . . . . 0.0 112.478 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -76.86 -32.39 57.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 0.0 111.868 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.07 -25.01 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.656 HG23 ' N ' ' A' ' 19' ' ' ALA . 32.3 m -61.74 -55.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.976 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.656 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -57.6 -31.76 66.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.068 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.47 -43.11 91.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.406 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 83.8 p -75.75 -17.64 59.83 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.131 0.491 . . . . 0.0 110.574 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.9 p -76.66 -15.5 59.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.821 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -84.47 -41.19 16.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.272 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -68.1 -38.52 13.97 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 120.869 1.668 . . . . 0.0 114.2 -177.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.678 ' O ' HG22 ' A' ' 28' ' ' VAL . 79.5 Cg_exo -46.35 -23.45 2.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.877 3.052 . . . . 0.0 114.847 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 27' ' ' LEU . 10.5 p -59.0 -42.31 85.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.642 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.1 tp -49.85 -27.87 5.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.1 m -71.01 -29.3 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.27 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.2 mm -60.93 -43.06 95.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.1 mm? -55.64 -52.11 64.91 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.553 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -55.41 -41.27 72.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.88 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -63.51 -44.14 97.08 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.98 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.73 -50.66 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.24 -42.07 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.299 1.047 . . . . 0.0 108.871 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.32 95.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.4 mp -71.27 -30.81 66.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.716 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.7 p -60.55 -35.58 76.37 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.55 76.88 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.137 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.1 mm? -74.96 -51.63 13.21 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.285 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -96.73 3.75 52.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.655 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 55.47 70.18 1.04 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.0 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.59 19.8 18.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.069 0.935 . . . . 0.0 109.541 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 46' ' ' VAL . 90.2 mt -45.84 -56.75 4.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -66.48 -39.48 88.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.917 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.602 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.8 m-85 -57.41 -41.22 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.974 -0.536 . . . . 0.0 111.12 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.1 t -11.04 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' TYR . 4.0 mm? -54.31 -47.84 71.99 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 mp -61.14 -59.11 14.78 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.64 -24.88 4.95 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.793 1.662 . . . . 0.0 112.59 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.48 -29.96 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.853 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.5 mm? -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.432 0.634 . . . . 0.0 109.554 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.01 97.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.606 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -62.75 -51.05 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.605 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.97 -40.52 85.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.657 0.662 . . . . 0.0 110.5 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.31 -42.36 93.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.0 109.781 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.28 -43.48 96.9 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.225 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.49 -49.8 73.95 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.769 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.7 m -52.95 -41.95 65.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.14 -44.16 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.768 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.05 -39.86 72.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -72.77 -53.86 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.082 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.4 mt -50.18 -45.2 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 67' ' ' GLN . 3.2 pp0? -68.46 -33.8 74.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.086 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 38.4 ttp180 -78.02 -21.81 50.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.137 0.975 . . . . 0.0 111.593 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' ALA . 18.8 tptm -76.54 -33.71 58.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -83.24 -39.74 20.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.596 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 70' ' ' ALA . 10.7 pt20 -86.13 -11.59 52.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.624 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -41.82 -39.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.791 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -60.81 -51.85 67.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -62.37 -40.44 96.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.483 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 70' ' ' ALA . 2.7 p 78.34 162.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.275 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -60.84 -41.34 95.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.473 ' OG1' ' CG2' ' A' ' 15' ' ' THR . 37.9 p -125.06 80.47 64.12 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.96 -39.11 69.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.77 2.314 . . . . 0.0 112.589 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp 51.88 44.27 29.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.496 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -127.77 128.04 44.64 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 62.61 155.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.68 -173.83 46.4 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.75 138.77 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.426 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.48 145.18 45.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 tptp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.463 179.912 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -62.16 -39.81 93.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.898 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 48.74 57.05 18.4 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.39 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.15 -14.37 37.9 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.008 2.472 . . . . 0.0 112.704 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -77.73 -51.02 11.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.1 p -80.99 -29.87 35.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.134 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.71 -46.38 88.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.233 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.46 -21.12 53.39 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.573 1.149 . . . . 0.0 112.397 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' ILE . 67.0 ttt180 -68.25 -36.56 79.64 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.382 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.5 -32.51 36.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 15' ' ' THR . 69.2 m -74.42 -53.88 8.69 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-N 119.97 1.259 . . . . 0.0 111.866 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 13' ' ' ILE . 23.5 pt -54.72 -48.83 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 122.501 1.143 . . . . 0.0 112.686 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' N ' HG13 ' A' ' 12' ' ' ILE . 19.9 tt -59.54 -38.81 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.908 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.28 -51.79 3.81 Favored Glycine 0 CA--C 1.549 2.171 0 CA-C-O 122.963 1.313 . . . . 0.0 110.448 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.658 ' N ' ' O ' ' A' ' 11' ' ' SER . 36.3 m -56.93 -27.54 61.11 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 111.851 -2.174 . . . . 0.0 112.222 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -77.4 -32.77 55.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 tp -74.03 -26.52 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.41 -51.7 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 117.668 -1.613 . . . . 0.0 109.313 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -32.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.522 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.82 -44.33 81.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.045 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 36.8 t -75.9 -23.64 55.55 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 p -70.29 -13.49 62.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.867 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -80.36 -39.92 27.61 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.702 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 27.3 m -64.79 -39.24 37.11 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.673 1.578 . . . . 0.0 115.158 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.9 Cg_exo -44.41 -21.9 0.5 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.692 2.928 . . . . 0.0 115.386 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -60.38 -44.4 95.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.271 0.941 . . . . 0.0 110.172 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? -49.16 -26.28 2.72 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 25' ' ' PRO . 2.8 p -69.0 -29.94 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.713 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -57.11 -34.12 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.3 tt -56.62 -52.85 63.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.447 0.567 . . . . 0.0 110.614 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.91 -40.26 75.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.678 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.64 98.7 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' SER . 54.3 t -56.62 -50.35 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.76 -42.64 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.24 -44.99 96.06 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.42 -33.3 72.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.535 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 41' ' ' GLY . 73.3 m -61.96 -39.77 93.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.07 -37.78 75.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.96 -53.62 6.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.883 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 m -107.83 -16.23 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 57.01 94.4 0.01 OUTLIER Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.966 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.92 20.89 13.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 91.8 mt -46.26 -56.82 5.22 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.164 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.742 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.6 m-85 -55.77 -41.65 74.33 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.492 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 43' ' ' LEU . 9.8 p -20.56 -14.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.742 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.8 tt -88.65 -47.03 8.56 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.047 0.84 . . . . 0.0 110.15 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -60.5 -45.51 97.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.577 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 55.9 Cg_endo -68.35 -25.29 36.21 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.576 1.518 . . . . 0.0 112.453 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.68 -30.1 63.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.648 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.26 -39.05 93.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.36 92.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.162 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.29 -50.84 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.533 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' THR . 60.6 m-85 -59.74 -38.64 82.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.055 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 87.8 mt -65.02 -41.14 91.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.837 0.827 . . . . 0.0 109.127 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.94 99.14 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.109 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.01 -49.62 75.29 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.817 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PHE . 50.1 p -51.56 -37.92 51.9 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.292 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.86 -44.72 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.192 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -48.17 -33.15 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.321 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.85 63.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.6 mp -73.76 -43.27 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 118.397 0.544 . . . . 0.0 112.2 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.2 -39.94 93.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.417 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 68' ' ' ALA . 15.9 mmm180 -66.26 -54.48 24.41 Favored 'General case' 0 C--O 1.204 -1.299 0 C-N-CA 118.894 -1.123 . . . . 0.0 108.515 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -52.03 -25.74 9.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -83.63 -51.89 6.91 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 119.354 0.979 . . . . 0.0 113.146 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.4 pt20 -86.47 -11.47 51.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.595 1.158 . . . . 0.0 112.725 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.75 -42.89 2.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.274 -174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.79 -50.27 74.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.48 -38.9 88.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.41 ' OG ' ' NH1' ' A' ' 64' ' ' ARG . 28.6 t -57.45 -17.08 11.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.202 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.2 m -59.15 -40.84 86.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.967 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.401 ' N ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -178.36 -56.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.069 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 73' ' ' THR . 73.5 Cg_endo -72.36 151.32 53.85 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.945 1.763 . . . . 0.0 112.392 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? 46.13 90.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.789 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -138.52 127.5 23.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.379 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.8 t30 54.2 42.87 31.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.65 -131.84 52.25 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.02 141.91 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.797 0.332 . . . . 0.0 110.481 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptp 50.64 -136.87 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.537 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.408 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 53.91 42.02 31.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 23.7 p-10 -132.62 59.27 42.09 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 120.761 0.315 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.7 65.88 7.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.15 -50.38 12.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.723 0.773 . . . . 0.0 112.244 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.3 p -80.91 -29.97 35.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.043 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.47 -43.15 98.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.58 -1.645 . . . . 0.0 109.653 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.6 -23.0 46.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.4 1.48 . . . . 0.0 112.918 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -67.78 -35.03 77.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.868 -1.514 . . . . 0.0 113.524 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.01 -31.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -68.56 -53.5 22.56 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 120.037 1.289 . . . . 0.0 111.249 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' THR . 17.3 tt -53.99 -44.92 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 122.505 1.145 . . . . 0.0 110.781 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 12' ' ' ILE . 72.8 mt -59.48 -41.93 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 113.008 -1.906 . . . . 0.0 111.535 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.57 -51.21 4.16 Favored Glycine 0 CA--C 1.548 2.101 0 CA-C-O 122.936 1.298 . . . . 0.0 110.589 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 11' ' ' SER . 32.3 m -56.91 -28.83 62.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.875 -2.162 . . . . 0.0 113.085 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' ILE . 33.2 p -78.09 -30.01 49.38 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.802 -0.561 . . . . 0.0 112.104 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -74.14 -27.54 60.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.98 -52.26 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 117.598 -1.641 . . . . 0.0 109.681 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.29 -31.92 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.982 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 20' ' ' LEU . 3.1 tt -67.7 -44.61 77.32 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.673 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 80.5 p -75.17 -16.28 60.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.027 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -78.26 -19.12 54.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.496 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -41.46 17.09 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.308 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.2 p -68.92 -37.2 8.91 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 120.837 1.653 . . . . 0.0 115.027 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 28' ' ' VAL . 82.5 Cg_exo -47.13 -22.96 2.51 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.893 3.062 . . . . 0.0 115.041 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 27' ' ' LEU . 33.9 m -57.98 -38.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.806 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HG23 ' A' ' 26' ' ' VAL . 93.7 mt -50.52 -26.52 5.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 25' ' ' PRO . 3.9 p -70.16 -29.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.11 -41.57 86.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.35 -50.74 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.009 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -56.14 -40.62 74.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.054 0.843 . . . . 0.0 110.178 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.22 -43.59 98.33 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.26 -50.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.1 -42.22 85.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 122.161 0.981 . . . . 0.0 109.01 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -46.09 94.35 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.6 -31.08 67.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.311 0.577 . . . . 0.0 110.649 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' GLY . 47.0 t -61.51 -41.35 97.17 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.92 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.77 76.0 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.82 -51.49 13.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.244 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.1 p -95.77 4.83 52.56 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 53.47 72.88 0.47 Allowed Glycine 0 N--CA 1.469 0.858 0 CA-C-N 115.613 -0.722 . . . . 0.0 114.015 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.62 20.6 15.82 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -46.27 -55.59 6.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.6 p-10 -68.31 -38.83 82.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.906 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.3 m-85 -58.98 -41.37 87.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.784 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.8 p -11.27 -47.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 45' ' ' TYR . 97.3 mt -55.65 -46.41 77.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.081 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.7 mt -62.67 -59.95 11.24 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.341 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.9 -26.08 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.509 1.472 . . . . 0.0 112.066 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.14 66.41 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.017 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.13 -39.54 93.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.521 0.677 . . . . 0.0 109.484 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.77 97.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.428 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.93 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.495 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -59.5 -41.44 89.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.63 0.65 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.6 -43.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 0.0 109.983 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.2 97.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.925 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.56 -50.62 70.61 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.4 m -53.3 -42.26 66.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.016 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -43.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.48 -37.32 72.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -74.16 -55.49 6.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.007 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 62' ' ' ILE . 29.2 pt -50.59 -38.01 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.031 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.629 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 20.6 pt20 -70.02 -36.83 75.38 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.87 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -78.11 -20.36 52.32 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.697 0.799 . . . . 0.0 111.424 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.4 ttpt -71.52 -31.21 66.81 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.645 -1.161 . . . . 0.0 113.897 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -78.08 -60.84 2.21 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.0 mp0 -60.68 -12.68 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.752 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -31.91 0.52 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.958 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -54.48 -55.56 27.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.39 -40.16 89.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 p 64.78 11.92 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.727 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.3 p -153.96 161.77 41.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.52 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.451 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -156.39 -62.25 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.431 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 73' ' ' THR . 61.0 Cg_endo -69.56 149.68 68.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.009 1.806 . . . . 0.0 111.965 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -150.21 136.91 19.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -127.2 145.35 50.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -61.35 -40.71 95.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.458 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.39 162.65 27.92 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.43 -34.51 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.08 131.58 47.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.375 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.555 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.498 1.74 0 CA-C-O 121.012 0.338 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -77.68 -49.31 14.75 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.808 0.813 . . . . 0.0 112.741 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.4 p -79.59 -28.86 41.04 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.097 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.8 mm? -62.49 -45.21 94.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.753 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.15 -21.92 53.37 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.012 1.325 . . . . 0.0 112.525 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -66.39 -33.77 76.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.259 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 7' ' ' LEU . 5.3 p -65.48 -31.69 54.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' THR . 81.8 p -65.07 -52.2 57.08 Favored 'General case' 0 C--O 1.201 -1.476 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.408 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 16' ' ' THR . 95.0 mt -54.91 -46.9 76.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.742 1.258 . . . . 0.0 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.25 -44.96 93.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.692 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.87 -28.42 28.94 Favored Glycine 0 CA--C 1.556 2.607 0 CA-C-O 122.308 0.949 . . . . 0.0 112.486 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 11' ' ' SER . 55.4 m -75.41 -27.71 59.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 113.235 -1.483 . . . . 0.0 112.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 12' ' ' ILE . 28.1 p -76.51 -29.14 56.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.053 0.454 . . . . 0.0 111.46 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tp -72.03 -25.8 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.663 HG23 ' N ' ' A' ' 19' ' ' ALA . 35.4 m -59.61 -54.19 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.123 -1.431 . . . . 0.0 110.042 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -58.38 -32.26 68.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.314 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.6 -44.56 74.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.991 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 74.0 m -78.57 -26.37 45.52 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.942 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -84.32 -16.59 42.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.16 -42.86 18.48 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.675 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 p -69.21 -37.52 9.03 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 24' ' ' THR . 87.1 Cg_exo -48.2 -23.33 4.6 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 123.772 2.982 . . . . 0.0 115.506 -176.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.33 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.737 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 tp -50.25 -28.34 7.51 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.41 -34.06 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 45.5 mm -61.29 -41.14 88.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.432 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.57 -50.42 73.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.255 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.48 -40.92 84.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.859 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.6 -43.64 98.71 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.5 t -56.09 -50.17 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 37' ' ' SER . 65.1 t -60.02 -42.58 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 122.058 0.932 . . . . 0.0 109.401 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.8 -46.25 93.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.52 -29.45 68.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 0.0 110.784 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.5 p -59.69 -28.06 66.97 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -31.09 56.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.229 1.014 . . . . 0.0 109.526 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -77.5 -50.29 12.94 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.098 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -101.61 -7.97 22.25 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 52.14 39.19 49.7 Favored Glycine 0 N--CA 1.47 0.9 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.25 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.92 14.71 31.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.965 0.383 . . . . 0.0 111.332 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.663 ' O ' HG13 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -56.52 -14.29 3.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.748 -176.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.634 ' N ' HD12 ' A' ' 43' ' ' LEU . 66.3 t0 -60.79 -40.6 93.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.6 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 47' ' ' LEU . 69.2 m-85 -58.65 -41.51 86.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.923 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 43' ' ' LEU . 30.2 m -10.88 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' TYR . 61.8 tp -53.49 -47.98 69.34 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.367 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' TYR . 6.7 mp -62.15 -61.66 7.26 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.06 -26.07 13.97 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.508 1.472 . . . . 0.0 112.136 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.52 -30.63 66.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.468 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.01 -38.75 92.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.59 -42.85 97.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.566 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.93 -50.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.682 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' THR . 80.6 t80 -59.53 -40.15 86.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.787 0.721 . . . . 0.0 110.339 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.63 -42.2 92.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.892 0.853 . . . . 0.0 110.203 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.05 -44.58 66.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.445 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.9 -52.77 13.4 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.443 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 59' ' ' ILE . 11.6 t -50.74 -39.19 51.39 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.334 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.44 ' N ' HG23 ' A' ' 58' ' ' THR . 9.3 mm -65.49 -43.26 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.385 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.72 -36.77 74.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.7 72.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.075 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.91 -37.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.349 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' NE2' ' OE1' ' A' ' 67' ' ' GLN . 1.2 pp0? -67.03 -35.12 79.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.272 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 68' ' ' ALA . 57.8 ttt85 -79.09 -21.2 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.257 1.023 . . . . 0.0 111.575 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -74.84 -33.86 62.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.427 1.108 . . . . 0.0 113.381 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -81.33 -34.98 31.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.198 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' OE1' ' NE2' ' A' ' 63' ' ' GLN . 98.0 mt-30 -86.69 -12.93 46.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.469 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.67 -40.29 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.748 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.229 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo . . . . . 0 N--CA 1.501 1.967 0 N-CA-C 113.118 0.391 . . . . 0.0 113.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -77.62 -50.24 12.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.597 0.713 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.1 m -80.52 -31.6 37.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.464 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.12 -49.55 69.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.526 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.49 -23.72 50.24 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.291 1.436 . . . . 0.0 113.521 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.1 -30.56 69.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.046 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.82 -39.89 84.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -63.11 -52.49 62.38 Favored 'General case' 0 C--O 1.201 -1.478 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.863 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 16' ' ' THR . 45.0 mm -55.39 -46.61 78.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.613 1.197 . . . . 0.0 110.529 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.91 -42.65 86.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.004 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.17 -50.14 4.69 Favored Glycine 0 CA--C 1.552 2.348 0 CA-C-O 122.864 1.258 . . . . 0.0 110.7 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.715 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.2 m -57.51 -27.63 62.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.028 -2.086 . . . . 0.0 112.811 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 12' ' ' ILE . 13.1 t -77.83 -30.33 51.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.024 -0.422 . . . . 0.0 111.615 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.96 -25.66 60.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.74 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.368 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.77 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.35 -46.44 70.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.715 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 38.2 t -77.52 -26.23 50.93 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.173 0.511 . . . . 0.0 112.023 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -73.01 -14.4 61.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.607 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.7 -40.47 25.32 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.719 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 31.0 m -66.22 -39.1 25.36 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-N 120.684 1.584 . . . . 0.0 115.039 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 24' ' ' THR . 83.8 Cg_exo -45.44 -22.73 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 123.803 3.002 . . . . 0.0 115.166 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -61.61 -45.69 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.485 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.0 tp -48.86 -27.5 3.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.84 -33.6 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.5 -33.64 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.86 -49.99 75.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.44 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -55.71 -40.51 72.53 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.807 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -44.02 97.83 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.024 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 37' ' ' SER . 48.9 t -55.79 -50.34 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.06 -42.25 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.176 0.989 . . . . 0.0 108.996 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.29 -46.05 94.45 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.53 -31.43 68.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.378 0.609 . . . . 0.0 110.405 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.5 t -61.39 -40.34 93.97 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.368 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.71 75.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.158 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.86 -51.71 11.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.635 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -95.89 3.27 53.75 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.192 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.43 69.81 1.16 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.301 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 20.27 18.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.97 0.885 . . . . 0.0 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.4 tp -45.99 -59.3 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.404 0.621 . . . . 0.0 112.287 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.99 -40.81 95.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.993 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 47' ' ' LEU . 48.4 m-85 -58.65 -43.55 89.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.454 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.58 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -11.4 -48.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.7 tp -54.81 -48.58 72.6 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.711 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.39 -57.73 23.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.99 -24.93 5.78 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.717 1.612 . . . . 0.0 112.364 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.85 -30.26 70.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 51' ' ' LEU . 7.8 mp -64.94 -40.59 95.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.776 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.01 97.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.697 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.25 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.842 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 58' ' ' THR . 85.0 t80 -58.9 -40.76 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.516 0.598 . . . . 0.0 110.544 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.28 -41.62 92.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.718 0.77 . . . . 0.0 109.635 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 -40.99 98.7 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.281 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.59 -28.96 68.92 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 54' ' ' PHE . 54.9 p -72.34 -37.27 68.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.32 0.581 . . . . 0.0 110.132 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ILE . 41.3 mm -66.59 -44.62 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.294 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -57.25 -38.35 73.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.55 -27.19 62.06 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.579 -0.701 . . . . 0.0 112.166 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.63 -43.58 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 1.5 pp0? -63.76 -36.37 83.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.241 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.784 ' O ' ' N ' ' A' ' 68' ' ' ALA . 16.4 mmm180 -62.64 -53.09 59.84 Favored 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -52.42 -25.88 11.15 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -82.98 -49.35 9.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.745 1.157 . . . . 0.0 112.417 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 23.3 mp0 -85.39 -10.28 56.47 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.456 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.03 -39.5 1.94 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.082 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 t0 . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 N--CA 1.502 2.026 0 N-CA-C 113.479 0.53 . . . . 0.0 113.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 26.5 mtpp -75.28 -42.34 55.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.862 0.839 . . . . 0.0 110.869 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -80.51 -30.14 37.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.36 -1.746 . . . . 0.0 111.231 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.06 -51.18 57.77 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.799 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.4 mp -77.52 -22.06 51.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.959 1.303 . . . . 0.0 112.919 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 7.1 mmt180 -68.32 -30.11 69.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.105 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 7' ' ' LEU . 4.8 p -70.42 -33.37 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.7 t -70.71 -53.77 14.37 Favored 'General case' 0 C--O 1.202 -1.417 0 CA-C-N 119.77 1.168 . . . . 0.0 111.815 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 13' ' ' ILE . 18.7 tt -53.58 -44.45 57.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.959 1.361 . . . . 0.0 110.198 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.52 ' N ' HG23 ' A' ' 12' ' ' ILE . 91.1 mt -60.77 -45.34 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 111.999 -2.364 . . . . 0.0 111.933 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.0 -28.26 29.03 Favored Glycine 0 CA--C 1.553 2.466 0 CA-C-O 122.449 1.027 . . . . 0.0 112.078 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.676 ' N ' ' O ' ' A' ' 11' ' ' SER . 37.2 m -75.99 -27.24 57.37 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.849 -1.676 . . . . 0.0 112.919 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 17' ' ' LEU . 13.7 t -78.15 -29.95 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 16' ' ' THR . 5.2 mp -73.56 -25.33 60.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 19' ' ' ALA . 8.4 p -58.32 -54.22 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 117.973 -1.491 . . . . 0.0 109.664 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.651 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.84 -31.56 66.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.274 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.92 -44.3 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.92 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 84.0 p -75.26 -15.84 60.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -77.38 -18.06 57.66 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.963 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HZ ' ' HH ' ' A' ' 60' ' ' TYR . 3.3 m-85 -82.87 -41.57 18.82 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.925 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.546 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 36.1 m -67.74 -38.55 15.15 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 120.679 1.581 . . . . 0.0 114.563 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.74 ' O ' HG22 ' A' ' 28' ' ' VAL . 91.9 Cg_exo -46.23 -23.42 1.96 Allowed 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.689 2.926 . . . . 0.0 115.16 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 9.6 p -59.56 -43.07 90.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 119.302 0.955 . . . . 0.0 110.223 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.519 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.5 tp -49.03 -26.59 2.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.17 -29.43 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.916 0.389 . . . . 0.0 111.957 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.8 tt -59.56 -35.99 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.262 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.14 -51.21 70.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.48 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.1 mp -55.62 -40.89 72.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.8 0.81 . . . . 0.0 109.699 -178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -44.45 96.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.009 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' SER . 53.4 t -56.32 -50.58 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.432 ' O ' ' OG ' ' A' ' 37' ' ' SER . 61.7 t -58.86 -41.89 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 122.305 1.05 . . . . 0.0 108.722 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.78 94.83 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.41 -32.11 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.26 0.552 . . . . 0.0 110.985 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' GLY . 77.7 p -62.33 -37.54 86.04 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.54 74.63 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.456 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.64 -52.02 11.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.995 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -100.4 -1.34 36.23 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.85 75.41 0.25 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 115.849 -0.614 . . . . 0.0 114.272 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.5 20.46 17.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.76 0.78 . . . . 0.0 109.193 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.1 tt -45.2 -59.63 2.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.83 -39.21 93.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' LEU . 38.5 m-85 -58.22 -41.5 84.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.286 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.0 m -11.46 -48.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 45' ' ' TYR . 85.4 mt -56.12 -47.54 77.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.749 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 51' ' ' LEU . 4.4 mm? -61.64 -57.18 26.37 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.768 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.54 -24.98 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.649 1.566 . . . . 0.0 112.6 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.75 -30.34 70.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.314 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 51' ' ' LEU . 8.9 mp -64.67 -39.26 93.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.452 0.644 . . . . 0.0 109.479 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.8 97.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -63.55 -51.35 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.618 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 58' ' ' THR . 90.4 t80 -59.35 -41.77 90.0 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.53 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.403 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.2 mm -64.37 -42.36 95.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.789 0.804 . . . . 0.0 109.266 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 -40.95 99.86 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.658 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.66 -50.93 70.54 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 54' ' ' PHE . 46.2 p -52.26 -39.2 60.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.007 0.432 . . . . 0.0 110.861 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.36 -45.63 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.69 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.4 ' HH ' ' HZ ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -52.3 -41.33 62.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -27.08 67.33 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.127 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.83 -41.85 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 4.3 pt20 -67.97 -33.25 74.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 55.0 ttt85 -78.16 -22.12 49.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.972 0.909 . . . . 0.0 113.049 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -76.77 -33.61 58.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.06 -41.02 19.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.287 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 13.9 pt20 -86.1 -11.55 52.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.567 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -42.25 -42.82 3.2 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.808 -174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.207 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo . . . . . 0 N--CA 1.497 1.728 0 CA-C-O 120.822 0.259 . . . . 0.0 112.616 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -77.26 -50.39 12.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.616 0.722 . . . . 0.0 112.245 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.4 m -80.32 -30.19 38.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.227 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 10' ' ' VAL . 2.7 tt -62.67 -46.88 86.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.673 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 -21.34 56.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.048 1.339 . . . . 0.0 112.353 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -64.33 -32.09 73.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' LEU . 6.2 m -62.96 -31.02 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.724 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.9 p -63.97 -52.51 59.3 Favored 'General case' 0 C--O 1.199 -1.577 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.496 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.1 mm -54.66 -45.68 72.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.583 1.182 . . . . 0.0 110.046 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.484 ' O ' HD23 ' A' ' 17' ' ' LEU . 35.8 mm -59.11 -43.15 88.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.956 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.55 -49.81 4.73 Favored Glycine 0 CA--C 1.552 2.378 0 CA-C-O 122.924 1.291 . . . . 0.0 110.82 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.724 ' N ' ' O ' ' A' ' 11' ' ' SER . 28.5 m -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 111.869 -2.165 . . . . 0.0 112.581 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -76.25 -32.34 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.4 mm? -72.16 -25.18 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.639 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.7 p -54.49 -52.44 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 118.099 -1.44 . . . . 0.0 109.401 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.639 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.96 -31.35 66.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.735 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.36 -47.0 68.59 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.251 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 40.3 t -77.74 -27.74 50.58 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 112.092 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -83.7 -16.96 43.0 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.335 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.93 -42.95 18.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.775 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 55.2 m -68.06 -38.6 14.32 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.9 Cg_exo -47.78 -23.84 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 123.791 2.994 . . . . 0.0 116.029 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 29' ' ' ILE . 70.5 t -62.85 -46.44 96.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 119.455 1.025 . . . . 0.0 111.101 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.3 mm? -50.03 -26.67 4.55 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.4 m -72.03 -30.22 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 26' ' ' VAL . 3.8 tp -59.3 -35.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.73 -50.18 74.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.674 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.53 -40.74 79.49 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.164 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.34 -44.33 97.04 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 37' ' ' SER . 52.5 t -56.02 -50.27 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.44 -41.66 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 122.138 0.97 . . . . 0.0 108.691 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.21 -44.74 96.22 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.45 -33.27 71.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.549 0.69 . . . . 0.0 110.755 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.4 t -60.75 -40.29 91.88 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.537 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.79 75.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.07 -51.17 16.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.103 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.4 p -94.24 7.47 45.22 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.734 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.88 82.83 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.32 175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.3 21.53 10.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.4 mt -45.95 -56.59 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.528 . . . . 0.0 112.36 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.79 -39.64 87.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.905 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.9 m-85 -57.86 -41.14 81.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.134 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 47' ' ' LEU . 9.3 p -10.89 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 45' ' ' TYR . 89.7 mt -56.69 -46.14 81.36 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.566 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' TYR . 3.9 mm? -61.57 -58.38 18.84 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.82 -24.67 5.17 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.86 1.707 . . . . 0.0 112.458 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -65.52 -30.54 71.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.866 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.6 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.2 mm? -64.09 -39.34 93.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.527 0.68 . . . . 0.0 109.814 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.0 96.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.843 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 53' ' ' ILE . 2.4 mp -63.26 -50.51 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.764 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 58' ' ' THR . 52.7 m-85 -60.6 -39.1 86.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.244 0.929 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -66.85 -41.68 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.78 0.8 . . . . 0.0 109.041 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.05 -41.92 94.88 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.252 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.05 -30.75 70.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 54' ' ' PHE . 44.3 p -72.05 -37.69 69.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.5 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.68 -42.45 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.735 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.1 -34.07 13.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.486 -0.292 . . . . 0.0 111.513 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -69.68 -52.97 20.94 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.089 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.53 -43.26 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.255 0.479 . . . . 0.0 111.58 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.71 -36.49 78.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.911 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -20.16 50.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.861 0.864 . . . . 0.0 111.109 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 61' ' ' ALA . 65.8 tttm -72.3 -35.06 68.56 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -77.5 -60.44 2.36 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 118.759 -1.176 . . . . 0.0 107.987 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -59.15 -12.0 4.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.463 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.62 -37.33 1.66 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.858 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 t0 . . . . . 0 C--N 1.329 -0.294 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.737 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.5 1.868 0 CA-C-O 120.648 0.187 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -78.34 -51.28 10.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.422 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.8 p -80.73 -29.6 36.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.71 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.5 mm? -62.99 -45.76 90.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.208 -1.814 . . . . 0.0 109.689 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -76.88 -22.54 53.29 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.107 1.363 . . . . 0.0 112.184 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -65.8 -31.67 72.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.658 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.13 -38.79 83.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.077 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' THR . 74.8 m -61.36 -51.68 67.82 Favored 'General case' 0 C--O 1.201 -1.488 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 94.7 mt -55.98 -46.64 80.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.513 1.149 . . . . 0.0 110.728 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HD23 ' A' ' 17' ' ' LEU . 29.5 mm -59.19 -41.88 85.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.895 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.93 -50.03 4.8 Favored Glycine 0 CA--C 1.553 2.415 0 CA-C-O 122.877 1.265 . . . . 0.0 110.499 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.3 m -58.0 -27.62 63.67 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 111.942 -2.129 . . . . 0.0 112.41 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.6 m -76.43 -32.65 58.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.6 mm? -72.39 -25.21 61.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.3 p -54.61 -52.23 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 120.451 1.478 . . . . 0.0 109.306 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.83 -31.46 66.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.014 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.26 -46.55 73.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.342 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 73.6 m -77.16 -22.53 52.38 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 120.906 0.384 . . . . 0.0 111.281 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -84.07 -18.19 37.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.003 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -80.98 -41.89 22.06 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.731 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.555 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -68.44 -39.51 16.03 Favored Pre-proline 0 N--CA 1.483 1.175 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.8 Cg_exo -47.44 -23.29 3.26 Favored 'Trans proline' 0 C--N 1.301 -1.974 0 C-N-CA 123.886 3.057 . . . . 0.0 115.642 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.93 -46.89 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.245 0.93 . . . . 0.0 110.068 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -49.51 -27.96 4.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.4 t -70.41 -33.08 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.55 -42.51 91.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.28 -29.23 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.83 -43.4 46.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.281 1.038 . . . . 0.0 110.353 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.79 -48.77 68.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.788 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 34' ' ' VAL . 35.2 m -53.74 -47.27 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 33' ' ' VAL . 56.0 t -58.21 -40.97 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 122.185 0.993 . . . . 0.0 108.384 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.6 93.77 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.67 -30.61 67.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.282 0.563 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.759 ' O ' ' N ' ' A' ' 41' ' ' GLY . 66.1 m -60.91 -38.36 85.47 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.14 73.14 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -73.94 -51.78 14.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.024 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -94.39 5.94 50.25 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.621 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 54.58 70.29 0.99 Allowed Glycine 0 N--CA 1.469 0.899 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.541 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.38 20.46 17.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.991 0.895 . . . . 0.0 109.307 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HG22 ' A' ' 46' ' ' VAL . 92.5 mt -46.03 -55.69 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 15.0 p-10 -67.77 -38.42 83.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.65 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 47' ' ' LEU . 35.9 m-85 -58.65 -43.8 89.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.132 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 47' ' ' LEU . 29.0 m -9.92 -48.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -51.96 -49.15 63.77 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.368 0.604 . . . . 0.0 111.628 -178.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.6 mp -61.97 -57.7 22.29 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 37.1 Cg_endo -62.77 -27.96 75.83 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.791 1.661 . . . . 0.0 112.699 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.11 -30.79 60.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 111.024 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.49 -41.62 93.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.226 0.536 . . . . 0.0 110.083 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.01 93.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.588 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.78 -51.1 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.158 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.34 -41.67 94.07 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.457 0.571 . . . . 0.0 111.416 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.53 -41.48 92.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.814 0.816 . . . . 0.0 109.352 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.97 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.252 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.87 -30.78 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -71.32 -41.13 70.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 111.608 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 pt -64.79 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.482 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.11 -31.74 14.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.611 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.66 -26.38 61.61 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.44 -37.02 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.027 0.83 . . . . 0.0 111.607 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -33.31 74.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.325 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.785 ' O ' ' N ' ' A' ' 68' ' ' ALA . 76.1 mtp85 -65.29 -53.25 46.78 Favored 'General case' 0 C--O 1.201 -1.452 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.57 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.24 -25.08 12.95 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -82.61 -50.02 9.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.65 1.114 . . . . 0.0 112.247 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -85.59 -10.17 56.26 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.79 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.785 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.65 -39.62 1.71 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.203 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 t0 . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.816 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.494 1.508 0 N-CA-C 112.922 0.316 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -78.38 -51.14 10.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -81.3 -31.07 33.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.433 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.08 -46.98 86.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.322 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.5 mp -77.05 -20.65 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.653 1.181 . . . . 0.0 112.129 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.1 -33.34 75.57 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.921 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.14 -39.29 82.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.8 p -64.09 -53.19 53.65 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 13' ' ' ILE . 12.6 pt -53.35 -45.81 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 122.337 1.065 . . . . 0.0 111.451 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 12' ' ' ILE . 79.3 mt -60.42 -44.09 95.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.146 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -29.25 26.53 Favored Glycine 0 CA--C 1.551 2.312 0 CA-C-O 122.399 1.0 . . . . 0.0 112.183 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 m -75.64 -27.88 58.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.988 -1.606 . . . . 0.0 112.6 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.3 m -77.3 -32.93 55.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.07 -27.38 60.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.32 -52.3 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 117.667 -1.613 . . . . 0.0 109.835 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.62 69.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.543 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 20' ' ' LEU . 2.1 tt -68.29 -47.17 68.35 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.474 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 86.3 p -75.81 -18.95 59.3 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.918 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 t -75.42 -16.98 60.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.796 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -67.38 -39.76 22.41 Favored Pre-proline 0 N--CA 1.481 1.089 0 CA-C-N 120.692 1.587 . . . . 0.0 114.719 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 69.9 Cg_exo -45.08 -22.78 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 124.051 3.167 . . . . 0.0 114.987 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.79 -44.71 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.78 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 27' ' ' LEU . 11.3 mp -49.6 -26.7 3.79 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.18 -33.35 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -51.7 -33.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.79 -29.82 65.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 tp -75.7 -42.92 49.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.26 -47.5 84.11 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 113.345 -1.752 . . . . 0.0 112.677 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' VAL . 30.8 m -52.98 -45.91 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' VAL . 53.7 t -58.46 -39.04 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.304 1.049 . . . . 0.0 108.269 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.99 95.61 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.04 -29.75 66.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.733 -0.733 . . . . 0.0 110.507 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' GLY . 67.1 m -60.52 -38.59 84.88 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.39 71.6 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.02 -53.76 6.7 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.132 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLY . 81.5 p -107.42 -13.48 15.08 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.4 115.19 0.01 OUTLIER Glycine 0 N--CA 1.47 0.947 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.855 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -129.12 23.31 5.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.852 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -46.09 -62.44 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -67.66 -41.9 83.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 47' ' ' LEU . 66.1 m-85 -59.26 -46.53 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.454 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -10.77 -48.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -52.06 -49.79 62.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.167 0.508 . . . . 0.0 111.842 -178.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.61 -56.74 30.16 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 30.1 Cg_endo -60.2 -25.52 80.24 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.723 1.616 . . . . 0.0 112.277 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.83 65.98 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.09 -38.23 90.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.14 97.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.049 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.91 -51.74 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.504 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 58' ' ' THR . 84.5 t80 -59.06 -40.81 86.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.654 0.661 . . . . 0.0 110.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 58' ' ' THR . 6.1 mm -64.4 -41.74 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.8 0.81 . . . . 0.0 109.023 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.05 97.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.073 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.37 -51.0 69.34 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 54' ' ' PHE . 41.3 p -51.62 -38.68 55.74 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.916 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.29 -44.39 94.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.345 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.94 -34.54 20.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.11 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -62.6 -52.49 63.17 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.44 -38.63 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.345 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.27 -43.54 81.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.313 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' ALA . 78.6 ttt-85 -79.38 -21.5 45.63 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.651 0.78 . . . . 0.0 112.823 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.9 ttmt -72.27 -31.34 65.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -77.2 -60.06 2.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -61.95 -14.45 34.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.82 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.92 -38.01 2.06 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.4 t0 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.088 175.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo . . . . . 0 N--CA 1.5 1.879 0 N-CA-C 113.494 0.536 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -77.63 -52.14 9.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.433 0.635 . . . . 0.0 112.63 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -80.45 -30.43 37.55 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.422 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -63.09 -47.91 80.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.439 -1.709 . . . . 0.0 109.998 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.36 -21.0 56.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.779 1.231 . . . . 0.0 112.247 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 13' ' ' ILE . 72.7 ttt-85 -66.52 -33.35 75.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.872 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.07 -38.63 80.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 15' ' ' THR . 67.2 m -71.16 -52.54 18.63 Favored 'General case' 0 C--O 1.199 -1.553 0 C-N-CA 118.928 -1.109 . . . . 0.0 112.311 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 16' ' ' THR . 97.2 mt -57.78 -49.81 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 122.395 1.093 . . . . 0.0 112.763 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 9' ' ' ARG . 2.2 pp -58.23 -37.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.48 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.35 -50.93 4.09 Favored Glycine 0 CA--C 1.554 2.498 0 CA-C-O 122.991 1.329 . . . . 0.0 111.103 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 11' ' ' SER . 66.3 m -57.29 -27.39 62.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.536 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 12' ' ' ILE . 37.9 p -76.22 -29.14 57.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.83 -24.52 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 19' ' ' ALA . 11.3 p -54.06 -51.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.028 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.627 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -56.49 -30.7 63.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.413 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -69.15 -47.97 63.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.519 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 86.1 p -76.48 -21.92 55.2 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.382 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.0 m -84.31 -15.52 46.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.577 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.53 -42.46 18.35 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.633 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -69.42 -37.62 8.86 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -176.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.677 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.5 Cg_exo -47.18 -23.11 2.69 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 124.029 3.153 . . . . 0.0 115.931 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 27' ' ' LEU . 7.7 p -58.59 -41.62 82.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.628 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 26' ' ' VAL . 55.6 tp -50.08 -27.95 6.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.25 -29.41 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.081 0.467 . . . . 0.0 111.709 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.25 -42.52 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.8 tt -51.42 -53.28 38.35 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.2 mp -54.13 -40.14 67.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.81 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.16 99.22 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 59.8 t -55.39 -48.95 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.54 -38.87 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.57 -43.63 95.99 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.07 -29.75 66.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.6 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.3 t -59.48 -39.44 83.72 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.82 75.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -77.92 -54.41 6.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.217 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' GLY . 67.2 p -107.92 -13.2 15.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 50.19 113.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.86 0 CA-C-N 115.069 -0.968 . . . . 0.0 113.133 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -131.75 22.78 4.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.898 0.479 . . . . 0.0 110.235 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.4 mp -45.24 -58.62 3.14 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 p-10 -65.48 -39.37 91.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.353 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' LEU . 29.6 m-85 -58.23 -41.77 84.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.05 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.5 m -10.74 -49.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.8 tp -55.74 -47.95 76.08 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.093 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD13 HD22 ' A' ' 51' ' ' LEU . 4.3 mm? -59.38 -57.4 27.27 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.402 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.76 -25.2 5.55 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.056 1.837 . . . . 0.0 112.795 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.39 -30.84 71.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.474 0.178 . . . . 0.0 110.643 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.0 mp -64.96 -40.11 94.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.534 0.683 . . . . 0.0 109.388 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.09 97.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.357 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.62 -50.82 78.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.967 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.17 -40.41 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.475 0.58 . . . . 0.0 110.433 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -67.67 -42.63 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.7 -42.41 97.23 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.862 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.71 -51.27 63.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -51.9 -41.96 62.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.382 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -44.23 95.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.356 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -55.55 -35.2 65.44 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.06 -26.55 63.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.86 -41.47 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 63' ' ' GLN . 9.6 pt20 -69.23 -37.64 78.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.545 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 68' ' ' ALA . 31.3 ptt180 -78.89 -19.76 51.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.127 0.571 . . . . 0.0 112.282 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -72.24 -28.01 62.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.285 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.59 -60.32 2.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.42 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 89.0 mt-30 -61.49 -14.52 29.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.657 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -43.46 -38.96 3.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.764 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.3 p-10 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 N-CA-C 111.388 -0.274 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.19 -51.43 10.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.523 0.678 . . . . 0.0 112.063 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -81.04 -30.43 34.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.838 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.48 -43.44 97.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.27 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 tp -77.85 -23.39 48.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.335 1.454 . . . . 0.0 112.518 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -67.42 -32.03 72.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.863 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.09 -40.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.1 t -63.75 -52.59 59.69 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 119.464 1.029 . . . . 0.0 111.051 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.82 -46.53 79.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.779 1.276 . . . . 0.0 110.863 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.99 -42.32 85.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.832 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.15 -50.61 4.49 Favored Glycine 0 CA--C 1.551 2.324 0 CA-C-O 122.924 1.291 . . . . 0.0 110.623 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.707 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.9 m -57.03 -27.85 62.0 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.005 -2.097 . . . . 0.0 112.478 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -76.86 -32.39 57.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 0.0 111.868 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.07 -25.01 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.656 HG23 ' N ' ' A' ' 19' ' ' ALA . 32.3 m -61.74 -55.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.976 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.656 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -57.6 -31.76 66.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.068 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.47 -43.11 91.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.406 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 83.8 p -75.75 -17.64 59.83 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.131 0.491 . . . . 0.0 110.574 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.9 p -76.66 -15.5 59.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.821 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -84.47 -41.19 16.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.272 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -68.1 -38.52 13.97 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 120.869 1.668 . . . . 0.0 114.2 -177.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.678 ' O ' HG22 ' A' ' 28' ' ' VAL . 79.5 Cg_exo -46.35 -23.45 2.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.877 3.052 . . . . 0.0 114.847 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 27' ' ' LEU . 10.5 p -59.0 -42.31 85.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.642 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.1 tp -49.85 -27.87 5.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.1 m -71.01 -29.3 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.27 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.2 mm -60.93 -43.06 95.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.1 mm? -55.64 -52.11 64.91 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.553 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -55.41 -41.27 72.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.88 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -63.51 -44.14 97.08 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.98 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.73 -50.66 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.24 -42.07 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.299 1.047 . . . . 0.0 108.871 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.32 95.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.4 mp -71.27 -30.81 66.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.716 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.7 p -60.55 -35.58 76.37 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.55 76.88 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.137 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.1 mm? -74.96 -51.63 13.21 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.285 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -96.73 3.75 52.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.655 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 55.47 70.18 1.04 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.0 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.59 19.8 18.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.069 0.935 . . . . 0.0 109.541 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 46' ' ' VAL . 90.2 mt -45.84 -56.75 4.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -66.48 -39.48 88.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.917 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.602 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.8 m-85 -57.41 -41.22 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.974 -0.536 . . . . 0.0 111.12 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.1 t -11.04 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' TYR . 4.0 mm? -54.31 -47.84 71.99 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 mp -61.14 -59.11 14.78 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.64 -24.88 4.95 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.793 1.662 . . . . 0.0 112.59 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.48 -29.96 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.853 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.5 mm? -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.432 0.634 . . . . 0.0 109.554 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.01 97.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.606 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -62.75 -51.05 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.605 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.97 -40.52 85.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.657 0.662 . . . . 0.0 110.5 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.31 -42.36 93.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.0 109.781 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.28 -43.48 96.9 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.225 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.49 -49.8 73.95 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.769 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.7 m -52.95 -41.95 65.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.14 -44.16 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.768 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.05 -39.86 72.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -72.77 -53.86 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.082 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.4 mt -50.18 -45.2 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 67' ' ' GLN . 3.2 pp0? -68.46 -33.8 74.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.086 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 38.4 ttp180 -78.02 -21.81 50.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.137 0.975 . . . . 0.0 111.593 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' ALA . 18.8 tptm -76.54 -33.71 58.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -83.24 -39.74 20.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.596 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' NE2' ' OE1' ' A' ' 63' ' ' GLN . 10.7 pt20 -86.13 -11.59 52.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.624 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -41.82 -39.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.791 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.4 t0 . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.209 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.498 1.77 0 CA-C-O 120.764 0.235 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -77.73 -51.02 11.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.1 p -80.99 -29.87 35.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.134 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.71 -46.38 88.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.233 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.46 -21.12 53.39 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.573 1.149 . . . . 0.0 112.397 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' ILE . 67.0 ttt180 -68.25 -36.56 79.64 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.382 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.5 -32.51 36.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 15' ' ' THR . 69.2 m -74.42 -53.88 8.69 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-N 119.97 1.259 . . . . 0.0 111.866 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 13' ' ' ILE . 23.5 pt -54.72 -48.83 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 122.501 1.143 . . . . 0.0 112.686 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' N ' HG13 ' A' ' 12' ' ' ILE . 19.9 tt -59.54 -38.81 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.908 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.28 -51.79 3.81 Favored Glycine 0 CA--C 1.549 2.171 0 CA-C-O 122.963 1.313 . . . . 0.0 110.448 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.658 ' N ' ' O ' ' A' ' 11' ' ' SER . 36.3 m -56.93 -27.54 61.11 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 111.851 -2.174 . . . . 0.0 112.222 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -77.4 -32.77 55.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 tp -74.03 -26.52 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.41 -51.7 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 117.668 -1.613 . . . . 0.0 109.313 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -32.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.522 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.82 -44.33 81.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.045 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 36.8 t -75.9 -23.64 55.55 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 p -70.29 -13.49 62.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.867 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -80.36 -39.92 27.61 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.702 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 27.3 m -64.79 -39.24 37.11 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.673 1.578 . . . . 0.0 115.158 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.9 Cg_exo -44.41 -21.9 0.5 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.692 2.928 . . . . 0.0 115.386 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -60.38 -44.4 95.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.271 0.941 . . . . 0.0 110.172 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? -49.16 -26.28 2.72 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 25' ' ' PRO . 2.8 p -69.0 -29.94 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.713 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -57.11 -34.12 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.3 tt -56.62 -52.85 63.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.447 0.567 . . . . 0.0 110.614 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.91 -40.26 75.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.678 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.64 98.7 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' SER . 54.3 t -56.62 -50.35 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.76 -42.64 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.24 -44.99 96.06 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.42 -33.3 72.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.535 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 41' ' ' GLY . 73.3 m -61.96 -39.77 93.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.07 -37.78 75.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.96 -53.62 6.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.883 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 m -107.83 -16.23 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 57.01 94.4 0.01 OUTLIER Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.966 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.92 20.89 13.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 91.8 mt -46.26 -56.82 5.22 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.164 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.742 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.6 m-85 -55.77 -41.65 74.33 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.492 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 43' ' ' LEU . 9.8 p -20.56 -14.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.742 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.8 tt -88.65 -47.03 8.56 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.047 0.84 . . . . 0.0 110.15 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -60.5 -45.51 97.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.577 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 55.9 Cg_endo -68.35 -25.29 36.21 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.576 1.518 . . . . 0.0 112.453 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.68 -30.1 63.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.648 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.26 -39.05 93.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.36 92.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.162 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.29 -50.84 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.533 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' THR . 60.6 m-85 -59.74 -38.64 82.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.055 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 87.8 mt -65.02 -41.14 91.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.837 0.827 . . . . 0.0 109.127 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.94 99.14 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.109 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.01 -49.62 75.29 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.817 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PHE . 50.1 p -51.56 -37.92 51.9 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.292 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.86 -44.72 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.192 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -48.17 -33.15 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.321 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.85 63.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.6 mp -73.76 -43.27 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 118.397 0.544 . . . . 0.0 112.2 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.2 -39.94 93.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.417 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 68' ' ' ALA . 15.9 mmm180 -66.26 -54.48 24.41 Favored 'General case' 0 C--O 1.204 -1.299 0 C-N-CA 118.894 -1.123 . . . . 0.0 108.515 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -52.03 -25.74 9.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -83.63 -51.89 6.91 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 119.354 0.979 . . . . 0.0 113.146 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.47 -11.47 51.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.595 1.158 . . . . 0.0 112.725 177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.75 -42.89 2.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.274 -174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.88 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 N-CA-C 111.29 -0.311 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.15 -50.38 12.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.723 0.773 . . . . 0.0 112.244 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.3 p -80.91 -29.97 35.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.043 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.47 -43.15 98.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.58 -1.645 . . . . 0.0 109.653 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.6 -23.0 46.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.4 1.48 . . . . 0.0 112.918 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -67.78 -35.03 77.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.868 -1.514 . . . . 0.0 113.524 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.01 -31.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -68.56 -53.5 22.56 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 120.037 1.289 . . . . 0.0 111.249 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' THR . 17.3 tt -53.99 -44.92 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 122.505 1.145 . . . . 0.0 110.781 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 12' ' ' ILE . 72.8 mt -59.48 -41.93 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 113.008 -1.906 . . . . 0.0 111.535 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.57 -51.21 4.16 Favored Glycine 0 CA--C 1.548 2.101 0 CA-C-O 122.936 1.298 . . . . 0.0 110.589 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 11' ' ' SER . 32.3 m -56.91 -28.83 62.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.875 -2.162 . . . . 0.0 113.085 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' ILE . 33.2 p -78.09 -30.01 49.38 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.802 -0.561 . . . . 0.0 112.104 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -74.14 -27.54 60.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.98 -52.26 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 117.598 -1.641 . . . . 0.0 109.681 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.29 -31.92 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.982 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 20' ' ' LEU . 3.1 tt -67.7 -44.61 77.32 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.673 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 80.5 p -75.17 -16.28 60.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.027 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -78.26 -19.12 54.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.496 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -41.46 17.09 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.308 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.2 p -68.92 -37.2 8.91 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 120.837 1.653 . . . . 0.0 115.027 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 28' ' ' VAL . 82.5 Cg_exo -47.13 -22.96 2.51 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.893 3.062 . . . . 0.0 115.041 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 27' ' ' LEU . 33.9 m -57.98 -38.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.806 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HG23 ' A' ' 26' ' ' VAL . 93.7 mt -50.52 -26.52 5.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 25' ' ' PRO . 3.9 p -70.16 -29.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.11 -41.57 86.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.35 -50.74 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.009 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -56.14 -40.62 74.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.054 0.843 . . . . 0.0 110.178 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.22 -43.59 98.33 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.26 -50.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.1 -42.22 85.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 122.161 0.981 . . . . 0.0 109.01 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -46.09 94.35 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.6 -31.08 67.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.311 0.577 . . . . 0.0 110.649 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' GLY . 47.0 t -61.51 -41.35 97.17 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.92 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.77 76.0 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.82 -51.49 13.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.244 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.1 p -95.77 4.83 52.56 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 53.47 72.88 0.47 Allowed Glycine 0 N--CA 1.469 0.858 0 CA-C-N 115.613 -0.722 . . . . 0.0 114.015 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.62 20.6 15.82 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -46.27 -55.59 6.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.6 p-10 -68.31 -38.83 82.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.906 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.3 m-85 -58.98 -41.37 87.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.784 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.8 p -11.27 -47.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 45' ' ' TYR . 97.3 mt -55.65 -46.41 77.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.081 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.7 mt -62.67 -59.95 11.24 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.341 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.9 -26.08 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.509 1.472 . . . . 0.0 112.066 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.14 66.41 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.017 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.13 -39.54 93.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.521 0.677 . . . . 0.0 109.484 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.77 97.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.428 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.93 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.495 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -59.5 -41.44 89.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.63 0.65 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.6 -43.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 0.0 109.983 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.2 97.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.925 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.56 -50.62 70.61 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.4 m -53.3 -42.26 66.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.016 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -43.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.48 -37.32 72.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -74.16 -55.49 6.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.007 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 62' ' ' ILE . 29.2 pt -50.59 -38.01 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.031 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.629 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 20.6 pt20 -70.02 -36.83 75.38 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.87 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -78.11 -20.36 52.32 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.697 0.799 . . . . 0.0 111.424 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.4 ttpt -71.52 -31.21 66.81 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.645 -1.161 . . . . 0.0 113.897 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -78.08 -60.84 2.21 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.0 mp0 -60.68 -12.68 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.752 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -31.91 0.52 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.958 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.299 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.46 -38.8 91.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 52.71 59.34 14.03 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.416 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.25 65.98 7.1 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.239 2.626 . . . . 0.0 111.24 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -77.68 -49.31 14.75 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.808 0.813 . . . . 0.0 112.741 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.4 p -79.59 -28.86 41.04 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.097 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 10' ' ' VAL . 3.8 mm? -62.49 -45.21 94.05 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.127 -1.851 . . . . 0.0 109.753 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.15 -21.92 53.37 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.012 1.325 . . . . 0.0 112.525 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -66.39 -33.77 76.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.259 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 7' ' ' LEU . 5.3 p -65.48 -31.69 54.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 15' ' ' THR . 81.8 p -65.07 -52.2 57.08 Favored 'General case' 0 C--O 1.201 -1.476 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.408 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.652 ' O ' HG23 ' A' ' 16' ' ' THR . 95.0 mt -54.91 -46.9 76.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.742 1.258 . . . . 0.0 110.519 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.25 -44.96 93.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 112.787 -2.006 . . . . 0.0 111.692 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.87 -28.42 28.94 Favored Glycine 0 CA--C 1.556 2.607 0 CA-C-O 122.308 0.949 . . . . 0.0 112.486 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.696 ' N ' ' O ' ' A' ' 11' ' ' SER . 55.4 m -75.41 -27.71 59.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 113.235 -1.483 . . . . 0.0 112.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 12' ' ' ILE . 28.1 p -76.51 -29.14 56.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.053 0.454 . . . . 0.0 111.46 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tp -72.03 -25.8 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.663 HG23 ' N ' ' A' ' 19' ' ' ALA . 35.4 m -59.61 -54.19 37.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 118.123 -1.431 . . . . 0.0 110.042 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -58.38 -32.26 68.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.314 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.1 mt -68.6 -44.56 74.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.991 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 74.0 m -78.57 -26.37 45.52 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.942 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 71.1 m -84.32 -16.59 42.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.16 -42.86 18.48 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.675 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 p -69.21 -37.52 9.03 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 24' ' ' THR . 87.1 Cg_exo -48.2 -23.33 4.6 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 123.772 2.982 . . . . 0.0 115.506 -176.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -62.33 -46.41 96.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.737 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 tp -50.25 -28.34 7.51 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.41 -34.06 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 45.5 mm -61.29 -41.14 88.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.432 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.57 -50.42 73.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.255 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -58.48 -40.92 84.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.859 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.6 -43.64 98.71 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 29' ' ' ILE . 52.5 t -56.09 -50.17 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' OG ' ' A' ' 37' ' ' SER . 65.1 t -60.02 -42.58 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 122.058 0.932 . . . . 0.0 109.401 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.8 -46.25 93.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.52 -29.45 68.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 0.0 110.784 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 24.5 p -59.69 -28.06 66.97 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -31.09 56.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.229 1.014 . . . . 0.0 109.526 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -77.5 -50.29 12.94 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 113.475 -1.693 . . . . 0.0 112.098 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -101.61 -7.97 22.25 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 52.14 39.19 49.7 Favored Glycine 0 N--CA 1.47 0.9 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.25 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.92 14.71 31.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.965 0.383 . . . . 0.0 111.332 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.663 ' O ' HG13 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -56.52 -14.29 3.0 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.748 -176.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.634 ' N ' HD12 ' A' ' 43' ' ' LEU . 66.3 t0 -60.79 -40.6 93.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.6 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 47' ' ' LEU . 69.2 m-85 -58.65 -41.51 86.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 118.904 -0.57 . . . . 0.0 111.923 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 43' ' ' LEU . 30.2 m -10.88 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 45' ' ' TYR . 61.8 tp -53.49 -47.98 69.34 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.367 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 45' ' ' TYR . 6.7 mp -62.15 -61.66 7.26 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.121 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.06 -26.07 13.97 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.508 1.472 . . . . 0.0 112.136 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.52 -30.63 66.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.468 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.01 -38.75 92.2 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.59 -42.85 97.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.566 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.93 -50.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.682 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' O ' HG22 ' A' ' 58' ' ' THR . 80.6 t80 -59.53 -40.15 86.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.787 0.721 . . . . 0.0 110.339 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.0 mt -65.63 -42.2 92.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.892 0.853 . . . . 0.0 110.203 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.05 -44.58 66.36 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.445 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.9 -52.77 13.4 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.443 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 59' ' ' ILE . 11.6 t -50.74 -39.19 51.39 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.334 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.44 ' N ' HG23 ' A' ' 58' ' ' THR . 9.3 mm -65.49 -43.26 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.385 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.72 -36.77 74.8 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.7 72.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 118.038 -1.465 . . . . 0.0 108.075 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.91 -37.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.349 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' NE2' ' OE1' ' A' ' 67' ' ' GLN . 1.2 pp0? -67.03 -35.12 79.21 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.272 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 68' ' ' ALA . 57.8 ttt85 -79.09 -21.2 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.257 1.023 . . . . 0.0 111.575 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -74.84 -33.86 62.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 122.427 1.108 . . . . 0.0 113.381 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -81.33 -34.98 31.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.92 -1.946 . . . . 0.0 110.198 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 70' ' ' ALA . 98.0 mt-30 -86.69 -12.93 46.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.469 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.67 -40.29 2.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.748 -175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.25 -50.73 72.48 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.26 -39.49 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.722 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.2 t 59.96 -79.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.527 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' ALA . 83.1 p -71.58 161.74 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.96 0.409 . . . . 0.0 111.028 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 t -61.38 139.37 94.8 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.72 139.92 23.51 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.508 1.472 . . . . 0.0 111.851 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -61.72 -39.45 91.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.464 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -63.06 -39.31 94.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.516 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -86.64 109.49 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.43 171.4 38.27 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.21 159.15 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.601 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.19 -39.37 92.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.565 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.439 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 63.8 mttp -77.93 136.54 38.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 56.5 m-20 -133.58 72.92 73.54 Favored Pre-proline 0 N--CA 1.466 0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.669 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -53.89 -24.21 30.58 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.174 2.583 . . . . 0.0 113.118 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -77.62 -50.24 12.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.597 0.713 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.1 m -80.52 -31.6 37.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.464 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 59.6 tp -65.12 -49.55 69.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.538 -1.664 . . . . 0.0 111.526 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.49 -23.72 50.24 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.291 1.436 . . . . 0.0 113.521 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.1 -30.56 69.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.046 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.4 t -66.82 -39.89 84.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -63.11 -52.49 62.38 Favored 'General case' 0 C--O 1.201 -1.478 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.863 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 16' ' ' THR . 45.0 mm -55.39 -46.61 78.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 122.613 1.197 . . . . 0.0 110.529 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.91 -42.65 86.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 112.688 -2.051 . . . . 0.0 111.004 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.17 -50.14 4.69 Favored Glycine 0 CA--C 1.552 2.348 0 CA-C-O 122.864 1.258 . . . . 0.0 110.7 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.715 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.2 m -57.51 -27.63 62.72 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.028 -2.086 . . . . 0.0 112.811 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 12' ' ' ILE . 13.1 t -77.83 -30.33 51.01 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.024 -0.422 . . . . 0.0 111.615 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.96 -25.66 60.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.74 -51.87 67.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 117.742 -1.583 . . . . 0.0 109.368 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.77 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.504 -1.226 . . . . 0.0 112.326 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.35 -46.44 70.15 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.715 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 38.2 t -77.52 -26.23 50.93 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 121.173 0.511 . . . . 0.0 112.023 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.5 m -73.01 -14.4 61.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.607 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -80.7 -40.47 25.32 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.719 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.51 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 31.0 m -66.22 -39.1 25.36 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-N 120.684 1.584 . . . . 0.0 115.039 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 24' ' ' THR . 83.8 Cg_exo -45.44 -22.73 1.08 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 123.803 3.002 . . . . 0.0 115.166 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.6 t -61.61 -45.69 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.485 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.0 tp -48.86 -27.5 3.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.6 t -70.84 -33.6 52.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.5 -33.64 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.86 -49.99 75.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.44 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -55.71 -40.51 72.53 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.807 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -44.02 97.83 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.024 178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 37' ' ' SER . 48.9 t -55.79 -50.34 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.06 -42.25 85.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 122.176 0.989 . . . . 0.0 108.996 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.29 -46.05 94.45 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.53 -31.43 68.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.378 0.609 . . . . 0.0 110.405 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.5 t -61.39 -40.34 93.97 Favored 'General case' 0 C--O 1.205 -1.261 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.368 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.71 75.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.158 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.86 -51.71 11.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.635 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 m -95.89 3.27 53.75 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.192 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.43 69.81 1.16 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.536 -0.756 . . . . 0.0 114.301 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 20.27 18.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.97 0.885 . . . . 0.0 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.4 tp -45.99 -59.3 2.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.404 0.621 . . . . 0.0 112.287 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.99 -40.81 95.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.993 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 47' ' ' LEU . 48.4 m-85 -58.65 -43.55 89.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.454 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.58 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -11.4 -48.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.7 tp -54.81 -48.58 72.6 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.711 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -61.39 -57.73 23.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -47.99 -24.93 5.78 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.717 1.612 . . . . 0.0 112.364 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.85 -30.26 70.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.865 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 51' ' ' LEU . 7.8 mp -64.94 -40.59 95.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.776 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.01 97.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.697 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.25 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.842 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 58' ' ' THR . 85.0 t80 -58.9 -40.76 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 118.516 0.598 . . . . 0.0 110.544 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.28 -41.62 92.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.718 0.77 . . . . 0.0 109.635 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.04 -40.99 98.7 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.281 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.59 -28.96 68.92 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 54' ' ' PHE . 54.9 p -72.34 -37.27 68.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.32 0.581 . . . . 0.0 110.132 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ILE . 41.3 mm -66.59 -44.62 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.294 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -57.25 -38.35 73.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.55 -27.19 62.06 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.579 -0.701 . . . . 0.0 112.166 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.63 -43.58 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 1.5 pp0? -63.76 -36.37 83.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.241 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.784 ' O ' ' N ' ' A' ' 68' ' ' ALA . 16.4 mmm180 -62.64 -53.09 59.84 Favored 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -52.42 -25.88 11.15 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -82.98 -49.35 9.68 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.745 1.157 . . . . 0.0 112.417 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' ALA . 23.3 mp0 -85.39 -10.28 56.47 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.456 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.03 -39.5 1.94 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.082 -174.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -60.59 -51.62 68.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.23 -39.76 91.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.807 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.9 t 57.67 -115.79 0.88 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.667 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.7 m -66.21 147.94 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 110.989 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.9 p -70.35 152.26 95.58 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.115 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.4 67.46 7.06 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.044 1.829 . . . . 0.0 112.481 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -70.0 -21.99 63.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.141 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.77 -39.32 91.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.687 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -61.45 131.26 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.305 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.95 -164.57 48.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 77.7 t -112.93 124.48 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 110.429 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.4 -42.82 99.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.042 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.203 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -138.21 -23.09 1.02 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -62.29 131.34 93.66 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.716 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.05 -22.41 5.04 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 122.215 1.943 . . . . 0.0 113.479 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 26.5 mtpp -75.28 -42.34 55.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.862 0.839 . . . . 0.0 110.869 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.7 m -80.51 -30.14 37.26 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 113.36 -1.746 . . . . 0.0 111.231 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.523 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.0 OUTLIER -67.06 -51.18 57.77 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.799 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.4 mp -77.52 -22.06 51.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.959 1.303 . . . . 0.0 112.919 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' LYS . 7.1 mmt180 -68.32 -30.11 69.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.105 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 7' ' ' LEU . 4.8 p -70.42 -33.37 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.7 t -70.71 -53.77 14.37 Favored 'General case' 0 C--O 1.202 -1.417 0 CA-C-N 119.77 1.168 . . . . 0.0 111.815 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 13' ' ' ILE . 18.7 tt -53.58 -44.45 57.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 122.959 1.361 . . . . 0.0 110.198 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.52 ' N ' HG23 ' A' ' 12' ' ' ILE . 91.1 mt -60.77 -45.34 98.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.229 0 CA-C-N 111.999 -2.364 . . . . 0.0 111.933 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.0 -28.26 29.03 Favored Glycine 0 CA--C 1.553 2.466 0 CA-C-O 122.449 1.027 . . . . 0.0 112.078 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.676 ' N ' ' O ' ' A' ' 11' ' ' SER . 37.2 m -75.99 -27.24 57.37 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 112.849 -1.676 . . . . 0.0 112.919 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 17' ' ' LEU . 13.7 t -78.15 -29.95 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 16' ' ' THR . 5.2 mp -73.56 -25.33 60.32 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 19' ' ' ALA . 8.4 p -58.32 -54.22 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 117.973 -1.491 . . . . 0.0 109.664 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.651 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.84 -31.56 66.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.274 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.92 -44.3 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.92 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 84.0 p -75.26 -15.84 60.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -77.38 -18.06 57.66 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.963 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HZ ' ' HH ' ' A' ' 60' ' ' TYR . 3.3 m-85 -82.87 -41.57 18.82 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.925 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.546 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 36.1 m -67.74 -38.55 15.15 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 120.679 1.581 . . . . 0.0 114.563 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.74 ' O ' HG22 ' A' ' 28' ' ' VAL . 91.9 Cg_exo -46.23 -23.42 1.96 Allowed 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.689 2.926 . . . . 0.0 115.16 -177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 29' ' ' ILE . 9.6 p -59.56 -43.07 90.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 119.302 0.955 . . . . 0.0 110.223 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.519 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.5 tp -49.03 -26.59 2.68 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.17 -29.43 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.916 0.389 . . . . 0.0 111.957 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.8 tt -59.56 -35.99 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.262 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.14 -51.21 70.68 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.48 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.1 mp -55.62 -40.89 72.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.8 0.81 . . . . 0.0 109.699 -178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -44.45 96.51 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.009 178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 37' ' ' SER . 53.4 t -56.32 -50.58 71.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.432 ' O ' ' OG ' ' A' ' 37' ' ' SER . 61.7 t -58.86 -41.89 84.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 122.305 1.05 . . . . 0.0 108.722 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.78 94.83 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.41 -32.11 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.26 0.552 . . . . 0.0 110.985 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' GLY . 77.7 p -62.33 -37.54 86.04 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.54 74.63 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.456 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.4 tp -75.64 -52.02 11.49 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.995 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -100.4 -1.34 36.23 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 56.85 75.41 0.25 Allowed Glycine 0 N--CA 1.47 0.966 0 CA-C-N 115.849 -0.614 . . . . 0.0 114.272 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.5 20.46 17.69 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.76 0.78 . . . . 0.0 109.193 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 43' ' ' LEU . 4.1 tt -45.2 -59.63 2.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.83 -39.21 93.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.617 ' O ' ' N ' ' A' ' 47' ' ' LEU . 38.5 m-85 -58.22 -41.5 84.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.651 -0.69 . . . . 0.0 112.286 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.0 m -11.46 -48.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 45' ' ' TYR . 85.4 mt -56.12 -47.54 77.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.131 -0.627 . . . . 0.0 111.749 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD13 HD22 ' A' ' 51' ' ' LEU . 4.4 mm? -61.64 -57.18 26.37 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.768 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.54 -24.98 7.1 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.649 1.566 . . . . 0.0 112.6 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.75 -30.34 70.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.314 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 51' ' ' LEU . 8.9 mp -64.67 -39.26 93.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.452 0.644 . . . . 0.0 109.479 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.5 -42.8 97.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.255 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -63.55 -51.35 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.618 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' HG23 ' A' ' 58' ' ' THR . 90.4 t80 -59.35 -41.77 90.0 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.53 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.403 ' O ' ' OG1' ' A' ' 58' ' ' THR . 9.2 mm -64.37 -42.36 95.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.789 0.804 . . . . 0.0 109.266 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.07 -40.95 99.86 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.658 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.66 -50.93 70.54 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 54' ' ' PHE . 46.2 p -52.26 -39.2 60.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.007 0.432 . . . . 0.0 110.861 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.36 -45.63 95.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.69 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.4 ' HH ' ' HZ ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -52.3 -41.33 62.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.74 -27.08 67.33 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.511 -0.743 . . . . 0.0 112.127 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.83 -41.85 61.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.979 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 4.3 pt20 -67.97 -33.25 74.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 55.0 ttt85 -78.16 -22.12 49.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.972 0.909 . . . . 0.0 113.049 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -76.77 -33.61 58.05 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -83.06 -41.02 19.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.287 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' ALA . 13.9 pt20 -86.1 -11.55 52.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.567 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -42.25 -42.82 3.2 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.808 -174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 72' ' ' SER . 97.8 m-20 -59.52 -50.07 75.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.12 -37.89 81.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.04 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.3 m -60.98 -40.05 91.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.505 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' ASP . 40.9 t -124.84 132.34 53.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.43 . . . . 0.0 111.338 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.0 m 50.51 59.6 16.07 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.655 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -71.47 150.93 58.66 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.558 2.172 . . . . 0.0 111.946 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.05 -44.07 97.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.43 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -62.66 128.27 35.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.629 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -138.3 17.62 2.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.516 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.96 168.05 54.32 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.8 t -118.91 127.01 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -62.28 -39.55 93.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.353 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.9 tttm . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.358 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -87.74 94.8 9.85 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.934 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.6 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 12.1 t0 -62.54 -39.51 55.98 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.599 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 3' ' ' ASP . 22.9 Cg_exo -64.47 0.45 2.31 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.748 2.299 . . . . 0.0 112.616 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -77.26 -50.39 12.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.616 0.722 . . . . 0.0 112.245 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.4 m -80.32 -30.19 38.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.227 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.614 ' O ' HG22 ' A' ' 10' ' ' VAL . 2.7 tt -62.67 -46.88 86.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.673 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.28 -21.34 56.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.048 1.339 . . . . 0.0 112.353 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -64.33 -32.09 73.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.71 -1.586 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 7' ' ' LEU . 6.2 m -62.96 -31.02 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.724 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.9 p -63.97 -52.51 59.3 Favored 'General case' 0 C--O 1.199 -1.577 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.496 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.1 mm -54.66 -45.68 72.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.583 1.182 . . . . 0.0 110.046 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.484 ' O ' HD23 ' A' ' 17' ' ' LEU . 35.8 mm -59.11 -43.15 88.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 112.743 -2.026 . . . . 0.0 110.956 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.55 -49.81 4.73 Favored Glycine 0 CA--C 1.552 2.378 0 CA-C-O 122.924 1.291 . . . . 0.0 110.82 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.724 ' N ' ' O ' ' A' ' 11' ' ' SER . 28.5 m -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 111.869 -2.165 . . . . 0.0 112.581 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.8 m -76.25 -32.34 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.946 0.403 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.4 mm? -72.16 -25.18 61.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.639 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.7 p -54.49 -52.44 40.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 118.099 -1.44 . . . . 0.0 109.401 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.96 -31.35 66.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.735 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.4 tt -68.36 -47.0 68.59 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.251 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 40.3 t -77.74 -27.74 50.58 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 112.092 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.4 m -83.7 -16.96 43.0 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.335 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -81.93 -42.95 18.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.775 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 55.2 m -68.06 -38.6 14.32 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.9 Cg_exo -47.78 -23.84 4.34 Favored 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 123.791 2.994 . . . . 0.0 116.029 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' HG22 ' A' ' 29' ' ' ILE . 70.5 t -62.85 -46.44 96.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 119.455 1.025 . . . . 0.0 111.101 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.3 mm? -50.03 -26.67 4.55 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.4 m -72.03 -30.22 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 26' ' ' VAL . 3.8 tp -59.3 -35.23 56.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.171 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.73 -50.18 74.85 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.674 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.53 -40.74 79.49 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.164 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.34 -44.33 97.04 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 37' ' ' SER . 52.5 t -56.02 -50.27 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.44 -41.66 82.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 122.138 0.97 . . . . 0.0 108.691 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.21 -44.74 96.22 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.45 -33.27 71.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.549 0.69 . . . . 0.0 110.755 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.726 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.4 t -60.75 -40.29 91.88 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.537 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.79 75.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -74.07 -51.17 16.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.103 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.4 p -94.24 7.47 45.22 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.734 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.88 82.83 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.32 175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.3 21.53 10.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.4 mt -45.95 -56.59 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.21 0.528 . . . . 0.0 112.36 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.79 -39.64 87.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.905 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.613 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.9 m-85 -57.86 -41.14 81.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.134 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 47' ' ' LEU . 9.3 p -10.89 -48.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 45' ' ' TYR . 89.7 mt -56.69 -46.14 81.36 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.566 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' TYR . 3.9 mm? -61.57 -58.38 18.84 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -47.82 -24.67 5.17 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 121.86 1.707 . . . . 0.0 112.458 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -65.52 -30.54 71.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.866 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.6 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.2 mm? -64.09 -39.34 93.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.527 0.68 . . . . 0.0 109.814 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.0 96.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.843 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 53' ' ' ILE . 2.4 mp -63.26 -50.51 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.764 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.661 ' O ' HG23 ' A' ' 58' ' ' THR . 52.7 m-85 -60.6 -39.1 86.9 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.244 0.929 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.6 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -66.85 -41.68 88.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.78 0.8 . . . . 0.0 109.041 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.05 -41.92 94.88 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.252 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.5 tp -68.05 -30.75 70.04 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 54' ' ' PHE . 44.3 p -72.05 -37.69 69.64 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.5 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.68 -42.45 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.735 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -49.1 -34.07 13.11 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.486 -0.292 . . . . 0.0 111.513 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.488 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -69.68 -52.97 20.94 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.089 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.53 -43.26 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.255 0.479 . . . . 0.0 111.58 -176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.71 -36.49 78.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.911 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.63 -20.16 50.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.861 0.864 . . . . 0.0 111.109 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 61' ' ' ALA . 65.8 tttm -72.3 -35.06 68.56 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 tpm_? -77.5 -60.44 2.36 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 118.759 -1.176 . . . . 0.0 107.987 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 70' ' ' ALA . 20.5 pt20 -59.15 -12.0 4.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.463 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.62 -37.33 1.66 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.858 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -57.64 -56.73 18.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.56 -39.52 91.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.841 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 t 63.19 35.43 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.969 0.414 . . . . 0.0 110.295 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 91.0 p -156.67 164.02 38.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.564 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.6 t -131.77 140.3 37.84 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.062 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.95 152.26 62.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.104 1.869 . . . . 0.0 112.058 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -89.2 -3.68 58.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.508 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ASN . 88.3 m-85 55.86 -177.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.284 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 79.5 m-20 55.12 109.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.25 -40.22 97.06 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 81' ' ' LYS . 11.5 p -142.81 136.6 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.819 0.343 . . . . 0.0 110.398 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.88 -39.68 95.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.588 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' VAL . 65.0 tttp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.428 ' HZ2' HD22 ' A' ' 8' ' ' LEU . 62.1 pttt -153.48 142.85 21.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.415 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 94.2 m-20 -70.88 -48.6 14.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 3' ' ' ASP . 72.1 Cg_endo -73.18 70.66 3.77 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.604 1.536 . . . . 0.0 111.946 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -78.34 -51.28 10.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.591 0.71 . . . . 0.0 112.422 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.8 p -80.73 -29.6 36.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.71 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.5 mm? -62.99 -45.76 90.88 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.208 -1.814 . . . . 0.0 109.689 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.428 HD22 ' HZ2' ' A' ' 2' ' ' LYS . 5.9 tt -76.88 -22.54 53.29 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.107 1.363 . . . . 0.0 112.184 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -65.8 -31.67 72.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.807 -1.542 . . . . 0.0 111.658 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.13 -38.79 83.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.077 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 15' ' ' THR . 74.8 m -61.36 -51.68 67.82 Favored 'General case' 0 C--O 1.201 -1.488 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.641 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 94.7 mt -55.98 -46.64 80.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.513 1.149 . . . . 0.0 110.728 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HD23 ' A' ' 17' ' ' LEU . 29.5 mm -59.19 -41.88 85.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 112.793 -2.003 . . . . 0.0 110.895 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.93 -50.03 4.8 Favored Glycine 0 CA--C 1.553 2.415 0 CA-C-O 122.877 1.265 . . . . 0.0 110.499 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.3 m -58.0 -27.62 63.67 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 111.942 -2.129 . . . . 0.0 112.41 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.6 m -76.43 -32.65 58.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 13' ' ' ILE . 3.6 mm? -72.39 -25.21 61.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 19' ' ' ALA . 10.3 p -54.61 -52.23 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 120.451 1.478 . . . . 0.0 109.306 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -57.83 -31.46 66.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.014 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.26 -46.55 73.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.342 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 73.6 m -77.16 -22.53 52.38 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-O 120.906 0.384 . . . . 0.0 111.281 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 t -84.07 -18.19 37.79 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.003 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -80.98 -41.89 22.06 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.731 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.555 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -68.44 -39.51 16.03 Favored Pre-proline 0 N--CA 1.483 1.175 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 24' ' ' THR . 79.8 Cg_exo -47.44 -23.29 3.26 Favored 'Trans proline' 0 C--N 1.301 -1.974 0 C-N-CA 123.886 3.057 . . . . 0.0 115.642 -176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.93 -46.89 95.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.245 0.93 . . . . 0.0 110.068 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.6 tp -49.51 -27.96 4.92 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.4 t -70.41 -33.08 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 111.443 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -60.55 -42.51 91.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.217 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.28 -29.23 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 tp -75.83 -43.4 46.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 122.281 1.038 . . . . 0.0 110.353 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.79 -48.77 68.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.788 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 34' ' ' VAL . 35.2 m -53.74 -47.27 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 33' ' ' VAL . 56.0 t -58.21 -40.97 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 122.185 0.993 . . . . 0.0 108.384 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.6 93.77 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.67 -30.61 67.25 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.282 0.563 . . . . 0.0 110.214 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.759 ' O ' ' N ' ' A' ' 41' ' ' GLY . 66.1 m -60.91 -38.36 85.47 Favored 'General case' 0 C--O 1.203 -1.342 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.14 73.14 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.8 mp -73.94 -51.78 14.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.024 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.0 m -94.39 5.94 50.25 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.621 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.759 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 54.58 70.29 0.99 Allowed Glycine 0 N--CA 1.469 0.899 0 CA-C-N 115.117 -0.947 . . . . 0.0 114.541 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.38 20.46 17.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 117.991 0.895 . . . . 0.0 109.307 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HG22 ' A' ' 46' ' ' VAL . 92.5 mt -46.03 -55.69 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 15.0 p-10 -67.77 -38.42 83.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.65 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 47' ' ' LEU . 35.9 m-85 -58.65 -43.8 89.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.132 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 47' ' ' LEU . 29.0 m -9.92 -48.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -51.96 -49.15 63.77 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.368 0.604 . . . . 0.0 111.628 -178.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.6 mp -61.97 -57.7 22.29 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 37.1 Cg_endo -62.77 -27.96 75.83 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.791 1.661 . . . . 0.0 112.699 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.11 -30.79 60.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 111.024 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 tp -65.49 -41.62 93.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.226 0.536 . . . . 0.0 110.083 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.01 93.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.588 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.78 -51.1 74.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.158 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.34 -41.67 94.07 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 118.457 0.571 . . . . 0.0 111.416 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.6 mm -64.53 -41.48 92.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.814 0.816 . . . . 0.0 109.352 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -40.57 96.97 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.252 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -70.87 -30.78 67.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -71.32 -41.13 70.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.911 0.386 . . . . 0.0 111.608 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 pt -64.79 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.482 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -50.11 -31.74 14.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.611 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.66 -26.38 61.61 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 pp -74.44 -37.02 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 119.027 0.83 . . . . 0.0 111.607 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -33.31 74.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.325 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.785 ' O ' ' N ' ' A' ' 68' ' ' ALA . 76.1 mtp85 -65.29 -53.25 46.78 Favored 'General case' 0 C--O 1.201 -1.452 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.57 177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.24 -25.08 12.95 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -82.61 -50.02 9.22 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.65 1.114 . . . . 0.0 112.247 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 70' ' ' ALA . 97.1 mt-30 -85.59 -10.17 56.26 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.79 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.785 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.65 -39.62 1.71 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.203 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.42 -51.63 68.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.9 -39.96 91.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.865 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t 52.26 48.15 23.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.521 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.0 p -155.07 162.04 41.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.502 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.6 p -70.53 149.86 95.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.091 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.62 -21.79 38.86 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.052 1.835 . . . . 0.0 111.806 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -153.58 159.59 42.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.595 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -138.25 101.97 4.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.205 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -63.39 -42.67 98.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.68 -170.73 54.92 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.3 t -121.18 127.36 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -60.81 -43.51 98.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 tptm . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.471 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -66.02 -44.77 83.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -131.74 71.13 80.99 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.63 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.07 -9.45 19.28 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.907 2.405 . . . . 0.0 112.922 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -78.38 -51.14 10.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 96.7 m -81.3 -31.07 33.76 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.433 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.08 -46.98 86.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.322 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.5 mp -77.05 -20.65 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.653 1.181 . . . . 0.0 112.129 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -66.1 -33.34 75.57 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.921 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.14 -39.29 82.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' THR . 80.8 p -64.09 -53.19 53.65 Favored 'General case' 0 C--O 1.205 -1.247 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 13' ' ' ILE . 12.6 pt -53.35 -45.81 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 122.337 1.065 . . . . 0.0 111.451 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.407 ' H ' HG13 ' A' ' 12' ' ' ILE . 79.3 mt -60.42 -44.09 95.43 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 CA-C-N 113.196 -1.82 . . . . 0.0 112.146 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.91 -29.25 26.53 Favored Glycine 0 CA--C 1.551 2.312 0 CA-C-O 122.399 1.0 . . . . 0.0 112.183 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 11' ' ' SER . 50.1 m -75.64 -27.88 58.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 112.988 -1.606 . . . . 0.0 112.6 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.3 m -77.3 -32.93 55.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.5 tp -74.07 -27.38 60.88 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 68.1 t -60.32 -52.3 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 117.667 -1.613 . . . . 0.0 109.835 -177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.62 69.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.543 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 20' ' ' LEU . 2.1 tt -68.29 -47.17 68.35 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.231 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.474 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 86.3 p -75.81 -18.95 59.3 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.918 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 t -75.42 -16.98 60.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -40.24 22.18 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.796 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.539 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -67.38 -39.76 22.41 Favored Pre-proline 0 N--CA 1.481 1.089 0 CA-C-N 120.692 1.587 . . . . 0.0 114.719 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 24' ' ' THR . 69.9 Cg_exo -45.08 -22.78 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 124.051 3.167 . . . . 0.0 114.987 -177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.0 t -60.79 -44.71 98.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.78 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 27' ' ' LEU . 11.3 mp -49.6 -26.7 3.79 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.18 -33.35 60.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -51.7 -33.12 14.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.81 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.79 -29.82 65.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 tp -75.7 -42.92 49.68 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.36 1.076 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.26 -47.5 84.11 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 113.345 -1.752 . . . . 0.0 112.677 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 34' ' ' VAL . 30.8 m -52.98 -45.91 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.469 ' N ' HG23 ' A' ' 33' ' ' VAL . 53.7 t -58.46 -39.04 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.304 1.049 . . . . 0.0 108.269 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.99 95.61 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.04 -29.75 66.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.733 -0.733 . . . . 0.0 110.507 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' GLY . 67.1 m -60.52 -38.59 84.88 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.39 71.6 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.02 -53.76 6.7 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.132 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' GLY . 81.5 p -107.42 -13.48 15.08 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 49.4 115.19 0.01 OUTLIER Glycine 0 N--CA 1.47 0.947 0 CA-C-N 114.678 -1.146 . . . . 0.0 113.855 177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.561 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -129.12 23.31 5.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.852 -179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -46.09 -62.44 1.33 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -67.66 -41.9 83.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.246 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.608 ' O ' ' N ' ' A' ' 47' ' ' LEU . 66.1 m-85 -59.26 -46.53 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.454 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.7 p -10.77 -48.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -52.06 -49.79 62.8 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.167 0.508 . . . . 0.0 111.842 -178.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.61 -56.74 30.16 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 45' ' ' TYR . 30.1 Cg_endo -60.2 -25.52 80.24 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.723 1.616 . . . . 0.0 112.277 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.93 -29.83 65.98 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.09 -38.23 90.3 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.14 97.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.049 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.91 -51.74 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.504 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' HG23 ' A' ' 58' ' ' THR . 84.5 t80 -59.06 -40.81 86.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.654 0.661 . . . . 0.0 110.205 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 58' ' ' THR . 6.1 mm -64.4 -41.74 93.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.8 0.81 . . . . 0.0 109.023 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.05 97.92 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.073 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.37 -51.0 69.34 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 54' ' ' PHE . 41.3 p -51.62 -38.68 55.74 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.916 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.2 mt -65.29 -44.39 94.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.345 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.94 -34.54 20.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.11 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -62.6 -52.49 63.17 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -49.44 -38.63 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.345 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -67.27 -43.54 81.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.313 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' ALA . 78.6 ttt-85 -79.38 -21.5 45.63 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.651 0.78 . . . . 0.0 112.823 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.9 ttmt -72.27 -31.34 65.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -77.2 -60.06 2.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 70' ' ' ALA . 77.1 mt-30 -61.95 -14.45 34.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.82 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -42.92 -38.01 2.06 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -59.92 -56.97 15.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.088 175.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -62.14 -40.27 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.585 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 72' ' ' SER . 5.1 t 62.15 70.79 0.56 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 71' ' ' SER . 4.0 p 85.16 141.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.903 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.9 m -56.82 112.24 4.3 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.638 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.82 141.83 95.96 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.663 1.575 . . . . 0.0 112.223 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -75.29 -12.34 60.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.871 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -67.11 -31.96 72.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.728 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -59.6 -41.89 91.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.484 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.84 -158.13 52.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 t 57.55 54.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.349 . . . . 0.0 110.45 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -61.96 -22.51 65.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.262 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -152.86 42.01 0.6 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.312 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.29 150.88 97.12 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.104 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.12 -14.59 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.462 2.108 . . . . 0.0 113.494 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -77.63 -52.14 9.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.433 0.635 . . . . 0.0 112.63 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.5 m -80.45 -30.43 37.55 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.422 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -63.09 -47.91 80.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.439 -1.709 . . . . 0.0 109.998 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.36 -21.0 56.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.779 1.231 . . . . 0.0 112.247 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 13' ' ' ILE . 72.7 ttt-85 -66.52 -33.35 75.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.872 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.4 t -68.07 -38.63 80.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 15' ' ' THR . 67.2 m -71.16 -52.54 18.63 Favored 'General case' 0 C--O 1.199 -1.553 0 C-N-CA 118.928 -1.109 . . . . 0.0 112.311 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 16' ' ' THR . 97.2 mt -57.78 -49.81 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-O 122.395 1.093 . . . . 0.0 112.763 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 9' ' ' ARG . 2.2 pp -58.23 -37.1 60.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.48 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.35 -50.93 4.09 Favored Glycine 0 CA--C 1.554 2.498 0 CA-C-O 122.991 1.329 . . . . 0.0 111.103 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 11' ' ' SER . 66.3 m -57.29 -27.39 62.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 111.839 -2.181 . . . . 0.0 112.536 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 12' ' ' ILE . 37.9 p -76.22 -29.14 57.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.357 . . . . 0.0 111.297 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.8 mt -70.83 -24.52 62.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.627 HG13 ' N ' ' A' ' 19' ' ' ALA . 11.3 p -54.06 -51.63 44.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.028 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.627 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -56.49 -30.7 63.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.413 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -69.15 -47.97 63.58 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.519 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 25' ' ' PRO . 86.1 p -76.48 -21.92 55.2 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.382 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.0 m -84.31 -15.52 46.32 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.577 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -82.53 -42.46 18.35 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.633 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -69.42 -37.62 8.86 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -176.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.677 ' O ' HG22 ' A' ' 28' ' ' VAL . 84.5 Cg_exo -47.18 -23.11 2.69 Favored 'Trans proline' 0 N--CA 1.504 2.088 0 C-N-CA 124.029 3.153 . . . . 0.0 115.931 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 27' ' ' LEU . 7.7 p -58.59 -41.62 82.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.628 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 ' N ' HG13 ' A' ' 26' ' ' VAL . 55.6 tp -50.08 -27.95 6.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.8 m -70.25 -29.41 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.081 0.467 . . . . 0.0 111.709 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.5 mt -59.25 -42.52 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.8 tt -51.42 -53.28 38.35 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.2 mp -54.13 -40.14 67.11 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.81 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.16 99.22 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' SER . 59.8 t -55.39 -48.95 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.54 -38.87 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.57 -43.63 95.99 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.07 -29.75 66.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.676 -0.762 . . . . 0.0 110.6 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 41' ' ' GLY . 30.3 t -59.48 -39.44 83.72 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.82 75.83 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 tp -77.92 -54.41 6.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.217 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' GLY . 67.2 p -107.92 -13.2 15.03 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 50.19 113.84 0.01 OUTLIER Glycine 0 N--CA 1.469 0.86 0 CA-C-N 115.069 -0.968 . . . . 0.0 113.133 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -131.75 22.78 4.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.898 0.479 . . . . 0.0 110.235 -178.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 46' ' ' VAL . 10.4 mp -45.24 -58.62 3.14 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 p-10 -65.48 -39.37 91.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.353 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.601 ' O ' ' N ' ' A' ' 47' ' ' LEU . 29.6 m-85 -58.23 -41.77 84.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.05 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 43' ' ' LEU . 31.5 m -10.74 -49.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' TYR . 59.8 tp -55.74 -47.95 76.08 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.093 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD13 HD22 ' A' ' 51' ' ' LEU . 4.3 mm? -59.38 -57.4 27.27 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.402 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.76 -25.2 5.55 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.056 1.837 . . . . 0.0 112.795 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.39 -30.84 71.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.474 0.178 . . . . 0.0 110.643 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.0 mp -64.96 -40.11 94.51 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.534 0.683 . . . . 0.0 109.388 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.86 -44.09 97.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.357 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.62 -50.82 78.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.708 -0.397 . . . . 0.0 109.967 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -60.17 -40.41 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.475 0.58 . . . . 0.0 110.433 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 51' ' ' LEU . 1.4 mp -67.67 -42.63 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.7 -42.41 97.23 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.862 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -64.71 -51.27 63.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 93.5 m -51.9 -41.96 62.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.382 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -65.23 -44.23 95.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.356 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -55.55 -35.2 65.44 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.06 -26.55 63.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.86 -41.47 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 63' ' ' GLN . 9.6 pt20 -69.23 -37.64 78.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.545 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 68' ' ' ALA . 31.3 ptt180 -78.89 -19.76 51.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.127 0.571 . . . . 0.0 112.282 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -72.24 -28.01 62.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.285 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -77.59 -60.32 2.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.42 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 89.0 mt-30 -61.49 -14.52 29.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.657 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -43.46 -38.96 3.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.764 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 16.3 p-10 -55.54 -57.72 10.76 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' N ' ' OD1' ' A' ' 69' ' ' ASP . . . -61.45 -39.6 91.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 72' ' ' SER . 4.7 t 64.92 47.85 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.467 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . 10.5 m 59.93 138.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.524 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.465 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -152.63 -63.53 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.652 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 73' ' ' THR . 55.9 Cg_endo -67.38 147.22 77.34 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 121.959 1.773 . . . . 0.0 111.876 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.12 -44.79 96.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.576 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -156.86 -14.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.1 43.19 30.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.57 136.6 13.17 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.98 -45.44 98.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.753 0.311 . . . . 0.0 110.306 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -86.58 148.08 25.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.555 179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 82.9 tttt 48.39 53.35 12.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.087 0.47 . . . . 0.0 109.748 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -72.11 149.81 92.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.659 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.54 67.75 7.11 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.403 2.069 . . . . 0.0 111.388 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -78.19 -51.43 10.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.523 0.678 . . . . 0.0 112.063 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -81.04 -30.43 34.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.838 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.48 -43.44 97.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.27 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.7 tp -77.85 -23.39 48.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.335 1.454 . . . . 0.0 112.518 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -67.42 -32.03 72.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.863 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.09 -40.73 81.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 15' ' ' THR . 47.1 t -63.75 -52.59 59.69 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 119.464 1.029 . . . . 0.0 111.051 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.8 mt -55.82 -46.53 79.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.779 1.276 . . . . 0.0 110.863 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mm -58.99 -42.32 85.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 112.489 -2.141 . . . . 0.0 110.832 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.15 -50.61 4.49 Favored Glycine 0 CA--C 1.551 2.324 0 CA-C-O 122.924 1.291 . . . . 0.0 110.623 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.707 ' N ' ' O ' ' A' ' 11' ' ' SER . 31.9 m -57.03 -27.85 62.0 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.005 -2.097 . . . . 0.0 112.478 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -76.86 -32.39 57.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.882 0.372 . . . . 0.0 111.868 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.07 -25.01 59.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.656 HG23 ' N ' ' A' ' 19' ' ' ALA . 32.3 m -61.74 -55.3 25.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.976 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.656 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -57.6 -31.76 66.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.068 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.47 -43.11 91.29 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.406 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 83.8 p -75.75 -17.64 59.83 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 121.131 0.491 . . . . 0.0 110.574 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.9 p -76.66 -15.5 59.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.821 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -84.47 -41.19 16.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.869 -1.06 . . . . 0.0 113.272 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -68.1 -38.52 13.97 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 120.869 1.668 . . . . 0.0 114.2 -177.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.678 ' O ' HG22 ' A' ' 28' ' ' VAL . 79.5 Cg_exo -46.35 -23.45 2.07 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.877 3.052 . . . . 0.0 114.847 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 27' ' ' LEU . 10.5 p -59.0 -42.31 85.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.642 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' N ' HG13 ' A' ' 26' ' ' VAL . 57.1 tp -49.85 -27.87 5.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 25' ' ' PRO . 2.1 m -71.01 -29.3 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.197 0.522 . . . . 0.0 111.27 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.2 mm -60.93 -43.06 95.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 30' ' ' LEU . 4.1 mm? -55.64 -52.11 64.91 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.553 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 31' ' ' LEU . 4.0 mm? -55.41 -41.27 72.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.689 -0.804 . . . . 0.0 109.88 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -63.51 -44.14 97.08 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.98 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.73 -50.66 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.24 -42.07 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.299 1.047 . . . . 0.0 108.871 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -45.32 95.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 32' ' ' GLY . 8.4 mp -71.27 -30.81 66.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.31 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.716 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.7 p -60.55 -35.58 76.37 Favored 'General case' 0 C--O 1.204 -1.338 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.55 76.88 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.137 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 39' ' ' LEU . 4.1 mm? -74.96 -51.63 13.21 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.285 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.4 p -96.73 3.75 52.19 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.655 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.716 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 55.47 70.18 1.04 Allowed Glycine 0 N--CA 1.469 0.884 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.0 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.59 19.8 18.84 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.069 0.935 . . . . 0.0 109.541 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 46' ' ' VAL . 90.2 mt -45.84 -56.75 4.99 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -66.48 -39.48 88.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.917 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.602 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.8 m-85 -57.41 -41.22 79.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.974 -0.536 . . . . 0.0 111.12 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.1 t -11.04 -49.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' TYR . 4.0 mm? -54.31 -47.84 71.99 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 mp -61.14 -59.11 14.78 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -47.64 -24.88 4.95 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.793 1.662 . . . . 0.0 112.59 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . -66.48 -29.96 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.853 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.5 mm? -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.432 0.634 . . . . 0.0 109.554 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.01 97.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.606 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -62.75 -51.05 76.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.605 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.97 -40.52 85.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 118.657 0.662 . . . . 0.0 110.5 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.31 -42.36 93.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.764 0.792 . . . . 0.0 109.781 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.28 -43.48 96.9 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.225 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.49 -49.8 73.95 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.769 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.7 m -52.95 -41.95 65.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -65.14 -44.16 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.768 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.05 -39.86 72.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -72.77 -53.86 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.082 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 97.4 mt -50.18 -45.2 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 67' ' ' GLN . 3.2 pp0? -68.46 -33.8 74.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.086 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 38.4 ttp180 -78.02 -21.81 50.18 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.137 0.975 . . . . 0.0 111.593 178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' ALA . 18.8 tptm -76.54 -33.71 58.55 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -83.24 -39.74 20.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.596 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 70' ' ' ALA . 10.7 pt20 -86.13 -11.59 52.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.624 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 64' ' ' ARG . . . -41.82 -39.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.791 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -60.81 -51.85 67.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -62.37 -40.44 96.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.483 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 70' ' ' ALA . 2.7 p 78.34 162.89 0.21 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.275 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -60.84 -41.34 95.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.473 ' OG1' ' CG2' ' A' ' 15' ' ' THR . 37.9 p -125.06 80.47 64.12 Favored Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.525 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.96 -39.11 69.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.77 2.314 . . . . 0.0 112.589 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp 51.88 44.27 29.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.496 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -127.77 128.04 44.64 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.0 t30 62.61 155.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.589 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.68 -173.83 46.4 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.75 138.77 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.426 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.48 145.18 45.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 tptp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.463 179.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -62.16 -39.81 93.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.898 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 48.74 57.05 18.4 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.39 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.15 -14.37 37.9 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 123.008 2.472 . . . . 0.0 112.704 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -77.73 -51.02 11.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.1 p -80.99 -29.87 35.15 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.134 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.71 -46.38 88.4 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.703 -1.59 . . . . 0.0 110.233 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.46 -21.12 53.39 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.573 1.149 . . . . 0.0 112.397 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' ILE . 67.0 ttt180 -68.25 -36.56 79.64 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.141 -1.39 . . . . 0.0 113.382 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.8 m -73.5 -32.51 36.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 15' ' ' THR . 69.2 m -74.42 -53.88 8.69 Favored 'General case' 0 C--O 1.202 -1.427 0 CA-C-N 119.97 1.259 . . . . 0.0 111.866 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 13' ' ' ILE . 23.5 pt -54.72 -48.83 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 122.501 1.143 . . . . 0.0 112.686 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' N ' HG13 ' A' ' 12' ' ' ILE . 19.9 tt -59.54 -38.81 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 112.856 -1.975 . . . . 0.0 110.908 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.28 -51.79 3.81 Favored Glycine 0 CA--C 1.549 2.171 0 CA-C-O 122.963 1.313 . . . . 0.0 110.448 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.658 ' N ' ' O ' ' A' ' 11' ' ' SER . 36.3 m -56.93 -27.54 61.11 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 111.851 -2.174 . . . . 0.0 112.222 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -77.4 -32.77 55.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.8 tp -74.03 -26.52 60.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 66.3 t -59.41 -51.7 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 117.668 -1.613 . . . . 0.0 109.313 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.09 -32.23 69.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.522 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.82 -44.33 81.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.045 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 36.8 t -75.9 -23.64 55.55 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.017 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 53.7 p -70.29 -13.49 62.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.867 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -80.36 -39.92 27.61 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.702 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 27.3 m -64.79 -39.24 37.11 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.673 1.578 . . . . 0.0 115.158 -177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 70.9 Cg_exo -44.41 -21.9 0.5 Allowed 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.692 2.928 . . . . 0.0 115.386 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.2 t -60.38 -44.4 95.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 119.271 0.941 . . . . 0.0 110.172 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? -49.16 -26.28 2.72 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 25' ' ' PRO . 2.8 p -69.0 -29.94 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.713 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -57.11 -34.12 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.819 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 30' ' ' LEU . 1.3 tt -56.62 -52.85 63.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.447 0.567 . . . . 0.0 110.614 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.91 -40.26 75.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.678 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.63 -43.64 98.7 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 37' ' ' SER . 54.3 t -56.62 -50.35 74.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.76 -42.64 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.24 -44.99 96.06 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.9 tp -69.42 -33.3 72.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.535 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 41' ' ' GLY . 73.3 m -61.96 -39.77 93.29 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.07 -37.78 75.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.96 -53.62 6.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.883 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 m -107.83 -16.23 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 57.01 94.4 0.01 OUTLIER Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.966 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.92 20.89 13.65 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 46' ' ' VAL . 91.8 mt -46.26 -56.82 5.22 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -63.94 -41.15 97.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.164 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.742 ' O ' ' N ' ' A' ' 47' ' ' LEU . 36.6 m-85 -55.77 -41.65 74.33 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.492 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 43' ' ' LEU . 9.8 p -20.56 -14.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.742 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.8 tt -88.65 -47.03 8.56 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.047 0.84 . . . . 0.0 110.15 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -60.5 -45.51 97.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.577 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 48' ' ' LEU . 55.9 Cg_endo -68.35 -25.29 36.21 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.576 1.518 . . . . 0.0 112.453 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.68 -30.1 63.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.648 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.26 -39.05 93.15 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.36 92.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.162 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mm -62.29 -50.84 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.533 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' THR . 60.6 m-85 -59.74 -38.64 82.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.055 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.406 ' O ' ' OG1' ' A' ' 58' ' ' THR . 87.8 mt -65.02 -41.14 91.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.837 0.827 . . . . 0.0 109.127 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.47 -41.94 99.14 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.109 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.01 -49.62 75.29 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.817 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PHE . 50.1 p -51.56 -37.92 51.9 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.292 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.86 -44.72 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.192 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -48.17 -33.15 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.321 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.85 63.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.6 mp -73.76 -43.27 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 118.397 0.544 . . . . 0.0 112.2 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.2 -39.94 93.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.417 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.733 ' O ' ' N ' ' A' ' 68' ' ' ALA . 15.9 mmm180 -66.26 -54.48 24.41 Favored 'General case' 0 C--O 1.204 -1.299 0 C-N-CA 118.894 -1.123 . . . . 0.0 108.515 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -52.03 -25.74 9.24 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -83.63 -51.89 6.91 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 119.354 0.979 . . . . 0.0 113.146 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' ALA . 8.8 pt20 -86.47 -11.47 51.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.595 1.158 . . . . 0.0 112.725 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' ARG . . . -41.75 -42.89 2.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.274 -174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.79 -50.27 74.48 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -61.48 -38.9 88.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.916 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.41 ' OG ' ' NH1' ' A' ' 64' ' ' ARG . 28.6 t -57.45 -17.08 11.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.202 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.2 m -59.15 -40.84 86.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.967 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.401 ' N ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -178.36 -56.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.069 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 73' ' ' THR . 73.5 Cg_endo -72.36 151.32 53.85 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.945 1.763 . . . . 0.0 112.392 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? 46.13 90.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.789 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -138.52 127.5 23.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.379 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 63.8 t30 54.2 42.87 31.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.449 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.65 -131.84 52.25 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.02 141.91 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.797 0.332 . . . . 0.0 110.481 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptp 50.64 -136.87 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.537 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.408 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt 53.91 42.02 31.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 23.7 p-10 -132.62 59.27 42.09 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-O 120.761 0.315 . . . . 0.0 110.997 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.7 65.88 7.49 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -78.15 -50.38 12.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.723 0.773 . . . . 0.0 112.244 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 79.3 p -80.91 -29.97 35.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.007 -1.451 . . . . 0.0 111.043 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.47 -43.15 98.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.58 -1.645 . . . . 0.0 109.653 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.6 -23.0 46.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.4 1.48 . . . . 0.0 112.918 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -67.78 -35.03 77.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 113.868 -1.514 . . . . 0.0 113.524 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.9 m -72.01 -31.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 15' ' ' THR . 46.9 t -68.56 -53.5 22.56 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 120.037 1.289 . . . . 0.0 111.249 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 16' ' ' THR . 17.3 tt -53.99 -44.92 63.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 122.505 1.145 . . . . 0.0 110.781 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' N ' HG23 ' A' ' 12' ' ' ILE . 72.8 mt -59.48 -41.93 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 113.008 -1.906 . . . . 0.0 111.535 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.57 -51.21 4.16 Favored Glycine 0 CA--C 1.548 2.101 0 CA-C-O 122.936 1.298 . . . . 0.0 110.589 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 11' ' ' SER . 32.3 m -56.91 -28.83 62.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 111.875 -2.162 . . . . 0.0 113.085 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 12' ' ' ILE . 33.2 p -78.09 -30.01 49.38 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.802 -0.561 . . . . 0.0 112.104 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -74.14 -27.54 60.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.98 -52.26 63.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 117.598 -1.641 . . . . 0.0 109.681 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.29 -31.92 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.982 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 20' ' ' LEU . 3.1 tt -67.7 -44.61 77.32 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.673 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD ' ' A' ' 25' ' ' PRO . 80.5 p -75.17 -16.28 60.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.027 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -78.26 -19.12 54.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.496 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.1 -41.46 17.09 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.308 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.2 p -68.92 -37.2 8.91 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 120.837 1.653 . . . . 0.0 115.027 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.67 ' O ' HG12 ' A' ' 28' ' ' VAL . 82.5 Cg_exo -47.13 -22.96 2.51 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 123.893 3.062 . . . . 0.0 115.041 -176.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 27' ' ' LEU . 33.9 m -57.98 -38.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.806 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HG23 ' A' ' 26' ' ' VAL . 93.7 mt -50.52 -26.52 5.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 25' ' ' PRO . 3.9 p -70.16 -29.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.474 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 92.4 mt -60.11 -41.57 86.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.216 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.35 -50.74 71.98 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.009 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.0 mp -56.14 -40.62 74.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 119.054 0.843 . . . . 0.0 110.178 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.22 -43.59 98.33 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.26 -50.25 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.1 -42.22 85.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 122.161 0.981 . . . . 0.0 109.01 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.22 -46.09 94.35 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.6 -31.08 67.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.311 0.577 . . . . 0.0 110.649 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' GLY . 47.0 t -61.51 -41.35 97.17 Favored 'General case' 0 C--O 1.207 -1.133 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.92 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.21 -36.77 76.0 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.824 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.82 -51.49 13.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.244 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.1 p -95.77 4.83 52.56 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' SER . . . 53.47 72.88 0.47 Allowed Glycine 0 N--CA 1.469 0.858 0 CA-C-N 115.613 -0.722 . . . . 0.0 114.015 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.62 20.6 15.82 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -46.27 -55.59 6.99 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 19.6 p-10 -68.31 -38.83 82.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.906 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.618 ' O ' ' N ' ' A' ' 47' ' ' LEU . 41.3 m-85 -58.98 -41.37 87.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.784 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 47' ' ' LEU . 11.8 p -11.27 -47.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 45' ' ' TYR . 97.3 mt -55.65 -46.41 77.5 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.081 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' TYR . 2.7 mt -62.67 -59.95 11.24 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.341 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.9 -26.08 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.509 1.472 . . . . 0.0 112.066 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.14 66.41 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.017 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.13 -39.54 93.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.521 0.677 . . . . 0.0 109.484 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.77 97.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.428 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.93 -50.91 77.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.495 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -59.5 -41.44 89.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.63 0.65 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.6 -43.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 0.0 109.983 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.32 -43.2 97.25 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.925 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 62.7 tp -62.56 -50.62 70.61 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.4 m -53.3 -42.26 66.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.016 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -43.68 96.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.738 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.48 -37.32 72.73 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' LYS . . . -74.16 -55.49 6.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.007 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 62' ' ' ILE . 29.2 pt -50.59 -38.01 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.031 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.629 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 20.6 pt20 -70.02 -36.83 75.38 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.87 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -78.11 -20.36 52.32 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.697 0.799 . . . . 0.0 111.424 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 61' ' ' ALA . 38.4 ttpt -71.52 -31.21 66.81 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.645 -1.161 . . . . 0.0 113.897 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -78.08 -60.84 2.21 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 4.0 mp0 -60.68 -12.68 11.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.752 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -31.91 0.52 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.958 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -54.48 -55.56 27.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' GLN . . . -60.39 -40.16 89.92 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 p 64.78 11.92 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.727 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 94.3 p -153.96 161.77 41.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.52 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.451 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -156.39 -62.25 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.431 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 73' ' ' THR . 61.0 Cg_endo -69.56 149.68 68.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.009 1.806 . . . . 0.0 111.965 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -150.21 136.91 19.14 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -127.2 145.35 50.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.508 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -61.35 -40.71 95.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.458 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -144.39 162.65 27.92 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.43 -34.51 61.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.731 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.08 131.58 47.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.375 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.555 -179.959 . . . . . . . . 0 0 . 1 stop_ save_